The Poisons Regulations of 1973 Queensland Reprint Reprinted As At

Warning

“Queensland Statute Reprints” QUT Digital Collections

This copy is not an authorised reprint within the meaning of the Reprints Act 1992 (Qld). This digitized copy of a Queensland legislation pamphlet reprint is made available for non-commercial educational and research purposes only. It may not be reproduced for commercial gain.

©State of Queensland

QUEENSLAND

The Poisons Regulations of 1973

Published in Queensland Government Gazette dated lOth August, 1973, Vol. CCXLIII, No. 114, pages 2505-2621; as amended by Regulations published in Gazettes dated- 25th May, 1974, Vol. CCXLVI, No. 20, pages 581-86; 22nd February, 1975, Vol. CCXLVIII, No. 28, page 646; 15th March, 1975, Vol. CCXLVIII, No. 44, page 974; 2nd August, 1975, Vol. CCXLIX, No. 87, page 1606; 23rd August, 1975, Vol. CCXLIX, No. 98, page 1874; 15th November, 1975, Vol. CCL, No. 55, page 1101; 24th January, 1976, Vol. CCLI, No. 9, pages 213-28; 5th June, 1976, Vol. CCLII, No. 60, pages 777-84; 20th August, 1977, Vol. CCLV, No. 105, pages 2075-81; 26th November, 1977, Vol. CCL VI, No. 64, pages 1201; 24th December, 1977, Vol. CCLVI, No. 81, pages 1713-14; 15th July, 1978, Vol. CCLVIII, No. 86, page 1317; 9th September, 1978, Vol. CCLIX, No. 4, page 123; 21st July, 1979, Vol. CCLXI, No. 86, page 1628; 15th September, 1979, Vol. CCLXII, No. 13, page 281; 20th October, 1979, Vol. CCLXII, No. 35, page 786; lOth May, 1980, Vol. CCLXIV, No. 11, pages 143-67; 9th August, 1980, Vol. CCLXIV, No. 103, page 2282; 20th September, 1980, Vol. CCLXV, No. 17, page 331; 20th December, 1980, Vol. CCLXV, No. 81, page 1619; 31st January, 1981, Vol. CCLXVI, No. 13, page 293; 25th July, 1981, Vol. CCLXVII, No. 104, pages 2088-89; 12th September, 1981, Vol. CCLXVIII, No. 12, pages 149-50; 30th January, 1982, Vol. CCLXIX, No. 20, page 333; 6th February, 1982, Vol. CCLXIX, No. 26, page 429; 8th May, 1982, Vol. CCLXX, No. 21, pages 278-80; 28th August, 1982, Vol. CCLXX, No. 148, page 2844; 2nd October, 1982, Vol. CCLXXXI, No. 24, page 487; 11th December, 1982, Vol. CCLXXI, No. 84, page 1441; 5th March, 1983, Vol. CCLXXII, No. 43, pages 807-30; and 6th August, 1983, Vol. CCLXXIII, No. 101, pages 1937-55.

Extracts from the Health Act 1937-1982

65558-By Authority: S. R. HAMPSON, Government Printer, Queensland-·1984 CONTENTS

PAGE

THE POISONS REGULATIONS OF 1973 .. 1

EXTRACTS FROM THE HEALTH AcT 1937-1982 177

ALPHABETICAL SUBSTANCES INDEX 193

GENERAL INDEX 214 "THE POISONS REGULATIONS OF 1973

Department of Health, Brisbane, 9th August, 1973. HIS Excellency the Governor, acting by and with the advice of the Executive Council, has, in pursuance of the provisiOJlS of the Health Act 1937-1973, been pleased to approve of the following Regulations made by the Director-General of Health and Medical Services for the State of Queensland. S.D. TOOTH.

WHEREAS, by the Health Act 1937-1973, it is amongst other things enacted that the Director-General may make Regulations: Now, there fore, the Director-General, with the approval of His Excellency the Governor, with the advice of the Executive Council, doth hereby make the following Regulations:- PRELIMINARY 1. These Regulations may be cited as "The Poisons Regulations of 1973" and shall come into force on the First day of October, 1973.

2. "The Poisons Regulations of 1967", as well as all subsequent Regulations made in amendment thereof, are hereby repealed as from the coming into force of these Regulations: Provided that such repeal shall not- (a) Affect any previous operation of a repealed Regulation or Regulations or anything duly done or suffered thereunder; or (b) Affect a right, privilege, obligation or liability acquired, accrued or incurred under a repealed Regulation or Regulations; or (c) Affect a penalty, forfeiture or punishment incurred in respect of an offence committed against a repealed Regulation or Regulations; or (d) Affect an investigation, legal proceeding, or remedy in respect of any such right, privilege, obligation, liability, penalty, forfeiture or punishment as aforesaid: And provided further that such investigation, legal proceeding, or remedy may be instituted, continued or enforced, and such penalty, forfeiture or punishment may be imposed as if the repealed Regulation or Regulations had not been repealed. 2 The Poisons Regulations of 1973

3. These Regulations are divided into Parts as follows:- Part A-Definitions, Licensing Requirements Regulation Al. Definitions Regulation A2. Poisons, Restricted Drugs and Dangerous Drugs Regulation A3. New Drugs ~egulation A4. New Poisons Regulation AS. Prohibited Drugs Regulation A6. Certain Drugs Subject to Approval Regulation A 7. Prescribing, Dispensing and Selling Poisons Regulation AS. Limited Authorities to Sell Poisons Regulation A9. Prohibition of Sale of Poisons to Minors Regulation AlO. Wholesale Licence Regulation All. General Licence Regulation Al2. Licence to Sell Photographic Poisons Regulation Al3. Licence to sell Poisons for Purposes other than Human Therapeutic Use Regulation Al4. Employees and other Persons Authorized Regulation Al5. General Conditions of Licences. Part B-Paddng and Labelling Regulation Bl. Packing Regulation B2. Labelling-General Regulation B3. Immediate Container and Primary Pack Regulation B4. Immediate Wrapper Regulation B5. Selected Containers Regulation B6. Special Warnings Regulation B7. First Aid Measures Regulation B8. Dispensed Medicines Regulation B9. Offences. Part C-Storage and Sale of Poisons, Keeping of Records, Special Provisions concerning certain Poisons Regulation Cl. Keeping and Storage of Poisons Regulation C2. Records of Sales of Poisons Regulation C3. Sale and Use of Cyanide Regulation C4. Restricted Sales of F1uoroacetic Acid and Thallium Regulation C5. Restrictions on Packs of Organo-Phosphorus Compounds Regulation C6. Use of Arsenical Preparations for Jetting Sheep. Part D-Prohibitions and Authorities in respect of Dangerous Drugs, Restricted Drugs and Prohibited Plants Regulation Dl. Prohibitions Regulation D2. Authorities Regulation D3. Suspension Etc. The Poisons Regulations of 1973 3

Part E--Licences and Obligations for the Manufacture or Sale by Wholesale of Dangerons Drugs Regulation El. Licence to Manufacture Dangerous Drugs Regulation E2. Licence to Sell Dangerous Drugs by Wholesale Regulation E3. General Conditions of Licences Regulation E4. Records of Transactions in Dangerous Drugs Regulation E5. Reports of Transactions in Dangerous Drugs. Part F-Licences and Obligations for ,the Manufacture or Sale by Wholesale of Restricted Drugs Regulation Fl. Licence to Manufacture Restricted Drugs Regulation F2. Licence to Sell Restricted Drugs by Wholesale Regulation F3. General Conditions of Licences Regulation F4. Supply of Samples Regulation F5. Records of Transactions in Restricted Drugs Regulation F6. Wholesale Representative's Authority. Part G-Obtaining of Drugs on Written Order Regulation G 1. Authorised Persons to Obtain on Written Order Regulation G2. Delivery of Dangerous and Restricted Drugs Regulation G3. Endorsing and Disposal of Written Orders Regulation G4. Supplies of Drugs to Ships. Part H-Prescribing and Dispensing of Drugs Regulation Hl. Prescription Necessary to Dispense Regulation H2. Writing of Prescriptions Regulation H3. Conditions of Dispensing Regulation H4. Interstate Prescriptions and the Like Regulation H5. Endorsing and Disposal of Prescriptions Regulation H6. Records to be Kept of Transactions in Dangerous Drugs Regulation H7. Records to be Kept of Transactions in Declared Drugs Regulation H8. Keeping and Storage of Drugs. Part 1-0bligations of Medical Practitioners, Veterinary Surgeons and Dentists Regulation 11. Records of Dangerous Drugs Regulation 12. To Use Samples Only in Profession Regulation 13. Keeping of Dangerous and Restricted Drugs. Part J-Drugs in Hospitals and Institutions Regulation Jl. Possession and Use of Dangerous and Restricted Drugs Regulation J2. Keeping and Storage of Drugs Regulation J3. Records of all Transactions in Dangerous Drugs to be Kept Regulation J4. Authority to Supply or Administer Drugs. 4 The Poisons Regulations of 1973

Part K-Storage of Dmgs and Keeping of Records Regulation Kl. Keeping of Dangerous Drugs and Restricted Drugs Regulation K2. Records in Connection with Dangerous Drugs and Restricted Drugs. Part L--Possession and Use of Drugs by Prescribees Regulation L1. Prescribees' Authorities and Duties Regulation L2. Exemption from Recording. Part M-Lengtby Treatment with and Addiction to Drugs Regulation M1. Director-General to be Notified of Lengthy Treatment Regulation M2. Approval of Director-General Necessary for Treatment of Addicts Regulation M3. Obligations of Medical Practitioners in Treatment of Addicts Regulation M4. Self-administration of Dangerous Drugs by Authorised Persons Prohibited. Part N-Offences in respect of Dangerous and Restricted Dmgs Regulation Nl. Forging and Uttering Prescriptions Regulation N2. False Representations Regulation N3. Failure to Disclose Information to Practitioners Regulation N4. Accounting for Dangerous Drugs Regulation NS. False Entries. Part 0-Miscellaneous Requirements Regulation 01. Embalming Regulation 02. Biological Preparations Regulation 03. Hawking of Poisons Regulation 04. Samples of Poisons Regulation 05. Colouring of Grain Baits Regulation 06. Vaporisers and Other Devices Regulation 07. Prohibition of Sale of Certain Pencils, Crayons and the Like Regulation 08. Safe Keeping of Poisons and Drugs Regulation 09. Food Containers Prohibited Regulation 010. Use and Disposal of Dangerous Drugs, Restricted Drugs and Poisons Regulation 011. Labels and Containers Regulation 012. Advertising of Drugs and Poisons Regulation 013. Fireworks. Part P-Powers of Inspectors and Police Regulation Pl. Powers of Police Regulation P2. Powers of Inspectors, their Obligations Regulation P3. Service of Notices Regulation P4. Obstruction. Part Q-Offences and Penalties Regulation Q 1. Offences Regulation Q2. Penalties. The Poisons Regulations of 1973 5

PART A-DEFINITIONS, LICENSING REQUIREMENTS Al. Definitions Al.Ol. In these Regulations, unless the context otherwise indicates the terms used shall have the meanings respectively assigned to them by Section 5 of the Health Act 1937-1973, and the following terms shall have and include the meanings set against them respectively, that is to say:- "Approved name"-The .first name of a substance specified in the following order of priority:- (a) The English name, not including synonyms, by which a substance is described in the British Pharmacopoeia, the Australian Pharmaceutical Formulary, the British Pharma ceutical Codex or the British Veterinary Codex; (b) The approved name given to a substance by the General Medical Council of Great Britain; (c) The common English name given to a substance by the British Standards Institution or the Standards Association of Australia or the International Organization for Standardization; (d) The International non-proprietary name given to a substance by the World Health Organization; (e) The United States of America Adopted Name for a substance; (f) The accepted scientific name or the name descriptive of the true nature and origin of a substance: Provided that the approved name of a dangerous drug included in the Schedules to the Single Convention on Narcotic Drugs, 1961 (as set out in the First Schedule to the Narcotic Drugs Act 1967 of the Commonwealth of Australia) as from time to time amended, shall be the name of such dangerous drug as used in such Schedules; "Class"-In relation to dangerous drugs and restricted drugs, a class consists of those dangerous drugs or restricted drugs of the same nominal description, which nominal description includes all particulars necessary to distinguish such dangerous drugs or restricted drugs from other dangerous drugs or restricted drugs or articles of any different description with respect to composition, form, strength and/ or quantity; "Compounded preparation"-A preparation compounded of two or more medicinally active constituents in such a way that the poison, restricted drug or dangerous drug contained therein cannot be readily extracted; "Cyanide"-Cyanide of potassium, cyanide of sodium, double cyanides of mercury and zinc, and all other compounds of cyanogen containing more than the equivalent of 0 · 15 per centum of HCN, except the ferrocyanides and the ferricyanides; 6 The Poisons Regulations of 1973

"Dispensary"-Any building or place or any portion of any building or place used or intended to be used by a pharmaceutical chemist to dispense drugs or poisons: the term includes a dispensary associated with any shop, hospital or other premises whatsoever. "Dispense" (with its derivatives) --Sell or supply upon a prescription, with or without preparation and whether or not the terms of such prescription are thereby wholly or correctly fulfilled; "Face-depth"-In relation to the size of letters, the height of letters as printed; "Hospital" includes any premises for the reception and treatment of the sick; "Immediate container" includes all forms of containers in which a dangerous drug, restricted drug or poison in any state is directly packed but does not include any such container intended for consumption, or any immediate wrapper; "Immediate wrapper"-Tin foil, plastic foil, waxed paper and any other such material not intended for consumption used as the first wrapper for a single tablet, capsule, pastille, dose of powder, or other discrete product unit; "Inspector"-An inspector appointed by the Governor in Council under the provisions of the Act; "Institution"-An Institution as defined under "The Charitable Institutions Management Act of 1885": the term also includes a premises, not being a hospital, which is conducted for reward for the care of the aged or infirm and/or persons convalescing from illness; "Internal Use"-In respect of a substance means administration orally, parenterally, or by way of a body orifice, but does not include topical use in the nose, eyes, ears, mouth or throat or use as a rectal, vaginal or urethral douche; "Main label"-The face of a label whereon the name of the product is most prominently shown: where the name of the product is equally prominent on two or more of such faces, each such face shall be considered to be a main label; "Manufacture" includes- ( a) the carrying out of any process by which a dangerous drug, restricted drug or poison may be obtained, including the refining of a dangerous drug, restricted drug or poison and the transformation of one dangerous drug, restricted drug or poison into another dangerous drug, restricted drug or poison; (b) the making or preparation of tablets, pills, capsules, ampoules, vials or the like articles consisting of or containing a dangerous drug, restricted drug or poison; The Poisons Regulations of 1973 7

(c) the mixing or compounding of a dangerous drug, restricted drug or poison with one or more other drugs, poisons or substances; (d) the packing or re-packing of a dangerous drug, restricted drug or poison, but does not include any act as described in clause (b) or clause (c) or clause (d) of this definition when performed by a pharmaceutical chemist or another authorised person in or in connection with the dispensing of a dangerous drug, restricted drug or poison at a dispensary; "Measure Pack" means an immediate container which:- ( a) contains a quantity of pesticide ready for dilution; and (b) when opened, is not capable of being reclosed. "New drug"-A drug for which a human therapeutic use is claimed and which- (a) is not included in a Schedule to these Regulations; or (b) is included in a Schedule to these Regulations and of which the method of manufacture, or composition, or dosage, or route of administration has been varied, or for which the claims have been varied: such term does not include- ( a) drugs already exempted by the Schedules to these Regulations; or (b) drugs, which, in the opinion of the Director-General do not warrant inclusion in a Schedule; "Part"-A part of these Regulations as set out in Regulation 3 of these Regulations; "Per centum", "per cent", "%"-Per centum by weight (weight in weight, and abbreviated to w jw) unless specifically stated to the contrary; "Prescription"-Except in the case of a verbal prescription as prescribed by subregulation H2.02 of these Regulations, a prescription means a written instrument by which a person directs or authorises the supply of a dangerous drug, restricted drug or poison for therapeutic use, and includes any writing purporting or appearing to be a prescription: such term does not include a written order as prescribed in Part G of these Regulations; "Primary pack"-The complete pack in addition to the immediate container as presented to the purchaser in a single retail sale, excluding any wrapping, bag, carton or similar article in which an immediate container is placed at the time of sale; "Regulation"-A Regulation of "The Poisons Regulations of 1973"; "Responsible person"-A person of eighteen years of age or over of normal intelligence; "Schedule"-A Schedule to these Regulations; 8 The Poisons Regulations of 1973

"Selected container" means- (a) An injection vial or ampoule having a capacity of ten millilitres or less; (b) A single use syringe; or (c) A container for substances for therapeutic use having a capacity of ten millilitres or less; "State analyst"-A person appointed pursuant to the provisions of the Act as a State Analyst; "The Act"-The Health Act 1937-1973, and any Act passed in amendment thereof or in substitution therefor; "Therapeutic use"-Use in or in connection with- ( a) the preventing, diagnosing, curing or alleviating of a disease, ailment, defect or injury in persons or animals; (b) the influencing, inhibiting or modifying of a physiological process in persons or animals; or (c) the testing of the susceptibility of persons or animals to a disease or ailment; "Transaction"---'-Every occurrence or event by which a substance comes into or passes out of the possession of a person, or by which the composition, form, strength and/ or mode of packing of a substance is or are altered: such term includes manufacturing, packing and re-packing processes and the transfer or movement of a substance with or without change of ownership from one premises or place to another, and whether or not any consideration is given or received; "Wholesale"-Sale or supply for the purpose of resale. A2. Poisons, Restricted Drngs and Dangerous Drugs A2.01. ·The substances specified in Schedules 1, 2, 3, 5, 6 and 7 are poisons. A2.02. The substances specified in Schedule 4 are restricted drugs. The Director-General, in his absolute discretion, may exempt from Schedule 4 a substance, which fs a,n ointment, liniment or other prepara tion for external use by humans or \'hich is for veterinary use and which, in his opinion, is not capable of bei*g used for consumption by man. A2.03. A substance for human use, exempted from Schedule 4 under the provisions of subregulation A2.02, shall be a poison and included in Schedule 3. A2.04. A substance for veterinary use, exempted from Schedule 4 under the provisions of subregulation A2.02, shall be a poison and included in Schedule 6. A2.05 (a) The substances specified in Schedule 8 are dangerous drugs. (b) The provisions of Regulations E4 and ES, Regulation G 1, The Poisons Regulations of 1973 9

Clause (b) of subregulation H5.01, Regulation H6, Regulations I 1 and I2, Regulations J3 and J 4, Subregulation K1.01, and Regulations M1 and M4 shall not apply to the following dangerous drugs:- Morphine in compounded preparations containing 0 · 1 per cent. or less of morphine calculated as anhydrous morphine, and Opium (excluding its alkaloids) in compounded preparations containing 0 · 1 per cent. or less of morphine calculated as anhydrous morphine. A2.06. Unless the context of a Schedule otherwise indicates or requires, each of the following substances is deemed to be specified in such Schedule:- ( a) A substance named or described, or if ail entry in a Schedule describes a group of substances every substance belonging to or coming within the description of such group; (b) An alkaloid or active principle of a substance specified in clause (a) hereof; (c) A salt or ester of a substance specified in clause (a) or clause (b) hereof; (d) A preparation, admixture or substance containing any proportion of a substance specified in clauses (a) , (b), or (c) hereof. A2.07. The following products, if they contain a substance specified in a Schedule are exempted from the requirements of these Regulations and from such Schedule:- (a) Timber and wallboard; (b) Ceramics; (c) Electrical components and electric lamps; (d) Vitreous enamels; (e) Explosives; (f) Glazed pottery; (g) Matches; (h) Motor fuels and lubricants other than as specified in Schedule 5; (i) Paper; (j) Photographic paper and photographic film; (k) Inorganic pigments other than as specified in Schedule 6; (l) Paint as defined in the Act; (m) Blankets moth-proofed with dieldrin in the mill during finishing, as specified by C.S.I.R.O.; (n) Printing Inks. 10 The Poisons Regulations of 1973

A2.08. The following quantities of drugs, including their salts and, except where otherwise provided, all preparations and admixtures con taining such drugs or salts, are prescribed for the purpose of section 130J (1) (a) of the Act:-

Drug Prescribed Quantity

Acetyldihydrocodeine except when included in Schedule 2 or in Schedule 4 .. 0·5 gram Acetylmethadol 0·5 gram Alphacetylmethadol 2·0 grams Alphameprodine 0·05 gram Alphaprodine 3·0 grams Amphetamine 0·5 gram Anileridine 2·5 grams

I Barbituric acid, its derivatives and all preparations and admixtures containing more than 0·2 per centum of barbituric acid, its salts, its derivatives or their salts 30·0 grams Benzylmorphine 1·5 grams Betaprodine 1·25 grams Bufotenine 0·7 gram

Cannabis 25·0 grams Cocaine 0·5 gram Coca Leaf 200·0 grams Codeine except when included in Schedule 2 Schedule 3 or in Schedule 4 .. 3·0 grams

Desomorphine .. 0·5 gram Dexamphetamine 0·5 gram Dextromoramide 1·0 gram Diacetylmorphine (heroin) 0·5 gram Diethylthiambutene .. 1·0 gram Dihydrocodeine except when included in Schedule 2 or in Schedule 4 3·0 grams Dimethylthiambutene 5·0 grams Dimethyltryptamine .. 0·7 gram Diphenoxylate except when included in Schedule 4 1·0 gram Dipipanone 2·5 grams Ethylmethylthiambutene ...... 2·5 grams Ethylmorphine except when included in Schedule 2 or in Schedule 4 1·5 grams

Fentanyl 0·03 gram

Hydrocodone 0·75 gram Hydromorphinol 0·75 gram Hydromorphone 0·25 gram

Isomethadone .. 1·0 gram

Levomethorphan 0·75 gram Levophenacylmorphan 0·15 gram Levorphanol 0·225 gram Lysergic acid diethylamide .. I 0·004 gram The Poisons Regulations of 1973 11

Drug Prescribed Quantity

Mescaline 7·0 grams Methadone 0·5 gram Methylamphetamine 0·5 gram Methylphenidate 0·5 gram Metopon 0·5 gram Morphine 0·5 gram Myrophine 5·0 grams

Nicocodine except when included in Schedule 2 or in Schedule 4 0·5 gram Normethadone 1·0 gram Normorphine .. 20·0 grams

Opium in any form except the alkaloid papaverine 5·0 grams Oxycodone 1·5 grams Oxymorphone .. 0·5 grams

Pethidine 5·0 grams Phenadoxone 2·5 grams Phenazocine 0·25 gram Phenmetrazine .. 1·25 grams Phenoperidine ...... 0·25 gram Pholcodine except when included in Schedule 2 or in Schedule 4 0·75 gram Piminodine 2·5 grams Pro peri dine 25·0 grams Psilocyn 0·1 gram Psilocybin 0·1 gram

Racemethorphan 1·5 grams Racemoramide 2·0 grams Racemorphan .. 0·45 gram

Tetrahydrocannabinols 0·5 gram Thebacon 0·5 gram Thebaine .. , 0·75 gram Trimeperidine .. 3·0 grams

A3. New Drugs A3.01. All new drugs shall be restricted drugs, and shall be included in Schedule 4. A3.02. Applications for the scheduling of new drugs or for a variation in their scheduling shall be made to the Director-General in Form X of Schedule 9. The applicant shall supply twelve copies of such application to the Director-General.

A4. New Poisons A4.01. Applications for the scheduling of new poisons or for a variation in the existing scheduling of a poison shall be made to the Director-General in Form X of Schedule 9. The applicant shall supply twelve copies of such application to the Director-General. 12 The Poisons Regulations of 1973

AS. Prohibited Dmgs AS.Ol. A person shall not have in his possession, prescribe, dispense, sell, lend, give away, supply nor use any of the following substances unless such person is engaged upon medical or scientific research or analyses and has received the written approval of the Director-General in that regard:- Allylisopropylacetylurea Amidopyrine and its derivatives for human therapeutic use Amygdalin Bithionol for human therapeutic use Buclosamide Buniodyl sodium Calamus for human therapeutic use Cannabis (Indian Hemp) and cannabis resin and extracts and tinctures of cannabis Desomorphine Dulcin Etorphine Ketobemidone Methapyrilene Methyl Cincophen (methyl ester of phenylcinchoninic acid) Nitrofen Oxyphenisatin and its acetyl derivatives Tetrahydrocannabinols Thalidomide 1,1,1-trichloroethane in aerosols for therapeutic use Triparanol or a preparation containing any proportion whatsoever of any of the substances listed in this subregulation. AS.02. A person shall not have in his possession, prescribe, dispense, sell, lend, give away, supply nor use any of the following substances in preparations for external application for human therapeutic use:- ( a) Tetrachlorosalicylanilide; (b) 5-Bromo-4-chlorosalicylanilide; (c) Fenticlor. AS.03. A person shall not have in his possession, prescribe, dispense, sell, lend, give away, supply nor use Diacetylmorphine (heroin) unless such person has received the written approval of the Director-General, which approval shall be given subject to such terms, conditions or restrictions as the Director-General in a particular case thinks fit.

A6. Certain Drugs Subject to Approval A6.01. (a) (i) A person shall not prescribe, dispense, sell, lend, give away, supply nor use any of substances to which the The Poisons Regulations of 1973 ,13

provisions of this subregulation apply otherwise than upon and in accordance with the written approval of the Director-General. ( ii) A medical ptactitioner or veterinary surgeon who pr~ scribes a substance to which the provisions, of this subregulation apply shall write upon the face of the prescription in his own handwriting the word "approved". (b) the provisions of subclause (i) of clause (a) hereof shall not apply to the dispensing of such substances upon or in accordance with the written prescription of a medical prac titioner or veterinary surgeon, which prescription bears upon its face the word "approved" in, or apparently in, the handwriting of such medical practitioner or veterinary surgeon. (c) The provisions of this subregulation apply to the following substances, their salts; and to all preparations and admixtures containing any proportion thereof:- Bufotenine; N,N-Diethyltryptamine (DET); 2,5-dimethoxy-4-methylamphetamine (DOM or STP); 3- ( 1,2-Dimethylheptyl) -1-hydroxy-7,8,9,10-tetrahydro- 6,6,9-trimethyl-6H-dibenzo (b,d) pyran (DMPH); N ,N-Dimethyltryptamine; Lysergic acid; Lysergic acid diethylamide (Lysergide); Mescaline; Parahexyl; Psilocin; Psilocybin; All substances having hallucinogenic properties structur ally derived from any of the above specified substances or from methoxyphenylethylamine; Sources and raw materials from which any of the above specified substances may be derived; Hydromorphone; Clomiphene, cyclofenil and other substances specifically prepared to stimulate ovulation; Dextromoramide; Prostaglandins.

A6.02. (a) (i) A medical practitioner shall not prescribe, dispense, sell, lend, give away, supply, nor use any of the substances to which the provisions of this subregulation apply other than for the treatment of a person suffering from the medical condition of narcolepsy, or of a child suffering from brain damage, or upon and in accordance with the written approval of the Director-General. 14 The Poisons Regulations of 1973

(ii) A medical practitioner who prescribes a substance to which the provisions of this subregulation apply shall write upon the face of the prescription in his own handwriting the words "specified condition". (b) A person other than a medical practitioner shall not- (i) prescribe a substance to which the provisions of this sub regulation apply; (ii) dispense, sell, lend, give away, supply nor use a substance to which the provisions of this subregulation apply otherwise than upon and in accordance with the written prescription of a medical practitioner, which prescription bears upon its face the words "specified condition" in, or apparently in, the handwriting of such medical practitioner. (c) The provisions of this subregulation apply to the following substances, their salts, and to all preparations and admixtures containing any proportion thereof:- (i) Amphetamine; (ii) Dexamphetamine; (iii) Methyl amphetamine; (iv) Methyl phenidate; ( v) Phenmetrazine. A6.03. The provisions of this Regulation shall not apply to- (a) the sale of any such substance by a licensed manufacturer of or a licensed wholesale seller of dangerous drugs or restricted drugs in accordance with Part G of these Regulations; or (b) the use, in the manner directed, of any such substance by a person under medical treatment who has been lawfully supplied with such substance in accordance with these Regulations. A7. Prescribing, Dispensing and Selling Poisons A7.01 (a) Unless he is licensed or authorised by or under these Regulations so to do a person shall rlot prescribe, dispense nor sell a poison specified in Schedules 1, 2, 3 or 7 or in Appendix A to Schedule 6. (b) A person shall not commit an offence against this Regulation merely by handing or delivering to the prescribee or his agent a poison which has been dispensed by an authorised person. A 7 .02. A medical practitioner or a veterinary surgeon is hereby authorised, only to the extent necessary for the practice of his respective profession, and subject to the provisions of these Regulations, to prescribe, dispense, and sell a poison referred to in subregulation A7.01. A7.03. A dentist is hereby authorised, only to the extent necessary for the practice of his profession, and subject to the provisions of these Regulations, to prescribe and sell a poison referred to in subregulation A7.01. The Poisons Regulations of 1973 15

A7.04. A pharmaceutical chemist is hereby authorised, subject 'to the provisions of these Regulations, to dispense and sell a poison referred to in subregulation A7.01 upon premises which include a dispensary constructed, kept and equipped in the manner prescribed by the Dispensary Regulations 1973. A7.05.- ( a) A person who has obtained the Degree of Bachelor of Pharmacy of the University of Queensland or other recognized university; or (b) A student, enrolled in the course leading to the degree of Bachelor of Pharmacy of the University of Queensland or other recognized university; or (c) A bona-fide paid assistant of a pharmaceutical chemist who has been authorised under the provisions of subregulation D2.03 of these Regulations, is hereby authorised, subject to the provisions of these Regulations, to dispense and sell a poison referred to in subregulation A7.01 under the direction and personal supervision of a pharmaceutical chemist upon premises which include a dispensary constructed, kept, and equipped in the manner prescribed by the Dispensary Regulations 1973. A7.06. A person authorised by the provisions of subregulation A 7.04 or A 7.05 to sell a poison included in Schedule 3 shall not sell such poison unless it is supplied in a container which shall have securely attached thereto a label on which are written- ( a) the words "Keep out of the Reach of Children" in red on a background of contrasting colour and in bold faced sans serif capital letters with a face depth of not less than 1· 5 millimetres; (b) the name of the patient for whose treatment the poison is intended or, as the case may be, ·the name of the owner of the animal for the treatment of which the poison is intended; (c) the name and address of the seller or supplier; (d) directions for use; (e) the description of the contents in one of the following forms (i) ,the approved name of the preparation; (ii) the trade name of the preparation; or (iii) the approved name of each poison present in the preparation; (f) the date of dispensing; and (g) where the poison is sold for animal treatment, the words "For Anin;tal Treatm~nt Only" in red on a background o~ contrastmg colour m bold faced sans serif capital letters with a face depth of not less than 1 · 5 millimetres. 16 The Poisons Regulations of 1973

A7.07. A competent and responsible person acting on behalf of a pharmaceutical chemist is hereby authorised, subject to the provisions of these Regulations, to sell a poison specified in Schedules 1, 2 or 7 or .in Appendix A to Schedule 6 upon premises which include a dispensary constructed, kept, and equipped in the manner prescribed by the Dispensary Regulations 1973.

A7.08. A school dental therapist who is performing prescribed duties under and within the meaning of the Dental Act 1971-1973 may, subject to these Regulations, use such of those poisons contained in Schedule 2 and Schedule 3 to these regulations as are specified here under:-

SCHEDULE 2 Ether and substances containing more than 10 per cent. of ether except when included in Schedule 4, Schedule 5 or Schedule 6. Fluorides:- (i) Sodium fluoride in substances for human ingestion containing 2 · 2 mg or less of sodium fluoride per dosage unit; and (ii) other metallic fluoride substances including ammonium fluoride for therapeutic use except- ( a) in dentifrices containing 0 · 5 per cent. or less of fluoride ion; and (b) in substances containing 15 mg/kg or less of fluoride ion. Mercury, metallic (excluding its salts) except in scientific instruments. Phenol and any homologue of phenol boiling below 220°C, creosote and sub&tances containing more than 3 per cent of such substances or homologues, for therapeutic use.

ScHEDULE 3 Anaesthetics, local, lignocaine only, when included in preparations for external use, other than eyedrops, c::ontaining ten per cent. or less of lignocaine. AS. Limited Authorities to Sell Poisons AS.Ol. Subject to the provisions of these Regulations, a Local Authority, acting in accordance with the provisions of the Act, or "The Stock Routes and Rural Lands Protection Acts, 1944 to 1967," and a Cane Pest and Disease Control Board, constituted under the Sugar Experiment Stations Act 1900-1973 are hereby authorised to sell a poison specified in Schedules 6 or 7 for the purpose of disinfection or for the destruction of weeds or vermin.

A8.02. Subject to the provisions of these Regulations, a Local Authority is hereby authorised to sell sodium fluoride tablets of a concentration not greater than 2 · 2 milligrams of sodium fluoride per tablet. The Poisons Regulations of 1973 17

A9. Prohibition of Sale of Poisons to Minors A9.01. A person other than a medical practitioner, or a pharma ceutical chemist acting upon the prescription of a medical practitioner, veterinary surgeon or dentist, shall not dispense, sell nor supply to a person under the age of eighteen years a poison specified in Schedules 1, 2, 3, 6 or 7.

LICENCES AlO. Wholesale Licence AlO.Ol. A person shall not manufacture and/or sell by wholesale a poison specified in Schedules 1, 2, 3 or 7 or in Appendix A to Schedule 6 unless such person is licensed so to do by the Director-General. Al0.02. A person who satisfies the Director-General that he intends to conduct a bona-fide business as a manufacturer and/ or wholesale seller of all or any of the poisons specified in Schedules 1, 2, 3 and 7 and in Appendix A to Schedule 6, that he is a fit and proper person to be allowed to manufacture and/or sell such poisons and that the actual manufacture and/ or sale of such poisons will be at all times under the personal supervision of a competent and responsible person may at the absolute discretion of the Director-General and on payment of a fee of Fifty-seven dollars fifty cents ($57 .50) be granted a licence in Form G of Schedule 9 to manufacture and/ or sell by wholesale such poisons at the premises specified in such licence, under and subject to the provisions of these Regulations. A10.03. An application for a licence under this Regulation shall be made in Form F of Schedule 9 and shall be accompanied by the prescribed fee of Fifty-seven dollars fifty cents ($57 .50). A10.04. A manufacturer and/or wholesale seller of poisons shall not sell a poison specified in Schedules 1, 2, 3 or 7 or in Appendix A to Schedule 6 by retail except to- ( a) a medical practitioner, a pharmaceutical ~chemist, a dentist, or a veterinary surgeon; (b) a college, university, educational establishment, scientific or public institution on the signed written order of the principal thereof; (c) a Department of the Government of the State or Common wealth on the signed written order of the permanent head of such Department or his nominee; (d) a primary producer on his signed written order for use on his property; (e) a person, on his signed written order, for use in a technical process connected with his business, trade or industry; 18 The Poisons Regulations of 1973

(f) a registered mining company, in regard to cyanide only in quantities of not less than fifty kilograms on the signed written order of the manager of such mining company, or (g) a person on his signed written order for first aid requisites required to be provided and maintained for his employees. Al0.05. The foregoing provisions of this Regulation shall not be so construed as to exempt a manufacturer and/ or wholesale seller of poisons from the operations of Regulation C3 of these Regulations in regard to the sale of cyanide. A10.06. Except as provided in subregulation A10.04 of these Regulations, a manufacturer and/or wholesale seller of poisons shall not sell a poison specified in Schedules 1, 2, 3 or 7 or in Appendix A to Schedule 6 other than to a person authorised or licensed to sell such poison. Al0.07. A manufacturer and/or wholesale seller of any of the poisons specified in Schedules 1, 2, 3 and 7 and in Appendix A to Schedule 6 shall, at the time of each sale or supply of any such poison, issue to the purchaser or person supplied an invoice containing the following particulars:- ( a) the date of such sale cr supply; (b) the name and address of the purchaser or person supplied; and (c) the name and quantity of the poison sold or supplied, and shall keep at his place of business a faithful record of every such invoice and the particulars contained therein for a period of not less than two years from the date of such invoice and shall make such record available for inspection on demand by an inspector.

All. General Licence All.Ol. A person who satisfies the Director-General that he intends to conduct a bona-fide business as a seller of all or any of the poisons specified in Schedules 1, 2 and 7 and in Appendix A to Schedule 6 at a place not within twenty-five kilometres by the nearest practicable road of a place at which a pharmaceutical chemist conducts and maintains an open chemist's shop and that he is a fit and proper person to be allowed to sell such poisons may at the absolute discretion of the Director-General and on payment of a fee of Thirty-two dollars fifty cents ($32.50) be granted a licence in Form C of Schedule 9 to sell such poisons at the premises specified in such licence, under and subject to the provisions of these Regulations. A11.02. An application for a licence under this Regulation shall be made in Form A of Schedule 9 and shall be accompanied by the prescribed fee of Thirty-two dollars fifty cents ($32.50). All.03. If a pharmaceutical chemist shall commence business at a place within twenty-five kilometres by the nearest practicable road of the premises specified in a licence granted under this Regulation, such The Poisons Regulations of 1973 19 licence shall not be renewed after the expiration thereof: Provided that the Director-General may, in his discretion and without payment of a fee, renew such licence for a period not exceeding six months to enable the licensee to dispose of any unsold stock of poisons which he may have on hand at the expiration of such licence. Al2. Licence to Sell Photographic Poisons A12.01. A person who satisfies the Director-General that he intends to conduct a bona-fide business as a dealer in photographic materials and that he is a fit and proper person to be allowed to sell the poisons specified in Schedules 1, 2 and 7 and in Appendix A to Schedule 6 may at the absolute discretion of the Director-General and on payment of a fee of Twelve dollars fifty cents ($12.50) be granted a licence in Form I of Schedule 9 to sell such poisons for photographic purposes only at the premises specified in such licence, under and subject to the provisions of these Regulations. A12.02. An application for a licence under this Regulation shall be made in Form H of Schedule 9 and shall be accompanied by the prescribed fee of Twelve dollars fifty cents ($12.50). Al3. Licence to Sell Poisons for Purposes other than Human Therapeutic Use A13.01. A person who satisfies the Director-General that he intends to conduct a bona-fide business as a seller of all or any of the poisons specified in Appendix A to Schedule 6 and in Schedule 7 for purposes other than human therapeutic use and that he is a fit and proper person to be allowed to sell such poisons may at the absolute discretion of the Director-General and on payment of a fee of Twenty-one dollars fifty cents ($21.50) be granted a licence in Form K of Schedule 9 to sell such poisons for purposes other than human therapeutic use at the premises specified in such licence, under and subject to the provisions of these Regulations. A13.02. An application for a licence under this Regulation shall be made in Form J of Schedule 9 and shall be accompanied by the prescribed fee of Twenty-one dollars fifty cents ($21.50). A14. Employees and other Persons Authorised A14.01. A competent and responsible person acting on behalf of a person licensed under this Part is hereby authorised to sell a poison subject to the same provisions, limitations, and restrictions as such licensed person. A15. General Conditions of Licences AlS.Ol. (a) A licence, granted by the Director-General under the provisions of this Part, shall be in force only in respect of single individual premises specified in the application for such licence, and in such licence, until the thirtieth day of September then next following, unless sooner suspended or cancelled. 20 The Poisons Regulations of 1973

(b) Such licence may be renewed annually in the discretion of the Director-General on payment, not less than one · ( 1) day before the expiration of the existing licence, of a fee of- (i) Fifty-seven dollars fifty cents ($57.50) for each renewal of a licence issued under Regulation AlO; (ii) Thirty-

A15.02. (a) The Director-General may suspend or cancel a licence granted under the provisions of this Part held by a person- (i) who has been convicted of an offence against the provisions of the Act or of these Regulations; (ii) who is deemed by the Director-General to be unfit to hold such licence; or (iii) whose premises are deemed by the Director-General to be unfit for the purpose for which such licence was granted. (b) The Director-General, in his discretion, may at any time reinstate or cancel a suspended licence.

A15.03. A person licensed under the provisions of Regulation All, A12 or Al3 to sell all or any of the poisons specified in Schedules 1, 2 and 7 and in Appendix A to Schedule 6, in addition to complying with any other provisions of these Regulations, shall not- ( a) sell, keep nor have any such poison except upon the premises specified in his licence: Provided that the provisions of this clause shall be deemed not to prevent a person from exercising an authority expressly given to him by the Director-General under the provisions of Regulation 03 of these Regulations; (b) make a sale of any such poison except by himself or a competent and responsible person acting upon his behalf; (c) sell any such poison unless it is packed and labelled in accordance with the requirements of these Regulations; nor (d) sell by retail any such poison, except in the original unbroken package in which it is received by him from the manufacturer, packer or wholesaler. The Poisons Regulations of 1973 21

PART B-PACKING AND LABELLING Bl. Packing Bl.Ol. The immediate container in which any dangerous drug, restricted drug or poison is sold shall- ( a) be impervious to such dangerous drug, restricted drug or poison; (b) be sufficiently strong to prevent breakage or leakage arising from the ordinary risks of handling, storing or transport; (c) be securely closed and, except when containing a substance packed for use on one occasion only, be capable of being reclosed; (d) have sufficient excess capacity to prevent breakage of the container or leakage of the contents if the contents thereof are likely to expand during handling, storage or transport; (e) not be capable of causing a chemical reaction with such dangerous drug, restricted drug or poison. B1.02. A dangerous drug, restricted drug or poison, other than a poison specified in Schedule 5, shall not be sold in a bottle or jar having a capacity of two litres or less unless- ( a) the outer surface of such bottle or jar has embossed thereon the word "Poison" or the words "Not to be taken"; (b) the outer surface of such bottle or jar has embossed thereon prominent vertical ribs or grooves or prominent points or stars of sufficient number to render the bottle or jar distinguishable by sight and by touch from bottles or jars ordinarily used as containers for any food, drink, condiment, or medicine for internal use; (c) the outer surface of such bottle or jar has a panel or panels free from ribs, grooves, points or stars of sufficient area for the purpose of labelling; (d) such bottle or jar if made of glass is coloured brown; and (e) such bottle or jar if made of plastic complies with the Australian Standard Specification for Glass and Rigid Plastics Containers for Poisonous Substances as published by the Standards Association of Australia (AS 2216). Bl.03. A dangerous drug, restricted drug or poison, other than a poison specified in Schedule 5, shall not be sold in a bottle or jar having a capacity of more than two litres, or in any other immediate container unless- ( a) the word "Poison" is embossed on the side of such bottle, jar or other immediate container; or (b) the word "Poison" is indelibly written on the side of such bottle, jar or other immediate container in colour contrast to the background colour, in letters of a height not less than one thirty-second part of the depth of such bottle, jar or other immediate container. 22 The Poisons Regulations of 1973

B1.04. The provisions of subregulations B1.02 and B1.03 shall not apply to the immediate container of a dangerous drug, restricted drug or poison- ( a) made up ready for internal human or internal animal use; or (b) made up ready for use as eye, ear or nose drops or sprays if such container has a capacity of 15 millilitres or less. (c) prepared for use in automatic photographic and photocopying processing machines if such container is specifically designed to fit into the machine. Bl.OS. A person shall not sell a drug or medicine for internal use by man or any food, drink or condiment in a container- (a) of like description to that prescribed by subregulations B1.02 B1.03 or Bl.07; or (b) of such a description as not to be readily distinguishable by sight and touch from a container as prescribed by sub regulations B1.02 or Bl.07. B1.06. A person shall not use an immediate container having the name of a dangerous drug, restricted drug or poison embossed or per manently marked thereon as a container for a substance other than such dangerous drug, restricted drug or poison.

B1.07. (a) A poison specified in Schedule 5 shall not be sold in a container unless such container- (i) is readily distinguishable from a container in which food or drink is sold; and (ii) has embossed or indelibly written thereon the word "Poison" or the words "Not to be taken" or the words "Not to be used as a food container". (b) The following poisons specified in Schedule 5, namely Methylated Spirit, Oil of Turpentine, Kerosene, Mineral Turpentine, Petrol, White Spirit and any other liquid hydrocarbon shall not be sold in a bottle or jar having a capacity of two Iitres or less unless- (i) the outer surface of such bottle or jar has embossed thereon prominent vertical ribs or grooves or prominent points or stars of sufficient number to render the bottle or jar dis tinguishable by sight and by touch from bottles or jars ordinarily used as containers for any food, drink, condiment or medicine for internal use; (ii) such bottle or jar if made of glass is coloured brown; and (iii) such bottle or jar complies with the provisions of clause (a) of this subregulation; (iv) such bottle or jar is fitted with a closure of a type approved by the Director-General. The Poisons Regulations of 1973 23

B1.08. Notwithstanding any other provision of these Regulations the Director-General may, at his discretion, approve of another container which, in his opinion, is suitable for containing a poison. B2. Labelling-General B2.01. (a) Every word, symbol, phrase, name, expression, statement and brand (each of which is hereinafter referred to as a "particular") required to be written on a label or container used in connection with a dangerous drug, restricted drug or poison shall be written- (i) in the English language; (ii) on the outside face of such label or container; (iii) in durable characters; and (iv) in such colour or colours as to afford a distinct contrast to the background colour. (b) Every label, used in connection with a dangerous drug, restricted drug or poison, shall be securely attached to the outside of the container or pack used in connection therewith. (c) Where a specific direction or authorisation is not given regarding the manner in which any particular shall be written, such particular shall be written in bold faced letters with a face depth of not less than 1 · 5 millimetres. (d) Any particular required to be written in letters of a prescribed size may, with the approval of the Director-General, be written in letters of proportionally reduced size where the area of the container or pack available for labelling is small with regard to the text of the labelling, provided that letters with a face depth of less than 1 · 25 millimetres shall not be approved. B2.02. (a) The word"\ POISON I" or the word "I CAUTION I" or the words " IDANGEROUS POISON I " or the word " l WARNING I" as the case may be, together with the classification symbol, if any, specified in the Table in clause (a) of subregulation B3.01 and in subregulation B3.03 shall be written- (i) in red on a white background and surrounded by a rectangular red frame; (ii) on the first line of the main label; and (iii) in bold faced sans serif capital letters. Any other word or words shall not be written on the same line.

(b) The word "I POISON r" or the word "I CAUTION I" or the words "I DANGEROUS POISON I" as the case may be on the label 24 The Poisons Regulations of 1973 of any substance other than a poison specified in Schedule 5 shall be written in letters with a face depth of- (i) not less than 1· 5 millimetres; and (ii) not less than one half the face depth of the largest letter or numeral on such label.

Schedule 5 shall be written in letters with a face depth of- (i) not less than 4 · 5 millimetres; and (ii) not less than one quarter the face depth of the largest letter or numeral on such label. (d) The term "classification symbol" means the letter "S" followed by a numeral, denoting the Schedule in which such substance is specified.

B2.03. Where one of the following phrases is required to be written on a label, viz.:- "NOT TO BE TAKEN"; "USE STRICfLY AS DIRECTED"; "SUPPLY WITIIOUT PRESCRIPTION OR POSSESSION WITIIOUT AUTIIORITY ILLEGAL"; "SUPPLY WITHOUT PRESCRIPTION ILLEGAL"; "UNAUTIIORISED SUPPLY ILLEGAL", such phrase shall be written- (i) on the next line or lines immediately below the word "POISON" or the word "CAUTION" as the case may be; and (ii) in bold faced sans serif capital letters. Any other word or words shall not be written on the same line or lines.

B2.04. The words "KEEP OUT OF REACH OF CHILDREN" shall be written- (i) in red; (ii) on the next line immediately below the word "WARNING" on the label of a poison specified in Schedule 5 or the relevant phrase referred to in sub-regulation B2.03 on any other label; and (iii) in bold faced sans serif capital letters. Any other word or words shall not be written on the same line. The Poisons Regulations of 1913 25

B2.05. Where the phrase "READ SAFETY DIRECTIONS BEFORE OPENING" is required to be written on a label it shall be written (i) on the next line or lines immediately below the words "KEEP OUT OF REACH OF CHILDREN", and (ii) in bold faced sans serif capital letters. Any other word or words shall not be written on the same line or lines. B2.06. The approved name of each dangerous drug, restricted drug and poison present in a preparation shall be written- (i) on the main label; and (ii) in bold faced sans serif capital letters.

82.07. The statement of strength as required by clause (b) of subregulation B3.01, clause (b) of subregulation B4.01 or clause (b) of subregulation BS.Ol shall be written on the main label and shall be expressed in the appropriate one of the following forms:- (a) in respect of a tablet, capsule, pastille, packaged single dose of powder, or similar discrete product unit, the quantity of each dangerous drug, restricted drug and poison in such product unit; (b) in respect of a solid preparation intended for extemporaneous preparation of either a single dose or a single stated amount of a liquid for therapeutic use, the quantity of each dangerous drug, restricted drug and poison in the immediate container; (c) in respect of a liquid for internal therapeutic use, the volume of the normal dose and the quantity of each dangerous drug, restricted drug and poison in such volume; (d) in respect of any other preparation, the proportion of each dangerous drug, restricted drug and poison in such preparation, expressed as follows:- (i) in respect of a liquid preparation, either the weight of the dangerous drug, restricted drug or poison per unit volume of such preparation or its percentage weight in volume; or (ii) in respect of a solid or semi-solid preparation, either the weight of the dangerous drug, restricted drug or poison per unit weight of such preparation or its percentage weight in weight. B2.08. (a) The abbreviations"%" or "per cent." shall, unless other wise qualified, denote the percentage weight in volume of a liquid preparation and the percentage weight in weight of a solid or semi-solid preparation. (b) In the case of a preparation containing more than one derivative of the same substance it shall be sufficient to state the equivalent quantity or proportion of one derivative that such preparation would be calculated to contain on the assumption that all the derivatives in such preparation were that derivative. 26 The Poisons Regulations of 1973

B2.09. (a) A label used in connection with any dangerous drug, restricted drug or poison shall not include-- (i) a reference to these Regulations, or any comment on, reference to, or explanation of any expression required by these Regulations, which directly or by implication contradicts, qualifies or modifies such expression; (ii) a statement suggesting or implying that such dangerous drug, restricted drug or poison has been recommended or approved by the Government, or any governmental authority; (iii) a statement implying that such dangerous drug, restricted drug or poison is safe, harmless, non-toxic, non-poisonous or approved; (iv) an expression or device which is false or misleading in any particular concerning the safety of such dangerous drug, restricted drug or poison or any of its ingredients; ( v) a trade name which is false or misleading in any particular concerning such dangerous drug, restricted drug or poison or the ingredients or substances contained therein or which misrepresents the composition or any property or quality of such dangerous drug, restricted drug or poison or which gives any false or misleading indication of origin or place of manufacture. (b) A label shall not be attached to the immediate container or primary pack used in connection with a dangerous drug, restricted drug or poison in such a manner as to obscure-- (i) an expression required by these Regulations to be written or embossed on such container or pack; or (ii) any of the embossed ribs, grooves, points, or stars specified in Regulation Bl. 83. Immediate Container and Primary Pack 83.01. The immediate container and primary pack containing a dangerous drug, restricted drug or poison for sale shall be labelled with- (a) the words and classification symbol (if any) set forth in the following Table against the number of the Schedule in which such substance is specified and the purpose for which it is intended to be used:- THE TABLE

Schedule in Purpose for which Words and Classification Symbol required which substance it is intended to to be shown on label is specified be used

internal use POISON S1

USE STRICTLY AS DIRECTED KEEP OUT OF REACH OF CHILDREN The Poisons Regulations of 1973 27

THE TABLE-continued

1 any, other than internal use POISON S1

NOT TO BE TAKEN KEEP OUT OF REACH OF CHILDREN

2 internal use .. CAUTION S2 I I USE STRICTLY AS DIRECTED KEEP OUT OF REACH OF CHILDREN

2 any, other than internal use .. I POISON S2 I NOT TO BE TAKEN KEEP OUT OF REACH OF CHILDREN

3 any .. . . I I I CAUTION S3 I USE STRICTLY AS DIRECTED KEEP OUT OF REACH OF CHILDREN

4 I any CAUTION S4

SUPPLY WITHOUT PRESCRIPTION ILLEGAL KEEP OUT OF REACH OF CHILDREN

5 any \WARNING!

KEEP OUT OF REACH OF CHILDREN

6 internal use in animals CAUTION

USE STRICTLY AS DIRECTED KEEP OUT OF REACH OF CHILDREN 28 The Poisons Regulations of 1973

THE TABLE--continued

6 any, other than internal use in POISON animals I I NOT TO BE TAKEN KEEP OUT OF REACH OF CHILDREN I READ SAFETY DIRECTIONS BEFORE OPENING

7 internal use 0 0 I CAUTION S7 I UNAUTHORISED SUPPLY ILLEGAL KEEP OUT OF REACH OF CHILDREN

7 any, other than internal use 0 0 l DANGEROUS POISON SJ I NOT TO B'E TAKEN KEEP OUT OF REACH OF CHILDREN READ SAFETY DIRECTIONS BEFORE OPENING

8 any 0 0 0 0 CAUTION SB I I SUPPLY WITHOUT PRESCRIPTION OR POSSESSION WITHOUT AUTHORITY ILLEGAL KEEP OUT OF REACH OF CHILDREN

Such words and classification symbol (if any) shall be written on the main label in accordance with the provisions of subregulation B2o02, B2o03, B2o04 and B2o05; (b) the approved name of each dangerous drug, restricted drug and poison present and a statement of strength, which shall be written on the main label in accordance with the provisions of subregulations B2o06, B2o07 and B2o08; (c) directions for use if the substance (not being a substance specified in Schedule 4 or 8) is made up for a specific purpose; (d) the name and address of the manufacturer or distributor thereof; (e) directions for safe handling and the special warning applicable as approved by the Director-General; (f) first aid measures applicable as approved by the Director General; (g) the words "FOR ANIMAL TREATMENT ONLY" if the substance is for the treatment of animals only; and The Poisons Regulations of 1973 29

(h) the words "NOT TO BE USED FOR ANY OTIIER PURPOSE" in bold faced sans serif capital letters with a face depth of not less than 2 · 5 millimetres, if the substance is for use as a pesticide, and any other word or words shall not be written on the same line or lines.

83.02. The provisions of this Part shall not require the labelling of any transparent cover, or of any wrapper, hamper, packing case, crate or other cover used solely for the purpose of transport or delivery.

83.03. The immediate container and primary pack containing a dangerous drug, restricted drug or poison in a quantity of more than 25 litres or 25 kilograms, as the case may be, for bulk distribution for further processing, may, in lieu of the particulars prescribed by sub regulation B3.01, be labelled with-

(a) the word " POISON "· ' (b) the approved name of the dangerous drug, restricted drug or poison; and (c) the registered brand or the name of the manufacturer or distributor thereof.

84. Immediate Wrapper 84.01. An immediate wrapper containing a dangerous drug, restricted drug or poison for sale shall be-- (a) contained in a primary pack labelled as prescribed in Regulation B3; and (b) conspicuously labelled with- (i) the approved name of each dangerous drug, restricted drug and poison present and a statement of strength in accord ance with the provisions of subregulations B2.06, B2.07 and B2.08; and (ii) the registered brand or the name of the manufacturer or distributor thereof.

85. Selected Containers 85.01. Unless a selected container which contains a dangerous drug, restricted drug or poison is itself labelled as prescribed in Regulation B3 it shall be- (a) contained in a primary pack which is labelled as prescribed in Regulation B3; and (b) labelled with- (i) the word or words set forth in the following Table against the number of the Schedule in which the substance is 2 30 The Poisons Regulations of 1973

specified and the purpose for which it is intended to be used:- THE TABLE

Schedule in which Purpose for which Words required to be substance is it is intended to shown on label specified be used

1 any .. POISON 2 internal use .. CAUTION 2 any, other than in- POISON ternal use 3 any .. CAUTION 4 any .. CAUTION 5 .. any WARNING 6 .. internal use .. CAUTION 6 any, other than in- POISON ternal use 7 internal use .. CAUTION 7 .. any, other than in- DANGEROUS POISON ternal use 8 any CAUTION

(ii) the approved name of each dangerous drug, restricted drug and poison present and a statement of strength in accordance with the provisions of subregulations B2.06, B2.07 and B2.08; (iii) the registered brand or the name of the manufacturer or distributor thereof; and (iv) the words "FOR ANIMAL TREATMENT ONLY" if the preparation is for the treatment of animals only.

B6. Special Warnings B6.01. The immediate container and primary pack containing any poison for sale shall be labelled with such warning statement or statements as approved by the Director-General. B7. First Aid Measures B7.01. The immediate container and primary pack containing any poison for sale shall be labelled with such first aid statement or statements as approved by the Director-General. · BS. Dispensed Medicines BS.Ol. In this Regulation the term "dispensed medicine" means a medicine for internal use by man or animal consisting of or containing a dangerous drug, restricted drug or poison and which is- ( a) supplied by a medical practitioner or a veterinary surgeon in the practice of his profession; or (b) dispensed by a pharmaceutical chemist or other authorised person upon the prescription of a medical practitioner, a veterinary surgeon or a dentist; or The Poisons Regulations of 1973 31

88.02. The requirements of Regulation B3 of these Regulations shall not apply to a dispensed medicine.

B8.03. A person who sells or supplies a dispensed medicine shall securely attach to the container thereof a label on which are written- ( a) the words "KEEP OUT OF REACH OF CHILDREN" in red on a background of contrasting colour and in bold faced sans serif capital letters with a face depth of not less than 1 · 5 millimetres; (b) the name of the patient or owner of the animal for whose treatment such dispensed medicine is intended; (c) the name and address of the seller or supplier; (d) directions for use; (e) a description of the contents as prescribed in subregulation B8.04; and (f) the date of dispensing. (g) "FOR ANIMAL TREATMENT ONLY" in red on a back ground of contrasting colour in bold-faced sans serif capital letters with a face depth of not less than 1 · 5 millimetres if such dispensed medicine is prescribed by a veterinary surgeon. B8.04 (a) The description of the contents of a dispensed medicine shall be in one of the following forms:- (i) the approved name of the preparation; (ii) the name of the preparation as written in the prescription; (iii) the trade name of the preparation; (iv) the approved name of each dangerous drug, restricted drug and poison present in the preparation; or ( v) the name of each dangerous drug, restricted drug and poison present in the preparation as written in the prescription. (b) Notwithstanding the provisions of clause (e) of subregulation B8.03 and of clause (a) hereof, a medical practitioner may, in a prescrip tion, specifically direct that the contents of a dispensed medicine- (i) are to be described in a particular manner (not being a false description); or (ii) are not to be described. (c) A pharmaceutical chemist or other authorised person shall comply with a specific direction given in accordance with the provisions of clause (b) hereof. 32 The Poisons Regulations of 1973

B9. Measure Pack B9.01. A measure pack shall:- ( a) be conspicuously labelled with- (i) the word or words set forth in the following Table against the number of the Schedule in which the substance is specified:- THE TABLE

Schedule in which substance is specified Words required to be shown on label

5 WARNING 6 POISON 7 DANGEROUS POISON

(ii) the approved name of each poison present and a statement of strength in accordance with the provisions of sub regulations B2.06, B2.07, and B2.08; (iii) the registered brand or name of manufacturer or distributor; (b) when presented for sale, be packaged with not less than one other measure pack in a primary pack labelled as prescribed in Regulation B3.

BlO. Sodium Fluoride BlO.Ol Every label required to be used in connection with sodium fluoride substances for human ingestion containing 2 · 2 mg or less of sodium fluoride per dosage unit shall contain such directions for use as are specified by the National Health and Medical Research Council. Bll. Offences Bll.Ol. A person shall not sell a dangerous drug, restricted drug or poison which is packed or enclosed for sale or labelled, branded, or marked in any manner contrary to or not in compliance with these Regulations.

PART C-STORAGE AND SALE OF POISONS, KEEPING OF RECORDS, SPECIAL PROVISIONS CONCERNING CERTAIN POISONS Cl. Keeping and Storage of Poisons Cl.Ol. A person shall not store a poison for sale (a) within reach of children; (b) unless it is separate and apart from food for man or animal; or (c) in such a manner that if the container breaks or leaks the poison could mix with or contaminate any food for man or animal. The Poisons Regulations of 1973 33

Cl.02. In a pharmacy or other premises where poisons are sold by retail, a person shall not store- (a) a poison specified in Schedule 1 or in Appendix A to Schedule 6 except- (i) in a dispensary, storeroom, or other portion of such pharmacy or other premises which is partitioned off or similarly separated from any portion of such pharmacy or other premises which the public is permitted to enter, or (ii) in a cupboard or drawer so situated as to be inaccessible to the public; (b) a poison specified in Schedule 2 or Schedule 3 unless it is stored in such a manner as to be inaccessible to the public; (c) a poison specified in Schedule 7 unless it is stored in a secure place under lock and key under his personal control or under the personal control of a competent and responsible person deputed by him for that purpose. Cl.02A. In any premises where there are sold by retail any poisons which contain an organic solvent distilling under 150°C at 101-3 k Pa and which are labelled as an adhesive or for use as an adhesive, a person shall not store such poisons unless they are stored in such a manner as to be inaccessible to the public. Cl.03. In premises where poisons are sold by wholesale, a person shall not store a poison specified in Schedule 1, 2, 3 or 7 or in Appendix A to Schedule 6 unless it is stored in such a manner as to be inaccessible to the general public. Cl.04. A person shall not have in his possession a container of poison which is damaged or cracked. If a container of poison becomes damaged or cracked, the, person in whose possession it is shall immediately empty such container of its contents and destroy it.

C2. Records of Sales of Poisons C2.01. (a) A person shall not sell by retail a poison specified in Schedule 1 or Schedule 7 or in Appendix A to Schedule 6 unless he makes a faithful record of each such transaction at the time of sale. The seller shall keep such record in a book, which shall be used for such purpose exclusively and which is referred to hereinafter in these Regulations as the "Poisons Sales Book". The seller shall include in such record the date of the sale, the name of the poison and the quantity of the poison sold, the purpose for which such poison is required and the name and address of the purchaser thereof, and shall obtain the signature of such purchaser in a space reserved for this purpose. (b) The seller shall keep such Poisons Sales Book for a period of two years from the date of the last recording therein and shall make it available for inspection on the demand of an inspector or of a Police Officer. 34 The Poisons Regulations of 1973

C2.02. (a) Where a sale and purchase of such poison is originated by correspondence or telegram, such correspondence or telegram shall be retained by the seller for a period of two years from the date of its receipt. In addition, the seller shall make the appropriate entry in the Poisons Sales Book, inserting, in the space reserved for the signature of the purchaser, the word '"correspondence" or "telegram", as the case may be. (b) Where such poison is ordered by telephone, the seller shall make the appropriate entry in the Poisons Sales Book and insert, in the space reserved for the signature of the purchaser, the words "telephone order".

C3. Sale and Use of Cyanide C3.01. A person shall not be in possession of nor use cyanide unless he is:- (a) A person so authorised by these Regulations; or (b) The holder of a permit in Form Nl of Schedule 9 to these Regulations. C3.02. A person desiring to obtain cyanide shall make an application to the Director-General in Form N of Schedule 9 to these Regulations. C3.03. The Director-General may, at his discretion, issue to the applicant a permit in Form Nl of Schedule 9 to these Regulations. C3.04. The holder of a permit which has been issued under this Regulation shall not:- (a) Use such cyanide for any purpose other than that stated in the permit; (b) Store such cyanide at a place other than that stated in the permit; (c) Have any cyanide in his possession after the expiration of the time stated in the permit. C3.05. A person shall not sell cyanide unless the intending purchaser produces a permit signed by the Director-General authorising such purchase: Provided that this prohibition shall not apply to a bona-fide wholesale sale by a licensed wholesale seller of poisons to a pharmaceutical chemist or to another licensed seller of poisons. C3.06. A person who has obtained cyanide as the holder of a permit shall keep such cyanide under lock and key in a secure place approved for this purpose by an inspector. The key of such secure place shall remain at all times in the possession of the holder of the permit or of a responsible person delegated by such permit holder. Such responsible person shall be charged by the permit holder with the duty of issuing for use such cyanide and shall not at any time leave such cyanide as to be accessible to others. The Poisons Regulations of 1973 35

. C3.07. A person who buys cyanide outside the State shall, immedi ately such cyanide comes into his possession at any place within the State, notify the Director-General to that effect and make application for a permit to be in possession of and for the use of such cyanide in accordance with the provisions of this Regulation.

C4. Restricted Sales of Fluoroacetic Acid, Fluoroacetamide, Thallium, Chlordimeform and Mirex C4.01. A person shall not buy nor attempt to buy, nor obtain nor attempt to obtain nor use- (a) fluoruacetic acid, fiuoroacetamide, or their salts, or their derivatives or a preparation or admixture thereof; (b) thallium or its salts or its compounds or a preparation or admixture thereof, containing more than .the equivalent of 0 · 25 per cent. of thallium; (c) chlordimeform; or (d) mirex, unless such person has obtained the written authority of the Director General to buy, obtain or use such poisons.

C4.02. (a) A person so authorised under the prov1s1ons of this Regulation, shall on the demand of an inspector produce such written authority. (b) The Director-General may, in his discretion, suspend or cancel an authority granted by him under this Regulation.

CS. Restrictions on Packs of Organo-Phosphoms and Dimethanonaph thalene Compounds CS.Ol. A person shall not pack for sale nor sell any liquid or emulsive preparation containing:- ( a) an organo-phosphorus compound specified in Schedule 7 in a package containing less than 500 millilitres of such preparation; (b) a dimethanonaphthalene compound in a package containing less than four litres of such preparation.

C5.02. A person shall not pack for sale nor sell in the dry or powder form a preparation containing:- (a) an organo-phosphorus compound specified in Schedule 7 in a package containing less than 750 grams of such preparation; (b) a dimethanonaphthalene compound in a package containing less than 20 kilograms of such preparation. 36 The Poisons Regulations of 1973

C6. Use of Arsenical Preparations for Jetting Sheep C6.01. During the period commencing on the day four months next succeeding the shearing of any sheep and ending at the commencement of the next ensuing shearing of such sheep, a person shall not- ( a) use for jetting, dipping, swabbing, or spraying such sheep, a preparation containing a compound of arsenic other than a water soluble compound of arsenic trioxide (As20a) of the same composition throughout; (b) use for jetting, dipping, swabbing, or spraying such sheep, a preparation containing a compound of arsenic (whether or not such compound of arsenic be held out in an advertisement as suitable for jetting, dipping, swabbing, or spraying sheep) unless- (i) such compound of arsenic shall comply with both of the following specifications:- (A) After the compound has been well mixed or shaken its arsenical contents shall be evenly distributed through out the whole of its bulk, and shall remain so distributed for a period of not less than twenty-four hours thereafter; (B) After the compound has been duly diluted for use the arsenical contents shall be evenly distributed throughout the whole of its bulk and shall remain so distributed for a period of not less than forty-eight hours thereafter; (ii) such compound shall contain not less than three per centum emulsified or saponified oil or fat; and (iii) such preparation shall contain not less than 0 · 1 per cent. of soap; or (c) jet, dip, swab or spray such sheep with a preparation the use whereof is prohibited hereunder. C6.02. A person shall not use in the dipping or spraying of sheep an arsenical preparation containing more than 0 · 2 per centum of arsenic, calculated as arsenic trioxide (AszOa). C6.03. A person shall not use in jetting or swabbing sheep at any time during the period of six weeks immediately preceding the shearing thereof an arsenical preparation containing more than 0 · 2 per centum of arsenic, calculated as arsenic trioxide (As20a). C6.04. A person shall not at any time in jetting or swabbing sheep carrying more than nine months' wool use a preparation containing more than- ( a) 0 · 7 per centum of arsenic, calculated as arsenic trioxide (As20a); (b) 0 · 5 per centum of arsenic, calculated as arsenic trioxide (As20 3 ) between eight weeks and six weeks immediately preceding the shearing of such sheep; or The Poisons Regulations of 1973 37

(c) 0 · 5 per centum of arsenic, calculated as arsenic trioxide (As20s) if such sheep shall not have been adequately crutched when carrying between six and eight months' wool.

C6.05. A person shall not at any time use for jetting or swabbing sheep, a preparation containing more than 0 · 8 per centum of arsenic, calculated as arsenic trioxide (As20s).

C6.06. A person shall not use a compound of arsenic in jetting, dipping, swabbing, or spraying sheep or causing such sheep to be jetted, dipped, swabbed, or sprayed, unless and until he has given to the Clerk of the Court of the district in which such work is to be carried out, notice of his intention to carry out such work and of the date on which he proposes to commence such work. Such notice, if not given in writing, shall be forthwith confirmed in writing posted in a prepaid letter addressed to the said Clerk of the Court or delivered to him personally.

C6.07. An inspector or other authorised officer of the Director General appointed under the Act may enter and inspect the premises or place where sheep are jetted, dipped, swabbed or sprayed, and may- ( a) examine and open an article or preparation used or intended to be used in such premises or place for the jetting, dipping, swabbing, or spraying of sheep, or a package enclosing or containing such article or preparation; (b) seize and remove from such premises or place for examination and/ or analysis such article or portion or portions of such article, or preparation or portion or portions thereof used or intended to be used as a jetting, dipping, swabbing, or spraying fluid for sheep; and (c) seize and remove from such premises or place or from sheep thereon for examination and/or analysis a portion or portions of the wool of such sheep.

C6.08. When an article, or portion or portions thereof, or a preparation or portion thereof, or wool has been removed by such officer in accordance with the provisions of subregulation C6.07 of these Regulations, such officer shall forthwith deliver or forward a portion of such article, preparation, or wool or portion or portions thereof so removed, marked and sealed or fastened up in such a manner as its nature permits, to the owner thereof, or the person in whose possession it has been found or to the person apparently in charge of such article, preparation, or wool, and deliver or forward the remainder thereof to a State Analyst, forwarding at the same time to the Director General of Health and Medical Services a full report of the circumstances in which the removal was made. Delivery to a State Analyst may be effected either personally or by means of a sealed package addressed to him by any means of transit. 38 The Poisons Regulations of 1973

C6.09. For the purposes of this Regulation, every inspector appointed under the provisions of the Act, the Stock Act 1915-1973, or "The Workers' Accommodation Act of 1952", and every member of the Police Force shall be deemed to be an authorised officer of the Director-General, provided that any such person has been duly authorised by the Director·· General under the Act. C6.10. The Director-General may, in writing, appoint any person or class of persons to be an authorised officer or authorised officers either generally or in respect of a particular instance. C7. Addition of an Emetic in Paraquat Preparations C7.01. A person shall not pack nor sell any preparation containing paraquat unless and until the preparation contains an emetic approved by the Director-General. CS. Sale and Use of Strychnine CS.Ol. A person shall not be in possession of nor use strychnine unless he is- ( a) A person so authorised by these regulations; or (b) The holder of a permit in Form B1 of Schedule 9 to these Regulations. C8.02. A person desiring to obtain strychnine shall make application to the Director-General in Form B of Schedule 9 to these Regulations. C8.03. The Director-General may, at his absolute discretion, issue to the applicant a permit in Form B1 of Schedule 9 to these Regulations. C8.04. The holder of a permit which has been issued under this Regulation shall not:- ( a) use such strychnine for any purpose other than ,that stated in the permit; (b) store such strychnine at a place other than that stated in the permit; (c) have any strychnine in his possession after the expiration of the time stated in the permit. CS.OS. A person shall not sell strychnine unless the intending purchaser produces a permit in Form B 1: Provided that this prohibition shall not apply to a bona fide whole sale sale by a licensed wholesale seller of poisons to a pharmacist or to another licensed seller of poisons. C8.06. A person who has obtained strychnine as the holder of a permit shall keep such strychnine under lock and key in a secure place. The key of such secure place shall remain at all times in the possession of the holder of the permit or of a responsible person delegated by such permit holder. C8.07. The permit holder or the responsible person delegated by him shall not at any time leave such strychnine as to be accessible to others. The Poisons Regulations of 1973 39

C8.08. A person who has strychnine in his possession at the time this regulation comes into force shall within the period of three months thereafter notify the Director-General to that effect and make application for a permit to be in possession of and for the use of such strychnine in accordance with the provisions of this Regulation. C8.09. A person who buys strychnine outside the State shall immediately such strychnine comes into his possession at any place within the State, notify the Director-General to that effect and make application for a permit to be in possession of and for the use of such strychnine in accordance with the provisions of this Regulation.

PART D-PROHIBITIONS AND AUTHORITIES IN RESPECT OF DANGEROUS DRUGS, RESTRICTED DRUGS AND PRO HIBITED PLANTS D 1. Prohibitions Dl.Ol. Unless he is authorised by or under these Regulations so to do a person shall not- ( a) have in his possession or on any premises or in any place; (b) supply or procure or offer to supply or procure to or for any person; (c) prescribe in a prescription; (d) dispense; (e) sell, a dangerous drug or a restricted drug.

D2. Authorities D2.01. A medical practitioner or a veterinary surgeon is hereby authorised only to the extent necessary for the practice of his respective profession and subject to the provisions of these Regulations- (a) to buy, obtain, administer, prescribe and dispense a dangerous drug or a restricted drug; (b) to have in his possession or upon the premises or place :~upied by him a dangerous drug or a restricted drug;

(c) to supply or procure or offer to supply or procure to or for a person a dangerous drug or a restricted drug. D2.02. A pharmaceutical chemist is hereby authorised only to the extent necessary for the conduct of his profession and subject to the provisions of these Regulations- (a} to buy, obtain, dispense and sell a dangerous drug or a restricted drug; (b) to have in his possession upon premises used as a dispensary and constructed, kept, and equipped in the manner prescribed by the Dispensary Regulations 1973 a dangerous drug or a restricted drug; and 40 The Poisons Regulations of 1973

D2.03. (a)- (i) A person who has obtained the degree of Bachelor of Pharmacy of the University of Queensland; (ii) A student enrolled in the course leading to the degree of Bachelor of Pharmacy of the University of Queensland; or (iii) A bona-fide paid assistant of a pharmaceutical chemist who has been authorised in writing by the Director General under this subregulation, is hereby authorised, subject to the provisions of these Regulations, to dispense and sell a dangerous drug or a restricted drug under the direction and personal supervision of a pharmaceutical chemist upon premises used as a dispensary and constructed, kept, and equipped in the manner prescribed by the Dispensary Regulations 1973. (b) A person who satisfies the Director-General that he is a bona-fide paid assistant of a pharmaceutical chemist and that he has served his apprenticeship under the By-laws of the Pharmacy Board then in force or has equivalent training and experience in dispensing to the satisfaction of the Director-General, may, at the absolute discretion of the Director-General be granted a written authority under this sub regulation to dispense and sell a dangerous drug, a restricted drug, or a poison under the direction and personal supervision of a pharmaceutical chemist. (c) A person, other than a person authorised to dispense and sell a dangerous drug or a restricted drug, shall not commit an offence against these Regulations merely by handing or delivering to the prescribee or his agent a dangerous drug or a restricted drug which has been dispensed by an authorised person.

D2.04. A dentist engaged in carrying on the practice of dentistry is hereby authorised only to the extent necessary for the practice of his profession and subject to the provisions of these Regulations- (a) to buy, obtain and administer in the treatment of his patients the dangerous drugs, cocaine and pethidine; (b) to have in his possession upon the premises or place occupied by him for the purpose of his practice of dentistry the dangerous drugs, cocaine and pethidine; (c) to buy, obtain and administer in the treatment of his patients and to have in his possession upon the premises or place occupied by him for the purpose of his practice of dentistry a restricted drug; and (d) to prescribe for the purposes of dental treatment of a person whom he is treating in the course of his practice of dentistry a restricted drug. The Poisons Regulations of 1973 41

D2.05. The master of every ship which is in port in the State is hereby authorised, subject to the provisions of these Regulations- ( a) to buy or obtain a dangerous drug or a restricted drug so far as is necessary to comply with the provisions of the Navigation Act 1912-1972 of the Commonwealth of Australia or the Queensland Marine Act 1958-1972 and any amendments thereto; and (b) to have upon such ship a dangerous drug or a restricted drug so far as is necessary to comply with the provisions of the Navigation Act 1912-1972 of the Commonwealth of Australia or the Queensland Marine Act 1958-1972 and any amendments thereto.

D2.06. (a) The vice-chancellor of a university is hereby authorised subject to the provisions of these Regulations and with the written approval of the Director-General- (i) to buy or obtain a dangerous drug or a restricted drug for bona-fide use in connection with a teaching or research function of such university; (ii) to have in his possession upon the premises of such university a dangerous drug or a restricted drug; and (iii) to supply to a member of the faculty or staff a dangerous drug or a restricted drug for bona-fide use in connection with a teaching or research function of such university. (b) The vice-chancellor of a university is hereby empowered to delegate the authorities prescribed in clause (a) hereof to the bursar or other officer of such university. (c) A member of the faculty or staff of a university is hereby authorised, subject to the provisions of these Regulations- (i) to have in his possession upon the premises of such university a dangerous drug or a restricted drug which has been supplied to him by the vice-chancellor or his delegate; and (ii) to use bona-fide such dangerous drug or restricted drug in connection with a teaching or research function of such university. D2.07. The permanent head of any Department of the Government of the State or Commonwealth or his nominee is hereby authorised, subject to the provisions of these Regulations- . (a) to buy or obtain a dangerous drug or a restricted drug; and (b) to have in or upon the premises of such Department a dangerous drug or a restricted drug.

D2.08. The medical superintendent of a hospital or an institution, or the pharmaceutical chemist in charge of the dispensary of a hospital or an institution, or the matron of a hospital or an institution, or the 42 The Poisons Regulations of 1973 person in charge of an institution are and each of them is hereby authorised, subject to the provisions of these Regulations- ( a) to buy, obtain and have in his or her possession upon such hospital or institution a dangerous drug or a restricted drug; and (b) to supply for the treatment of a patient of such hospital or institution, a dangerous drug or a restricted drug.

D2.09. A carrier, hired for the purpose of transport and delivery of dangerous drugs or restricted drugs, or a responsible person acting on his behalf, is hereby authorised to have such drugs in his possession, so far as such possession is necessary for the purpose of his hiring.

D2.10. The person in charge of any base or outpost established in the State by the Royal Flying Doctor Service of Australia is hereby authorised to buy or obtain and have in his possession such dangerous drugs and restricted drugs as may be, from time to time, considered necessary by a medical practitioner employed by the Royal Flying Doctor Service of Australia. D2.11. The Superintendent of an aerial ambulance service is hereby authorised to buy or obtain and have in his possession the dangerous drug pethidine in a quantity not exceeding six hundred milligrams.

D2.12. A registered nurse is hereby authorised to be in possession of a dangerous drug or a restricted drug only to the extent that such drug is required for the due performance of her professional duties and in pursuance of the instruction of a medical practitioner.

D2.13. (a) A licensed manufacturer of dangerous drugs is hereby authorised, subject to the provisions of these Regulations, to buy, obtain and have in his possession upon the premises or place specified in his licence the dangerous drug or dangerous drugs specified in his licence. (b) A licensed wholesale seller of dangerous drugs is hereby authorised, subject to the provisions of these Regulations, to buy, obtain and have in his possession upon the premises or place specified in his licence a dangerous drug. (c) A licensed manufacturer of restricted drugs or a licensed whole sale seller of restricted drugs is hereby authorised, subject to the provisions of these Regulations, to buy, obtain and have in his possession upon the premises or place specified in his licence a restricted drug. (d) A responsible adult employee of a licensed manufacturer of dangerous drugs or of a licensed wholesale seller of dangerous drugs or of a licensed manufacturer of restricted drugs or of a licensed whole sale seller of restricted drugs is hereby authorised within the scope of his employment and in pursuance of a bona-fide lawful transaction between such licensed manufacturer or wholesale seller and an authorised person to have in his possession a dangerous drug or a restricted drug in the course of its delivery to such authorised person: The Poisons Regulations of 1973 43

Provided that a dangerous drug in the possession of such employee is packed in accordance with the conditions prescribed by subregulation G2.03 of these Regulations. (e) A person who is the holder of a Wholesale Representative's Authority is hereby authorised, subject to the provisions of these Regulations, to obtain and to have in his possession or upon the premises .or place occupied by him the restricted drugs specified in such Authority. D2.14. An analyst or an inspector is hereby authorised to have in his possession a dangerous drug, restricted drug or a prohibited plant which has been obtained by him in the course of his duties. D2.15. The Director-General may authorise in writing the obtaining, possession, sale, supply or use of a dangerous drug or a restricted drug by a person under the conditions set out in such authority. D2.16. A school dental therapist who is performing prescribed duties under and within the meaning of the Dental Act 1971-1973 may, subject to these Regulations, use the following restricted drugs:- ScHEDULE 4 Anaesthetics, local, being synthetic cocaine substitutes, except when included in Schedule 3, lignocaine and prilocaine only. D2.17. An ambulance officer employed by a Queensland Ambulance Transport Brigade Committee and who has successfully completed a course at the Queensland Ambulance Transport Brigade Training School approved by the Director-General is hereby authorised to obtain, have in his possession and use the restricted drug ergometrine but only to the extent that such drug is required for due performance of his duties and in pursuance of the instruction of a medical practitioner. D2.18. The Commissioner of Police or his nominee is hereby authorised subject to the provisions of these Regulations- ( a) to acquire or obtain the prohibited plants or any species of a genus of such plants set out in the Schedule below; and (b) to have in or upon the premises of the Queensland Police Department the prohibited plants or any species of a genus of such plants set out in the said Schedule. SCHEDULE (a) Indian Hemp (Cannabis Sativa) ; (b) Mushroom (Psilocybe Cubensis); (c) Opium Poppy (Papaver Somniferum). D3. Suspension Etc D3.01. (a) The Director-General may at any time suspend or cancel an authority given pursuant to the provisions of Regulation D2 of these Regulations to any person, who has been convicted of an offence against the Act or against these Regulations or who is deemed by the Director General to be unfit to be so authorised. (b) The Director-General, in his discretion, may rescind any such suspension or cancellation. 44 The Poisons Regulations of 1973

PARTE-LICENCES AND OBLIGATIONS FOR TilE MANUFACTURE OR SALE BY WHOLESALE OF DANGEROUS DRUGS El. Licence to Manufacture Dangerous Drugs El.Ol. Unless he is licensed under these Regulations so to do a person shall not manufacture a dangerous drug: Provided that the provisions of this subregulation shall not apply to the manufacture of a substance, where such manufacture is subject to licence, permit, or authority under the provisions of the Narcotic Drugs Act 1967 of the Commonwealth of Australia. E1.02. A person who satisfies the Director-General that he intends to conduct a bona-fide business as a manufacturer of dangerous drugs, that he is a fit and proper person to be allowed to manufacture dangerous drugs, and that the manufacture of such dangerous drugs will be at all times under the personal supervision of a person qualified to the satis faction of the Director-General may at the absolute discretion of the Director-General and on payment of a fee of One hundred and sixteen dollars ($116) be granted a licence in Form T of Schedule 9 to manufacture the dangerous drugs or class or classes or dangerous drugs specified in such licence at the premises specified in such licence, under and subject to the provisions of these Regulations. E1.03. An application for a licence under this Regulation shall be made in Form S of Schedule 9 and shall be accompanied by the prescribed fee of One hundred and sixteen dollars ( $116).

E2. Licence to Sell Dangerous Drugs by Wholesale E2.01. Unless he is licensed under these Regulations so to do a person shall not sen by wholesale a dangerous drug. E2.02. A person who satisfies the Director-General that he intends to conduct a bona-fide business as a wholesale seller of dangerous drugs, that he is a fit and proper person to be allowed to sell dangerous drugs by wholesale, and that the sale of such dangerous drugs will be at all times under the personal supervision of a competent and responsible person may at the absolute discretion of the Director-General and on payment of a fee of One hundred and sixteen dollars ($116) be granted a licence in Form R of Schedule 9 to sell by wholesale dangerous drugs at the premises specified in such licence, under and subject to the provisions of these Regulations. For the purposes of this subregulation, the term "wholesale" shall be deemed to include sale or supply to a person authorised under Part D of these Regulations to buy or obtain a dangerous drug, whether or not for the purpose of resale. E2.03. An application for a licence under this Regulation shall be in Form Q of Schedule 9 and shall be accompanied by the prescribed fee of One hundred and sixteen dollars ( $116). The Poisons Regulations of 1973 45

E3. General Conditions of Licences E3.01. For the purposes of these Regulations a person licensed to manufacture dangerous drugs shall also be deemed to be licensed to sell by wholesale dangerous drugs. E3.02. (a) A licence granted by the Director-General under the provisions of .this Part shall be in force only in respect of single individual premises specified in the application for such licence, and in such licence, until the thirtieth day of September then next following, unless sooner suspended or cancelled. (b) Such licence may be renewed annually in the discretion of the Director-General on payment, not less than one (1) day before the expiration of ,the existing licence, of a fee of One hundred and sixteen dollars ( $116) for each renewal. (c) An application for the renewal of any such licence shall be made in Form L of Schedule 9 and shall be accompanied by the prescribed fee of One hundred and sixteen dollars ( $116) . (d) The renewal of such licence shall be in Form M of Schedule 9. E3.03. (a) The Director-General may suspend or cancel a licence granted under the provisions of this Part held by a person- (i) who has been convicted of an offence against the pro visions of the Act or of these Regulations; or (ii) W.h9,js deemed by the Director-General to be unfit to hdld s~cfi:J,icence; or (iii) whose premises are deemed by the Director-General to be unfit for the purpose for which such licence was granted. (b) The Director-General, in his discretion, may at any time reinstate or cancel a suspended licence. E3.04. A person licensed under this Part shall- ( a) not manufacture, sell, keep nor have a dangerous drug except upon the premises specified in his licence; (b) not manufacture a dangerous drug except under the personal supervision of the qualified person named in his licence; (c) not transact any dealing in a dangerous drug except by himself or a competent and responsible person acting on his behalf; (d) not sell nor supply a dangerous drug except to a person authorised under Part D of these Regulations to buy or obtain such dangerous drug and in accordance with the provisions of Part G of these Regulations; (e) keep and store every dangerous drug in his possession in accordance with the provisions of Part K of these Regulations.

E4. Records of Transactions in Dangerous Drugs E4.01. A manufacturer of and a wholesale seller of dangerous drugs shall keep at the premises or place specified in his licence a book or books, hereinafter referred to as the "Drugs Register" in which he shall record 46 The Poisons Regulations of 1973 or cause to be recorded in ink on the day of a transaction in a dangerous drug full particulars of each such transaction in the manner hereinafter provided. E4.02. (a) Such Drugs Register shall contain a separate book or a separate page or portion of a book for each class of dangerous drug. (b) Each page in such Drugs Register shall contain a general heading describing the class of dangerous drug recorded therein, and the unit of measure in which quantities of such class of dangerous drug are recorded. (c) Each such page shall be ruled into columns, and each such column shall contain a heading describing the nature of the particulars recorded therein. (d) Transactions in dangerous drugs of one and the same class shall be entered in the appropriately headed page on consecutive lines in chronological order of their occurrence. E4.03. The particulars prescribed to be recorded in such Drugs Register in respect of each transaction are the following:- ( a) The date of such transaction; (b) The name and the address of the person from whom a danger ous drug was obtained or to whom a dangerous drug was supplied in such transaction, or if such a person is not concerned in the transaction a description of the nature of the transaction; (c) The invoice number or other distinctive transaction number assigned to :;uch transaction by the supplier (if any); (d) The quantity of the class of dangerous drug obtained, supplied, or otherwise involved in such transaction; and (e) The quantity (called the "balance") of such class of dangerous drug in the stock of the licensed manufacturer or seller at the conclusion of such transaction. E4.04. A person who holds such licences in respect of more than one premises or place shall keep separate Drugs Registers and other records as prescribed in this Regulation in respect of each such premises or place. E4.05. The Director-General, in his absolute discretion, may, in a particular case, approve of any Drugs Register, record, or entry, being made or kept in a manner or form different from the manner or form prescribed in this Regulation. E4.06. (a) A manufacturer of and a wholesale seller of dangerous drugs shall keep each Drugs Register and book forming part of a Drugs Register for a period of two years from the date of the last transaction recorded therein. (b) A manufacturer of and a wholesale seller of dangerous drugs shall make each such Drugs Register and book available for inspection when so required by an inspector. The Poisons Regulations of 1973 47

ES. Reports of Transactions in Dangerous Dmgs ES.Ol. For the purposes of this Regulation a "report week" shall be a period, not necessarily of seven days, shown as a report week in a "Movements of Drugs of Dependence Calendar" published by the Director-General by notification in the Gazette. E5.02. A person licensed under this Part shall- (a) make and forward in the manner hereinafter prescribed a report of all transactions in dangerous drugs made by him during each report week; (b) make and forward to the Director-General a list of the account numbers used by. him in completing such reports, together with the name and address of the person to whom each such account number is respectively applicable; and (c) within seven days of making any addition, deletion or alteration affecting any such account number, name or address, notify the Director-General of the nature and particulars of such addition, deletion or alteration.

E5.03. Each such report shall- (a) be entitled "Report on Movements of Drugs of Dependence"; (b) be made in the form provided by the Director-General for that purpose; (c) be made in accordance with such instructions on the completion of such report as may be issued from time to time by the Director-General; (d) describe the composition, form, strength, size and quantity of a dangerous drug by means of a numerical code issued from time to time by the Director-General; (e) identify .the person from whom a dangerous drug has been obtained by him or to whom a dangerous drug has been supplied by him in a transaction by means of the account number applicable to such person as prescribed in subregula tion E5.02; (f) be completed and forwarded in duplicate by pre-paid post addressed to the Commonwealth Department of Health, Canberra not later than three days after the last day of the report week in respect of which such report is prescribed to be made; and (g) be endorsed on the face thereof with the word "Nil" if a transaction in a dangerous drug has not been made during such report week. 48 The Poisons Regulations of 1973

PART F-LICENCES AND OBLIGATIONS FOR THE MANUFACTURE OR SALE BY WHOLESALE OF RESTRICTED DRUGS Fl. Licence to Manufacture Restricted Drugs Fl.Ol. Unless he is licensed under these Regulations so to do a person shall not manufacture a restricted drug. F1.02. A person who satisfies the Director-General that he intends to conduct a bona-fide business as a manufacturer of restricted drugs, that he is a fit and proper ,person to be allowed to manufacture restricted drugs, and that the manufacture of such restricted drugs will be at all times un.<;l~r,.-the personaLsll.I?er:v:ision of a person qu;1lifi~d to the satis fa<;~ion of the, Director-General may at the absolute discretion of the Director-{:Jenetal and on payment of a fee of One hundred and sixteen dollars ($116) be granted a licence in Form Z of Schedule !l to manu facture restricted drugs at the premises specified in such licence under and subject to the provisions of these Regulations. F1.03. An application for a licence under this Regulation shall be in Form Y of Schedule 9 and shall be accompanied by the prescribed fee of One hundred and sixteen dollars ( $116).

F2. Licence to Sell Restricted Drugs by Wholesale F2.01. Unless he is licensed under these Regulations so to do a person shall not sell by wholesale a restricted drug. F2.02. A person who satisfies the Director-:General that he intends to conduct a bona-fide business as a wholesl\:lfV s&iler of restricted drugs, that he is a fit and proper person to be allowed to sell restricted drugs by wholesale, and that the sale of such restricted drugs will be at all times under the personal supervision of a competent and responsible person may at the absolute discretion of the Director-General and on payment of a fee of One hundred and sixteen dollars ( $116), be granted a licence in Form W of Schedule 9 to sell by wholesale restricted drugs at the premises specified in such licence under and subject to the provisions of these Regulations. ' For the purposes of this subregulation, the term "wholesale" shall be deemed to include sale or supply to a person authorised under Part D of these Regulations to buy or obtain a restricted drug, whether or not for the purpose of resale. F2.03. An application for a licence under this Regulation shall be in Form V of Schedule 9 and shall be accompanied by the prescribed fee of One hundred and sixteen dollars ( $116) . F3. General Conditions of Licences F3.01. (a) For the purposes of these Regulations a person licensed to manufacture restricted drugs shall also be deemed to be licensed to sell by wholesale restricted drugs. The Poisons Regulations of 1973 49

(b) For the purposes of these Regulations a person licensed to manufacture restricted drugs or to sell by wholesale restricted drugs shall also be deemed to be licensed to manufacture and/ or sell by wholesale the poisons specified in Schedules 1, 2, 3 and 7 and in Appendix A to Schedule 6.

F3.02. (a) A Licence granted by the Director-General under the provisions of this Part shall be in force only in respect of single individual premises specified in the application for such licence, and in such licence, until the thirtieth day of September then next following, unless sooner suspended or cancelled. (b) Such licence may be r~newed lillnually in the discretion of the Director-General on payment, p.ot less than one (1) day before the expiration of the existing licence~ of a fee of One hundred and sixteen dollars ( $116). (c) An application for the renewal of any such licence shall be made in Form L of Schedule 9 and shall be accompanied by the prescribed fee of One hundred and sixteen dollars ( $116). (d) The renewal of such licence shall be in Form M of Schedule 9.

F3.03. (a) The Director-General may :suspend or cancel a licence granted under the provisions of this Part held by a person- (i) who has been convicted of an offence against the provisions of the Act or of these Regulations; (ii) WFQ is .. deemed by the Director-General to be unfit to hold such licence; or ' (iii) whose premises are deemed by the Director-General to be unfit for the purpose for which such licence was granted. (b) The Director-General, .in his discretion, may at any time reinstate or cancel ·a' suspended lic~n~e.

F3.04. A person licensed under this Part shall- (a) not manufacture, sell, keep nor have a restricted drug except upon the premises specified in his licence; (b) not manufacture a restricted drug except under the personal supervision of the qualified person named in his licence; (c) not transact any dealing in a restricted drug or poison except by himself or a competent and responsible person acting on his behalf; (d) not sell nor supply a restricted drug except to a person authorised under Part D of these Regulations to buy or obtain such drug and in accordance with the provisions of Part G of these Regulations; (e) keep and store every restricted drug in his possession in accordance with the provisions of Part K of these Regulations. 50 The Poisons Regulations of 1973

F4. Supply of Samples F4.01. Notwithstanding the foregoing provlSlons of this Part, a licence granted under this Part shall be deemed to authorise the supply of a restricted drug as a sample at a place other than the premises specified in such licence if such supply is made by the holder of a Wholesale Representative's Authority acting as an employee of the licensee. F4.02. A person licensed or authorised under this Part shall not supply a restricted drug as a sample unless- (a) the person to whom the restricted drug is supplied is a person authorised to administer such restricted drug in the practice of his profession; and (b) he complies with all other provisions of these Regulations relating to the sale or supply of restricted drugs.

FS. Records of Transactions in Restricted Drugs FS.Ol. A person licensed under this Part shall at the time of each sale or supply of a restricted drug, issue to the purchaser or the person supplied an invoice containing the following particulars:- (a) The date of such sale or supply; (b) The name and address of the purchaser or the person supplied; and (c) The description and quantity of the restricted drug sold or supplied, and shall keep at his place of business a faithful record of every such invoice and the particulars contained therein for a period of not less than two years from the date of such invoice and shall make such record available for inspection on demand of an inspector. FS·.02. A person licensed under this Part who employs a person who is the holder of a Wholesale Representative's Authority shall- (a) at the time of each supply of a restricted drug to such person, issue to him an invoice in accordance with -subregula tion FS.Ol; (b) ensure that such person complies with the provisions of subregulation F6.05; (c) examine every copy invoice and "Return of Restricted Drugs" furnished by such person to ensure that each restricted drug is duly accounted for; (d) file and preserve at the premises specified in his licence, every such copy invoice and "Return of Restricted Drugs" for a period of two years, and make the same readily available for inspection upon the demand of an inspector; and (e) upon any discrepancy appearing in a return furnished by such person, or upon such person failing to give due account of a restricted drug supplied to him, forthwith report the circum stances to the Director-General. The Poisons Regulations of 1973 51

F6. Wholesale Representative's Authority F6.01. A person who satisfies the Director-General that he is employed by a licensed manufacturer of or a licensed wholesale seller of restricted drugs in a capacity which requires him to be in possession of restricted drugs for the purpose of display and/ or supply to medical, veterinary and/or dental practitioners, and that he is a fit and proper person to be allowed to have in his possession restricted drugs may, at the absolute discretion of the Director-General, and on payment of a fee of Twenty-four dollars ( $24), be granted a Wholesale Representative's Authority in Form P of Schedule 9 to have in his possession restricted drugs under and subject to the provisions of these Regulations and to the conditions set forth in such Authority. · F6.02. An application for an Authority under this Regulation shall be in Form 0 of Schedule 9 and shall be accompanied by the prescribed fee of Twenty-four dollars ( $24). F6.03. An Authority granted by the Director-General under the provisions of this Regulation shall be in force until the thirtieth day of September then next following, unless sooner suspended or cancelled, and shall not be renewable. F6.04. (a) The Director-General may suspend or cancel an Authority granted under the provisions of this Regulation held by a person- (i) who has been convicted of an offence against the provisions of the Act or of these Regulations; or (ii) who is deemed by the Director-General to be unfit to hold such Authority. (b) The Director-General, in his discretion, may at any time reinstate or cancel a suspended Authority. F6.05. The holder of a Wholesale Representative's Authority shall: ( a) Keep every restricted drug in his possession in a secure place under lock and key and in such a manner as not to be visible to the public; (b) At the time of each supply of a restricted drug whether as a sample, or by return to his employer, or otherwise, issue to the person supplied an invoice as prescribed in subregulation F5.01; (c) Within seven days after the issue of an invoice as aforesaid, forward a copy of such invoice to his employer; (d) at intervals not exceeding seven days furnish to his employer, at the address specified in his licence, a "Return of Restricted Drugs" containing the following particulars:- (i) The dates of the first and last days of the period covered by the return; (ii) The quantity of each class of restricted drug in his possession at the commencement of the period, being the quantity brought forward from the previous period (if any); 52 The Poisons Regulations of 1973

(iii) The quantity of each class of restricted drug respectively received, supplied, or returned by him during the period, together with the invoice number of each transaction; (iv) The quantity of each class of restricted drug in his posses sion at the conclusion of the period covered by the return; (e) Forthwith upon the occurrence of any loss or theft of a restricted drug, report the circumstances to the officer in charge of the nearest Police Station, and to his employer; (f) Account to the satisfaction of an inspector for each and every quantity of a restricted drug which has been in his possession at any time during the preceding twelve months; and (g) Have in his possession and produce upon the demand of an inspector the quantity of a restricted drug which ought to be in his possession according to the records relating thereto.

PART G-OBTAINING OF DRUGS ON WRITTEN ORDER Gl. Authorised Persons to Obtain on Written Order Gl.Ol (a) A person authorised by or under Regulation D2 of these Regulations to buy or obtain a dangerous drug or a restricted drug shall do so upon a written order in accordance with the provisions of this Part. (b) A person shall not sell nor supply a dangerous drug or a restricted drug to a person authorised by or under Regulation D2 of these Regulations to buy or obtain such dangerous drug or restricted drug otherwise than- (i) upon a dated and signed written order in accordance with the provisions of this Part; and (ii) by delivery in accordance with the provisions of Regulation G2 of these Regulations. (c) Notwithstanding the foregoing provisions of this Regulation, a written order shall not be required for the sale or supply to a medical practitioner, a veterinary surgeon, a dentist, or a pharmaceutical chemist of a restricted drug unless such restricted drug is a substance to which the provisions of subregulation A6.01 apply. Gl.02. A written order under this Part shall (a) be legibly written in ink; (b) bear on the face thereof- (i) the date when it is so written: The Poisons Regulations of 1973 53

(ii) the name and address of the person, hospital, university, institution, college, establishment, department, base, or service requiring the supply; and (iii) the quantity and description of the dangerous drug or the restricted drug to be supplied; and (c) be signed as prescribed by subregulation Gl.03.

Gl.03. (a) For a sale or supply of a dangerous drug or a restricted drug to a medical practitioner, a veterinary surgeon, a dentist or a pharmaceutical chemist, such written order shall be signed by such medical practitioner, veterinary surgeon, dentist or pharmaceutical chemist with his usual signature. (b) For a sale or supply of a dangerous drug or a restricted drug to the master of a ship which is in port in Queensland, such written order shall be signed by such master with his usual signature, or by the chief officer of the ship with his usual signature. (c) For a sale or supply of a dangerous drug or a restricted drug to a university, such written order shall be signed by the vice-chancellor or his delegate with his usual signature. (d) For a sale or supply of a dangerous drug or a restricted drug to a Department of the Government of the State or Commonwealth, such written order shall be signed by the permanent head or an officer nominated by him, with his usual signature. (e) For a sale or supply of a dangerous drug or a restricted drug to a hospital or institution such written order shall be signed by any one of the following persons associated with the hospital or institution: (i) the medical superintendent; (ii) a matron; (iii) a medical practitioner practising thereat; or (iv) a pharmacist in charge of the dispensary as an employee. (f) For a sale or supply of a dangerous drug or a restricted drug to the person in charge of a base or outpost established in the State by the Royal Flying Doctor Service of Australia, such written order shall be signed by a medical practitioner employed by the Royal Flying Doctor Service of Australia with his usual signature. (g) For a sale or supply of pethidine to the superintendent of an aerial ambulance service, such written order shall be signed by a medical practitioner with his usual signature. (h) For a sale or supply of a dangerous drug or a restricted drug to a licensed manufacturer of dangerous drugs, a licensed wholesale seller of dangerous drugs, a licensed manufacturer of restricted drugs, or a licensed wholesale seller of restricted drugs, such written order shall be signed by the licensee, or by a competent and responsible person authorised by him for this purpose, with his usual signature. 54 The Poisons Regulations of 1973

(i) For a sale or supply of a dangerous drug or a restricted drug to a person authorised under subregulation D2.15 of these Regulations, such written order shall be signed by such person, or by a competent and responsible person authorised by him for this purpose, with his usual signature.

G2. Delivery of Dangerous and Restricted Drugs G2.01. (a) Delivery of a dangerous drug to an authorised person may be made- (i) by personal delivery at the seller's premises by the seller or his responsible and competent employee to the authorised person or his responsible and competent employee; or (ii) by personal delivery at the authorised person's premises by the seller or his responsible and competent employee to the authorised person or his responsible and competent employee. (b) In every such case- (i) the seller shall obtain the written order hereinbefore prescribed at or before the time of delivery; and (ii) the seller shall obtain from the person to whom such dangerous drug is delivered a dated and signed acknowledgment of receipt of such dangerous drug at the time of delivery. Such acknowledgement of receipt shall be endorsed upon or attached to the written order and shall be forwarded or filed, as the case may be, together with such written order as prescribed by Regulation G3.

G2.02. (a) Delivery of a dangerous drug to an authorised person may be made by forwarding such dangerous drug by registered post or by a carrier or transport service whereby signed or officially receipted documentary proof of consignment and delivery is obtained. (b) In every such case- (i) the seller shall file and preserve every signed or officially receipted document affording proof of consignment for a period of two years from the date of such consignment; and (ii) the authorised person shall forward the written order herein before prescribed to the seller not later than twenty-four hours after the receipt of such dangerous drug. (c) A person who, having forwarded a dangerous drug for delivery to an authorised person in the manner prescribed in this subregulation, does not receive within seven days from such authorised person a written order in accordance with this Part for such dangerous drug shall forthwith report the circumstances to the Director-General. The Poisons Regulations of 1973 55

G2.03. A person shall not deliver nor forward for delivery a dangerous drug in the manner prescribed in subclause G2.01 (a) (ii) or in clause G2.02 (a) unless- ( a) Such dangerous drug is delivered or forwarded separately from goods of any other kind in a securely closed package addressed to such authorised person; and (b) Such package contains a packing slip or similar document, placed immediately beneath the outer enclosure or wrapping of such package, so as to be visible on the opening of such outer enclosure or wrapping, and such packing slip or similar document bears the following words in bold-faced sans-serif capital letters with a face depth of not less than 12 · 5 ., millimetres:- DANGEROUS DRUGS CHECK

CAREFULLY., G2.04. (a) Delivery of a restricted drug to an authorised person may be made- (i) by personal delivery at the seller's premises by the seller or his responsible and competent employee to the authorised person or his responsible and competent employee; (ii) by personal delivery at the authorised person's premises by the seller or his responsible and competent employee to the authorised person or his responsible and competent employee; or (iii) by forwarding such restricted drug by post or by a carrier or transport service. (b) A person shall not deliver nor forward for delivery a restricted drug in the manner prescribed in subclause (ii) or subclause (iii) of clause (a) hereof unless such restricted drug is contained in a securely closed package addressed to such authorised person. 56 The Poisons Regulations of 1973

G3. Endorsing and Disposal of Written Orders G3.01. A pharmaceutical chemist or a person authorised under the provisions of subregulation D2.03 who, pursuant to a written order as prescribed in Regulation G 1 of these Regulations, sells or supplies a dangerous drug or a substance to which the provisions of subregulation A6.01 apply shall endorse in ink in his own handwriting on the face of such order the date of such sale or supply and his usual signature, and shall further endorse the face of such order with the address of the dispensary at or from which the sale or supply was made, and shall forward such order within fourteen days of such date to the Director General. G3.02. A pharmaceutical chemist or a person authorised under the provisions of subregulation D2.03 who, pursuant to a written order as prescrib((d in Regulation G 1 of these Regulations, sells or supplies a restricted drug other than a substance to which the provisions of subregulation A6.01 apply and any other person who, pursuant to a written order as prescribed in Regulation G 1 of these Regulations, sells or supplies a dangerous drug or a restricted drug shall endorse in ink in his own handwriting on the face of such order the date of such sale or supply and his usual signature and shall file and preserve such order for a period of two years from such date. G3.03. In respect of an order written under the National Health Act 1953-1972 of the Commonwealth of Australia the duplicate of such order shall be and be deemed to be a written order for the purposes of this Regulation.

G4. Supplies of Drugs to Ships G4.01. The provision of this Regulation shall be in addition to those prescribed elsewhere in these Regulations. G4.02. A person shall not supply a dangerous drug or a restricted drug to the master of a ship unless such person has been specifically authorised so to do in writing by the Director-General under this Regulation. G4.03. A person shall not supply a dangerous drug or a restricted drug to the master of the ship unless- (a) the written order prescribed in Regulation G1 is received in duplicate; (b) such written order is endorsed in writing by the ship's owners or agents in Queensland; (c) he endorses both the original and duplicate of such order in the manner prescribed by this Regulation; and (d) within forty-eight hours after supplying such dangerous drug or restricted drug he forwards one copy of such order to the Director-General. The Poisons Regulations of 1973 57

PART H-PRESCRIBING DISPENSING AND SUPPLYING OF DRUGS Hl. Prescription Necessary to Dispense Hl.Ol. For the purpose of this Part a declared drug is an article or substance for the time being declared by the Governor in Council by Order in Council to be a dangerous drug for the purposes of Section 130 of the Act. Hl.02. Save as is by these Regulations otherwise expressly provided a person shall not dispense nor sell a dangerous drug or a restricted drug otherwise than upon and in accordance with the prescription of a person authorised by a provision of Regulation D2 of these Regula:tions to prescribe such dangerous drug or restricted drug: Provided however that a pharmacist may supply in an emergency and without prescription a restricted drug other than a declared drug to a person if:- (a) the pharmacist believes on reasonable grounds that: (i) an emergency exists; (ii) the person seeking the drug is under medical treatment which requires the use of such drug; and (iii) the continuation of the treatment is essential to the person's well being; (b) the quantity supplied does not exceed three day's supply or in the case of pre-packed liquids, creams, ointments and aerosols the minimum standard pack; (c) the drug supplied is in a container which shall have securely attached thereto a label on which is written- (i) the words "Keep Out of Reach of Children" in red on a background of contrasting colour and in bold faced sans serif capital letters with a face depth of not less than 1· 5 m.illimetres; (ii) the words "Emergency Supply" in such colour as to afford a distinct contrast to the background colour and in bold faced sans serif capital letters with a face depth of not less than 1 · 5 millimetres; (iii) the name of the patient for whose treatment such drug is intended; (iv) the name and address of the. seller or supplier; ( v) the date orf supply; (vi) a description of the contents in one of the following forms- (1) the approved name of the preparation; (2) the trade name of the preparation; ( 3) the approved name orf each drug or poison present in the preparation; and (d) the pharmacist keeps at every premises where he carries on his profession or of which he is in charge as an employee a 58 The Poisons Regulations of 1973

record book referred to as the "Emergency Supply Book", in which he shall record at the time of supplying a restricted drug in an emergency the following particulars- (i) the name and address of the person to whom the restricted drug was supplied; (ii) the date of supply; (iii) the description and quantity of the restricted drug supplied; (iv) the directions given for the use of the restricted drug; ( v) the name of the medical practitioner who last prescribed the drug.

H2. Writing of Prescriptions H2.01 (a) A person authorised to prescribe a dangerous drug or a restricted drug shall not prescribe in a prescription a dangerous drug or a restricted drug unless such prescription complies in full with the provisions, limitations and conditions prescribed in this Regulation. (b) Such prescription shall bear on the face thereof legibly printed or written in ink (i) the name; (ii) the professional qualifications; and (iii) the address of the person writing it, hereinafter referred to as "the prescriber". (c) Such prescription shall bear on the face thereof legibly written in ink in the handwriting of the prescriber- (i) the date when it is so written; (ii) the name and address of the person for whose treatment it is intended, or, if intended for animal treatment, the name and address of the owner of the animal; (iii) the description and quantity of dangerous drug, restricted drug or preparation to be dispensed; (iv) adequate directions for use, including, where applicable, the dose to be taken or administered: Provided that if the prescription is written by a medical practitioner and directs a dose in excess of the official dose such direction shall be underlined and initialled by the prescriber: Provided further that if the prescription is written by a dentist it shall not direct a dose in excess of the official dose; ( v) a direction setting out the number of times the dispensing is to be repeated, unless the prescriber intends that the dangerous drug, restricted drug or preparation shall be dispensed on one occasion only: Provided that- (i) a direction to repeat the dispensing of a danger ous drug or a declared drug within the meaning The Poisons Regulations of 1973 59

of Regulation H7 shall not be valid unless such direction also specifies the time interval between successive dispensings; (ii) a direction to repeat the dispensing of any item in a prescription which prescribes two or more items to be dispensed as separate articles shall not be valid if any of such items is a dangerous drug; and (iii) a direction to repeat the dispensing of a dangerous drug or a restricted drug upon the prescription of a veterinary surgeon shall not be valid for more than two such repeat dispensings; (vi) the words "for animal treatment only" if it is written by a veterinary surgeon; and (vii) the words "for dental treatment only" if it is written by a dentist. (d) Such prescription shall be signed in ink by the prescriber with his usual signature. (e) Such prescription shall not have anything written thereon in cipher or secret code. H2.02. (a) Notwithstanding the provisions of subregulation H2.01 a medical practitioner authorised by a provision of Regulation D2 of these Regulations to prescribe a dangerous drug or a restricted drug may, if he has reasonable grounds for believing an emergency exists, issue to a pharmacist a verbal prescription which prescribes a dangerous drug or a restricted drug. In every such case, such medical practitioner shall immediately thereafter reduce such verbal prescription to writing and within twenty-four hours of the issue of such verbal prescription, despatch the written prescription to such pharmacist. (b) A pharmaceutical chemist, who, having dispensed a dangerous drug or a restricted drug upon a verbal prescription, does not receive within seventy-two hours from the medical practitioner issuing such verbal prescription a written prescription in confirmation of such verbal pre scription, shall immediately report the circumstances to the Director General.

H3. Conditions of Dispensing H3.01. A person to whom a prescription prescribing a restricted drug or a dangerous drug is submitted for dispensing, shall first satisfy himself that such prescription is in accordance with the requirements of these Regulations. H3.02. A person shall not dispense a dangerous drug or a restricted drug upon a prescription- (a) unless and until he is satisfied that the medical practitioner or the veterinary surgeon or the dentist who signed the pre scription is a medical practitioner or a veterinary surgeon or a dentist duly registered within the State of Queensland; 60 The Poisons Regulations of 1973

(b) which is obliterated in whole or in part, or is illegible or is defaced, or if such prescription appears to him to have been altered in any way !>Y a person other than the prescriber; (c) which bears, stamped or written on it, the word "cancelled"; (d) beyond the number of times authorised by a valid direction to repeat therein, or after a less interval than the interval, if any, specified therein; (e) which has been written or bears a date more than six months prior to the date of its presentation; (f) unless the dangerous drug or restricted drug so dispensed conforms in quantity, description, composition, strength, form, and every other material particular to the directions of the prescriber; (g) unless such prescription complies in full with the provisions, limitations and conditions prescribed in Regulation H2 of these Regulations.

H3.03. (a) An authorised person shall retain possession of a prescription which prescribes a restricted drug or a dangerous drug which is presented to him for dispensing and which he suspects of being false in any particular and shall hold such prescription for such reasonable period as will enable him to satisfy himself as to its genuineness and make enquiries concerning the bona-fides of the person by whom it is presented or concerning the identity of the individual by whom such prescription purports to have been written. (b) When a person to whom a prescription is submitted for dis pensing is satisfied that such prescription is not in accordance with the requirements of these Regulations, he shall take possession of it, cancel it, and endorse upon its face in ink in his own handwriting the date and his usual signature, together with the address of the dispensary either stamped or written, and forward it to the Director-General within fourteen days. (c) A person shall not bring nor be entitled to bring an action against a person who retains, holds, endorses, cancels, and/ or forwards a prescription in compliance with the provisions of this subregulation.

H4. Interstate Prescriptions and the Like H4.01. (a) Notwithstanding the foregoing provisions of this Part, an authorised person may, in his discretion, dispense on one occasion only a restricted drug, other than a restricted drug to which the provisions of subregulation A6.01 apply, upon a prescription which reasonably appears to be- (i) written by a person who is a legally qualified practitioner of medicine, veterinary medicine, or dentistry at the place where the prescription was written, being a place in Australia outside the State; and (ii) in all other respects in accordance with the requirements of these Regulations. The Poisons Regulations of 1973 61

(b) An authorised person who dispenses a restricted drug under the authority of clause (a) hereof shall take possession of the prescription, endorse and cancel it in the manner prescribed by clause (a) of sub regulation H5.01 of these Regulations, and forward it to the Director-General within fourteen days of such dispensing.

HS. Endorsing and Disposal of Prescriptions HS.Ol. (a) A person who dispenses a dangerous drug or a restricted drug upon a prescription shall, on the day he dispenses such dangerous drug or restricted drug, endorse in ink on the face of such prescription (i) in his own handwriting, the date of such dispensing; (ii) his usual signature; (iii) the address of the dispensary; (iv) the repeat number, if it is a repeat dispensing; and ( v) the word "cancelled": Provided that in the case of a prescription bearing a valid direction to repeat, the provisions of subclause (v) shall apply only to the last occasion of dispensing upon such prescription as determined by the prescriber's direction thereon. (b) A person who dispenses a dangerous drug or a substance to which the provisions of subregulation A6.01 apply upon a prescription shall, within fourteen days of such dispensing, forward such prescription to the Director-General: Provided that in the case of a prescription bearing a valid direction to repeat, the provisions of this clause (b) shall apply only to the last occasion of dispensing upon such prescription as determined by the prescriber's direction thereon. (c) In respect of a prescription prescribing a dangerous drug or a substance to which the provisions of subregulation A6.01 apply issued under the National Health Act 1953-1972 of the Commonwealth of Australia or the Repatriation Act 1920-1973 of the Commonwealth of Australia the duplicate of such prescription shall be and be deemed to be a prescription for the purposes of this subregulation orily: Provided that it shall not be necessary to endorse on such duplicate the word "cancelled".

H6. Records to be Kept of Transactions in Dangerous Drugs H6.01. A pharmaceutical chemist shall keep at a dispensary of which he is in charge, either as an owner or employee, a record book (hereinafter referred to as the "Drugs Book") in or to the effect of Form D of Schedule 9, in which he shall record or cause to be recorded in ink on the day of a transaction in a dangerous drug all transactions in a dangerous drug in the manner hereinafter provided.

H6.02. (a) In such Drugs Book each page shall contain entries relating to one class of dangerous drug orily. 3 62 The Poisons Regulations of 1973

(b) Each such page shall have a heading describing the class of dangerous drug recorded therein and the unit of measure in which quantities of such class of dangerous drug are recorded. (c) Transaction;:; in dangerous drugs of one and the same class shall be entered in the appropriately headed page on consecutive lines in chronological order of their occurrence. (d) Upon commencing a new page in such Drugs Book such pharmaceutical chemist shall record as the first entry on such page a statement of the quantity (if any) of the class of dangerous drug described in the page heading in stock at the time such page is commenced, together with a reference to the last previous record (if any) relating to the same class of dangerous drug. (e) Upon commencing a new Drugs Book such pharmaceutical chemist shall take stock of all dangerous drugs in his possession and shall record a statement of the quantity (if any) of each class of dangerous drug in stock at the time such book is commenced as the first entry on each appropriately headed page, together with a reference to the last previous record (if any) relating to the same class of dangerous drug. H6.03. (a) In such Drugs Book a pharmaceutical chemist or other authorised person shall personally record full particulars, as herein after prescribed, of each quantity of dangerous drug from time to time purchased, obtained, received, sold, supplied, dispensed or compounded by him and of each quantity of dangerous drug in his possession or under his control involved in a transaction of any other kind. (b) Such pharmaceutical chemist or other authorised person shall initial the line containing such recorded particulars. (c) The particulars prescribed to be recorded in the Drugs Book in respect of each transaction are the following:- (i) the date of the transaction; (ii) the name and address of the person from whom a quantity of dangerous drug is purchased, obtained or received or to whom a quantity of dangerous drug is sold, supplied or dispensed in such transaction, or if such a person is not concerned in the transaction a description of the nature of the transaction; (iii) the quantity of the class of dangerous drug purchased, obtained or received, or sold, supplied, dispensed or com pounded or otherwise involved in the transaction; (iv) in the case of a quantity of dangerous drug purchased, obtained or received, the supplier's invoice number; or in the case of a quantity of dangerous drug sold, supplied or dispensed, the distinguishing number allotted by him to the prescription or order; (v) the quantity (called the "balance") of such class of dangerous drug in the stock of the dispensary at the conclusion of such transaction; and The Poisons Regulations of 1973 63

(vi) in the case of a quantity of dangerous drug sold, supplied or dispensed, the name of the person who wrote the prescription or order for such drug. '

H6.04. A person shall not alter, obliterate nor cancel an entry in a Drugs Book, other than for the purpose of correcting an error in such entry and he shall make every correction of an entry only by a marginal note or a footnote, which shall give the date of the correction and the correct particulars and shall subscribe his initials to such note or footnote. H6.05. (a) A pharmaceutical chemist who takes over for a period of seven days or longer the management of a dispensary either as an owner or as an employee shall immediately make an inventory of each dangerous drug included in the stock of such dispensary and shall forthwith enter in the appropriate balance column of the Drugs Book the quantity of each class of dangerous drug in such stock and shall sign each entry with his usual signature. (b) Upon finding any discrepancy between the quantity of a class of dangerous drug in stock and the quantity which ought, according to previous recordings, to be in stock, such pharmaceutical chemist shall forthwith notify the Director-General of the circumstances. H6.06. A pharmaceutical chemist shall keep each Drugs Book for a period of two years from the date of the last transaction recorded therein. A pharmaceutical chemist shall make each such Drugs Book available for inspection when so required by an inspector. H6.07. The provisions of this Regulation shall not apply to the recording of transactions in dangerous drugs at a hospital or institution.

H7. Records to be Kept of Transactions in Declared Drugs H7.01. (a) A pharmacist shall keep at every premises where he carries on his profession or of which he is in charge as an employee a record system in which he shall record or cause to be recorded on the day of dispensing of a declared drug the dispensing thereof in the manner hereinafter provided. (b) Such record system shall be kept by means of- (i) written entries in a bound prescription book or on con tinuous rolls of paper; (ii) a microfilm process; (iii) retention in a file of the original or duplicate prescription or a copy thereof, endorsed by the dispenser with the particulars prescribed by subclauses (ii), (vi) and (vii) of clause (c) hereof; or (iv) such other method as may be approved by the Director General. 64 The Poisons Regulations of 1973

(c) The particulars prescribed to be recorded in respect of each such dispensing are as set out hereunder:- (i) the name and address of the person to or for whom such declared drug was dispensed; (ii) the date of dispensing; (iii) the description and quantity of declared drug dispensed; (iv) the directions for use as written in the prescription; ( v) the name and address of the person who wrote the prescription; (vi) the distinguishing number allotted by him to the prescription; and (vii) the repeat number, if it is a repeat dispensing. (d) A pharmacist shall retain each record system kept pursuant to the provisions of this Regulation for a period of one year from the date of the last dispensing recorded therein, and shall make such record system readily available for inspection when so required by an Inspector.

HS. Keeping and Storage of Drugs 88.01. A pharmaceutical chemist shall keep and store every dangerous drug and every restricted drug in his possession in accordance with the provisions of Part K of these Regulations.

PART I-OBLIGATIONS OF MEDICAL PRACTITIONERS, VETERINARY SURGEONS AND DENTISTS I 1. Records of Dangerous Drugs I 1.01. (a) A medical practitioner, a veterinary surgeon or a dentist who buys or obtains or has in his possession a dangerous drug shall keep a record book, and shall record therein full particulars as hereinafter prescribed of each quantity of dangerous drug purchased or obtained by him and supplied, dispensed, or used by him. A separate record book or separate part of the record book shall be used for each class of dangerous drug and he shall make each entry on the day on which the dangerous drug is bought, obtained, supplied, dispensed, or used, or if that is not practicable on the following day. (b) The particulars prescribed to be recorded in such record book in respect of each transaction are the following:- (i) the date of the transaction; (ii) the name and address of the person from whom a quantity of dangerous drug is purchased or obtained or to or for whom a quantity of dangerous drug is supplied, dispensed or used; The Poisons Regulations of 1973 65

(iii) the quantity of the class of dangerous drug purchased, obtained, supplied, dispensed, or used in such transaction; and (iv) the quantity (called the "balance") of such class of dangerous drug in his possession at the conclusion of such transaction.

I 1.02. (a) A medical practitioner, a veterinary surgeon or a dentist shall not alter, obliterate, or cancel an entry in the record book except for the purpose of correcting an error in such entry and he shall make every correction of an entry only by a marginal note or footnote which shall give the date of the correction and the correct particulars. (b) Such record book shall be preserved by the person buying or obtaining and supplying, dispensing, or using such dangerous drug for a period of two years from the latest buying or obtaining or supplying, dis pensing, or using of such dangerous drug recorded therein. (c) Such record book shall be kept and made readily available for inspection when required by an inspector. I 1.03. A medical practitioner, a veterinary surgeon or a dentist shall, on the demand of an inspector, furnish all particulars required by such inspector as to the buying, obtaining, supplying, dispensing or using of a dangerous drug, or concerning stocks of such dangerous drugs held by him and of all transactions made therewith.

I 2. To Use Samples Only in Profession I 2.01. A medical practitioner, a veterinary surgeon or a dentist who receives from any source a sample of a dangerous drug shall not use nor apply to or for any purpose such sample nor any part thereof otherwise than in the practice of his profession; and he shall not, at any time use such sample otherwise than in accordance with the provisions of these Regulations.

I 3. Keeping of Dangerous and Restricted Drugs I 3.01. A medical practitioner, a veterinary surgeon or a dentist who has upon the premises occupied by him for the practice of his profession a dangerous drug or a restricted drug shall keep and store every such dangerous drug and restricted drug in accordance with the provisions of Part K of these Regulations. I 3.02. A medical practitioner or a veterinary surgeon who is in possession of a dangerous drug or a restricted drug, other than on the premises as aforesaid, shall keep every such dangerous drug and restricted drug in a secure place under his personal control. 66 The Poisons Regulations of 1973

PART J-DRUGS IN HOSPITALS AND INSTITUTIONS Jl. Possession and Use of Dangerous and Restricted Drugs Jl.Ol. A person in or at a hospital or an institution shall not have in his possession a dangerous drug or a restricted drug unless such dangerous drug or restricted drug has been lawfully obtained by him under the provisions of these Regulations. Jl.02. (a) The pharmaceutical chemist in charge of the dispensary of a hospital or an institution, or the matron of a hospital or an institution or the person in charge of an institution shall be responsible for the keeping of records in connection with all transactions in dangerous drugs at such hospital or institution as required by these Regulations. (b) Each such person referred to in clause (a) of this subregulation shall, at least once a week, inspect all books and records of all transac tions in dangerous drugs at such hospital or institution and shall endorse such books and records with the date of such inspection together with the result thereof. (c) Each such person shall report forthwith to the medical super intendent, if any, or the Director-General, any contravention of these Regulations or any use of a dangerous drug which appears to be excessive or any deficit in stock.

J2. Keeping and Storage of Drugs J2.01. A person in charge of dangerous drugs or restricted drugs at a hospital or an institution, whether in a dispensary, a ward, an operating theatre or other department of such hospital or institution shall keep and store every dangerous drug and every restricted drug in accordance with the provisions of Part K of these Regulations.

J3. Records of all Transactions in Dangerous Drugs to be Kept J3.01. The records of all transactions in dangerous drugs at a hospital or an institution shall be kept in one of the following methods:- (a)- (i) Where dangerous drugs are stored at a central storage point for issue to wards, operating theatres, or departments of such hospital or institution, the person in charge of such central storage point shall keep a book, to be called the "Main Issue Book", in which he shall record or cause to be recorded the description and quantity of each class of dangerous drug purchased or obtained, the date of such purchasing or obtaining, the name and address of the person from whom it is purchased or obtained, the descrip tion and quantity of each class of dangerous drug issued, the date it is issued, the designation of the ward or department to which it is issued, the signature of the person to whom it is delivered, and a progressive balance of that class of dangerous drug then in stock at the central storage point. The Poisons Regulations of 1973 67

(ii) Each page of the Main Issue Book shall contain entries relating to dangerous drugs of one and the same class only. (iii) The person in charge of a ward, operating theatre, or department to which a dangerous drug has been issued in accordance with the foregoing provisions of this clause shall keep a book, to be called the "Ward Drugs Book", in which he shall record or cause to be recorded the descrip tion and quantity of each class of dangerous drug received, the date it is received, and the description and quantity of each class of dangerous drug used or administered or supplied, the date and time of such use, administration or supply, the name of the patient on or to whom it is used, administered, or supplied, the signature of the person using, administering or supplying it, and a progressive balance of that class of dangerous drug then in stock in the ward or department. (iv) The person issuing a dangerous drug to a ward, operating theatre or department shall countersign the entry recording such issue in the Ward Drugs Book. (v) Each page of the Ward Drugs Book shall contain entries relating to dangerous drugs of one and the same class only; or (b)- (i) Where dangerous drugs are kept at one point only at a hospital or institution the person in charge of sueh dangerous drugs shall keep a suitable book or books in which he shall record or cause to be recorded the descrip tion and quantity of each class of dangerous drug pur chased or obtained, the date of such purchasing or obtain ing, the name and address of the person from whom it is purchased or obtained, the description and quantity of each class of dangerous drug used or administered or sup plied, the date and time of such use, administration or supply, the name of the patient on or to whom it is used, administered or supplied, the signature of the person using, administering or supplying it arid a progressive balance of that class of dangerous d_rug then remaining in stock. (ii) Each page of a book kept in this method shall contain entries relating to dangerous drugs of one and the same class only; or (c) Where dangerous drugs are stored at a central storage point for issue to wards, operating theatres, or departments of such hospital or institution and such dangerous drugs are also dispensed or supplied to patients at or from the same point a single book may be used to record all such transactions provided that all particulars required under clause (a) or clause (b) hereof are recorded for each transaction to which they are respectively applicable. 68 The Poisons Regulations of 1973

Notwithstanding the foregoing provisions of this subregulation, where, owing to the size or other circumstances of a hospital or an institution it is not practicable for the person issuing a dangerous drug from a central storage point to a ward, operating theatre, or department to obtain in the Main Issue Book the signature of the person to whom such dangerous drug is issued or to countersign the Ward Drugs Book, the issue and receipt of such dangerous drug may be effected on a form of transfer voucher signed by both the person issuing and the person receiving such dangerous drug. All such transfer vouchers shall be filed at the central storage point in such manner as to be readily available for inspection upon demand of an inspector. In all other respects the provisions of this subregulation shall be complied with. J3.02. Where a dangerous drug has been purchased or obtained for a particular patient, such patient's name and address shall be shown with the entry relating to such purchasing or obtaining in the relevant record.

J3.03. The person in charge of a central storage point at a hospital or an institution shall not issue a dangerous drug to a ward, operating theatre, or department of such hospital or institution unless and until he has satisfied himself of the necessity for such issue and that previous issues of dangerous drugs to such ward, operating theatre or department have been satisfactorily accounted for.

J4. Authority to Supply or Administer Drugs J4.01. A person shall not supply nor administer a dangerous drug to or for a patient in a hospital or an institution except on the written instruction of a medical practitioner. J4.02. A person shall not supply nor administer a restricted drug to or for a patient in a hospital or an institution except on the instruction of a medical practitioner or dentist so authorised by a provision of Regulation D2 of these regulations.

J4.03. (a) Notwithstanding the provisions of subregulation J4.01 a medical practitioner may if he has ·reasonable grounds for believing an emergency exists issue to a registered nurse a verbal instruction to supply or administer a dangerous drug to or for a patient in a hospital or institution. In every such case such medical practitioner shall reduce such verbal instruction to writing within twenty-four hours of the issue of such verbal instruction. (b) A registered nurse who having supplied or administered a dangerous drug upon a verbal instruction shall report the fact forthwith to the nursing superintendent or the person in charge of the hospital or institution. (c) A nursing superintendent or the person in charge of the hospital or institution shall report to the medical superintendent or the Director General the circumstances of the matter if the medical practitioner has not reduced such verbal instruction to writing within forty-eight hours. The Poisons Regulations of 1973 69

PART K-STORAGE OF DRUGS AND KEEPING OF RECORDS Kl. Keeping of Dangerous Drugs and Restricted Drugs Kl.Ol. (a) Except as specifically provided elsewhere in these Regulations, a person authorised by or under the provisions of Regulation D2 to have in his possession a dangerous drug shall keep every dangerous drug in his possession in a receptacle ·Of a type approved in writing for that purpose by the Director-General or in a secure place to the satisfaction of the Director-General. (b) Such person shall keep in his immediate and personal possession . the key to such approved receptacle or secure place. (c) Such person shall keep such approved receptacle or secure place locked at all times except when dangerous drugs are being placed into or removed from such receptacle or place. Kl.02. Except as specifically provided elsewhere in these Regula tions, a person authorised by or under the provisions of Regulation D2 to have in his possession a restricted drug shall keep every restricted drug in his possession in a dispensary, storeroom, or other portion of his premises which is partitioned off or similarly separated from any portion of such premises which the public is permitted to enter, or in a cupboard or drawer so situated in such premises as to be inaccessible to the public. Kl.03. An authorised person who has in his possession a dangerous drug specified in clause (b) of subregulation A2.05 shall keep such dangerous drug in a dispensary, storeroom or other portion of his premises which is partitioned off or similarly separated from any portion of such premises which the public is permitted to enter or in a cupboard or drawer so situated in such premises as to be inaccessible to the public.

K2. Records in Connection with Dangerous Dmgs and Restricted Dmgs K2.01. Except as specifically provided elsewhere in these Regulations, a person authorised with respect to any of the matters prescribed by Regulation D2 of these Regulations shall keep such records in such form and under such conditions as the Director-General, in his discretion, may from time to time require. K2.02. A person shall not alter, obliterate or cancel an entry in a book or record prescribed by these Regulations, not being a Drugs Book within the meaning of Regulation H6, other than for the purpose of correcting an error in such entry and he shall make every correction of an entry only by a marginal note or a footnote which shall give the date of the correction and the correct particulars, and shall subscribe his initials to such note or footnote. 70 The Poisons Regulations of 1973

PART L-POSSESSION AND USE OF DRUGS BY PRESCRIBEES Ll. Prescribees' Authorities and Duties Ll.Ol. A person who has been supplied with a dangerous drug or a restricted drug in accordance with the provisions of these Regulations by- (a) a medical practitioner; (b) a veterinary surgeon; (c) a pharmaceutical chemist, upon and in accordance with the prescription of a medical practitioner or a veterinary surgeon; or (d) a pharmaceutical chemist, upon and in accordance with the prescription of a dentist in respect of a restricted drug only, is hereby authorised for the purposes of paragraph (a) of subsection (1) of Section 130 of the Act and/or subregulation Dl.Ol of these Regulations to have such drug so supplied in his possession for the period necessary for such drug to be used for the purpose and in the manner directed by such medical practitioner, veterinary surgeon, or dentist. L1.02. Such person shall keep such dangerous drug or such restricted drug in his possession at all times. L1.03. Such person shall use or cause to be used such dangerous drug or such restricted drug only for the medical, dental or veterinary purpose for which it was so supplied.

L2. Exemption from Recording L2.01. Notwithstanding any other provision of these Regulations, a person shall not be required to keep any record respecting a dangerous drug or a restricted drug which has been supplied to him in the manner prescribed by subregulation Ll.Ol of these Regulations.

PART M-LENGTHY TREATMENT WITH AND ADDICTION TO DRUGS Ml. Dirictor-General to be Notified of Lengthy Treatment Ml.Ol. A medical practitioner who, in the course of his medical practice, supplies, dispenses, prescribes or administers a dangerous drug in the treatment of a patient for a period which will extend or which has extended for a period greater than two calendar months, shall forthwith report the circumstances of the case in writing to the Director-General. Such report shall contain the name and address of the patient, the name of the dangerous drug involved and the medical condition for which he considers the use of such dangerous drug necessary, together with all such other particulars as the Director-General may from time to time require. The Poisons Regulations of 1973 71

M2. Approval of Director-General Necessary for Treatment of Addicts M2.01. A medical practitioner shall not sell, supply, dispense, administer nor prescribe to or for a drug addict a dangerous drug or a restricted drug without the approval of the Director-General.

M3. Obligations of Medical Practitioners in Treatment of Addicts M3.01. A medical practitioner, who desires to treat a drug addict, and who considers it necessary for the purposes of such treatment that such drug addict should receive rational supplies of a dangerous drug or a restricted drug shall report the circumstances of the case of such drug addict to the Director-General, who may, at his discretion, grant approval to such medical practitioner to sell, supply, dispense, administer or prescribe quantities of such dangerous drug or such restricted drug in question as he shall deem necessary in the circumstances.

M3.02. The approval of the Director-General required by this Regulation shall be in writing, provided that the Director-General may, in a particular case, give his verbal approval, but shall forthwith confirm such verbal approval in writing. M3.03. The Director-General may, in his discretion, by notice in writing, addressed to the medical practitioner concerned, withdraw the approval, either verbal or written, that he may have given in accordance with the provisions of this Regulation. M3.04. A medical practitioner, who reports the case of a drug addict ~o the Director-General, shall report such further particulars as the Director-General may, from time to time, require. M3.05. A medical practitioner, who has been granted approval under the provisions of this Regulation to treat a drug addict, shall not sell, supply, dispense, administer nor prescribe to or for such drug addict a dangerous drug or a restricted drug in excess of the quantity approved in such case by the Director-General.

M4. Self-administration of Dangerous Drugs by Authorised Persons Prohibited M4.01. (a) A person authorised by the provisions of Regulation D2 of these Regulations shall not use nor attempt to use a dangerous drug or an article or substance for the time being declared by the Governor in Council by Order in Council to be a dangerous drug for the purposes of Section 130 of the Act for the purpose of self-administration. (b) The provisions of this Regulation do not apply to the bona-fide use for medical or dental purposes of a dangerous drug, article or substance for the time being declared by the Governor in Council by Order in Council to be a dangerous drug which has been lawfully supplied to such person by or upon the prescription of a medical practitioner or a dentist, not being such person himself. 72 The Poisons Regulations of 1973

PART N-OFFENCES IN RESPECT OF DANGEROUS AND RESTRICTED DRUGS Nl. Forging and Uttering Prescriptions Nl.Ol. A person shall not utter nor attempt to utter a prescription prescribing a dangerous drug or a restricted drug if such prescription has been written by a person not authorised so to do under these Regulations. N1.02. A person, other than the person who wrote a prescription, shall not alter nor obliterate nor make an endorsement on such prescription. N1.03. A person shall not utter nor attempt to utter a prescription prescribing a dangerous drug or a restricted drug if such prescription has thereto, therein or thereon an alteration, obliteration or endorsement made by a person other than the person who wrote such prescription. N1.04. The provisions of this Regulation shall not relate nor be deemed to relate to an endorsement made as prescribed by these Regulations by an authorised person. N2. False Representations N2.01. A person shall not, by a false representation, obtain nor attempt to obtain- ( a) a dangerous drug or a restricted drug from a person authorised by these Regulations to sell, supply, dispense or administer a dangerous drug or a restricted drug; or (b) a prescription for a dangerous drug or a restricted drug from a person authorised by these Regulations to prescribe a dangyrous drug or a restricted drug. N2.02. A person shall not make a false representation whatsoever concerning an order or prescription for a dangerous drug or a restricted drug given by a person authorised by these Regulations to give such order or prescription. N2.03. A person shall not state a false name or place of abode or address to a person authorised by these Regulations to sell, supply, dispense, prescribe or administer a dangerous drug or a restricted drug. N3. Failure to Disclose Information to Practitioners N3.01. A person shall not by representation made to a medical practitioner or a dentist obtain or attempt to obtain ( a) a dangerous drug; or (b) a restricted drug; or (c) a prescription for a dangerous drug; or (d) a prescription for a restricted drug, without first informing such medical practitioner or dentist of the quantity of such dangerous drug or such restricted drug or prescription which he has obtained from another medical practitioner or dentist within the period of two months prior to such representation. The Poisons Regulations of 1973 73

N4. Accounting for Dangerous Drugs N4.01. A person authorised with respect to any of the matters prescribed by Regulation D2 of these Regulations shall on the demand of an inspector- ( a) account to the satisfaction of such inspector for each and every quantity of a dangerous drug which has been in his possession at any time during the period of two years immediately preceding the date of such demand; (b) account to the satisfaction of such inspector for the total of all quantities of a dangerous drug which have been in his possession during any period not exceeding two years immediately preceding the date of such demand; and (c) produce the quantity of a dangerous drug shown by the record prescribed by these Regulations to be kept by him to be the quantity of that dangerous drug which ought to be in his possession.

NS. False Entries N5.01. A person shall not make an entry in a book or record prescribed by these Regulations, which entry is false or untrue in any particular.

PART 0-MISCELLANEOUS REQUIREMENTS 01. Embalming 01.01. A person shall not place upon nor introduce into the body or part of the body of a deceased person arsenic or strychnine or any substance or chemical compound containing arsenic or strychnine for the purpose of embalming such body or such part of a body.

02. Biological Preparations 02.01. A person shall not sell a biological preparation for the purpose of destroying rats unless and until he has been authorised in writing so to do by the Director-General. 02.02. A person shall not have in his possession nor sell for the purpose of destroying vetrebrate animals a biological preparation other than a biological preparation approved in writing by the Director-General for such purpose. 02.03. (a) A person other than a medical practitioner, a veterinary surgeon, a bacteriologist, an analyst or a person certified in writing by the Director-General as competent to use such preparations shall not have in his possession a biological preparation of living bacteria or living viruses. 74 The Poisons Regulations of 1973

(b) A person shall not sell nor supply a biological preparation of living bacteria or living viruses to a person other than a medical practitioner, a veterinary surgeon, a bacteriologist, an analyst or a person certified in writing by the Director-General as competent to use such preparations. (c) The provisions of this subregulation shall not apply to the possession, sale or supply, in accordance with the provisions of these Regulations, of a prepared vaccine.

03. Hawking of Poisons 03.01. (a) A person shall not sell a poison specified in Schedule 1, 2, 3, or 7 or in Appendix A to Schedule 6 in a street, or from house to house, or from place to place. (b) The provisions of this Regulation shall not apply to a case where the Director-General, in his discretion, authorises a licensed seller of poisons to sell such a poison from place to place under such conditions as he may prescribe. Such authority shall be revocable in the discretion of the Director-General.

04. Samples of Poisons 04.01. A person shall not distribute nor attempt to distribute a sample of a poison in a street, or from house to house or from place to place.

05. Colouring of Grain Baits 05.01. A person shall not sell nor use, for the purpose of pest destruction, a cereal, grain or meal containing a poison unless and until such cereal, grain or meal is coloured in a manner approved by the Director-General.

06. Vaporisers and Other Devices 06.01. A person shall not sell nor use a device, other than an electrical or other heating device, containing a poison for the destruction of insects, unless such device- (a) is so constructed that the poison contained therein is inaccessible to children and domestic animals; (b) does not constitute a hazard to people in its vicinity; and (c) has been approved in writing by the Director-General for such purpose. 06.02. A person shall not sell nor use an electrical or other heating device for the vaporisation of a poison unless- (a) its vaporisation rate, when fully charged with such poison, does not exceed one gram per day; and (b) such device has been approved for that purpose by the Director-General. The Poisons Regulations of 1973 75

07. Prohibition of Sale of Certain Pencils, Crayons and the Like 07.01. A person shall not sell chalks, pencils, crayons, school pastels, finger colours, show-card colours or poster paints which contain a poison; nor shall a person sell a pencil which contains a poison in the outside lacquer thereof.

08. Safe Keeping of Poisons and Drugs 08.01. A person shall not keep, store, handle nor carry a dangerous drug, restricted drug or poison- ( a) within reach of children; (b) unless it is separate and apart from food for man or animal; or (c) in such manner that if the container breaks or leaks the poison can mix with or contaminate any food for man or animal.

09. Food Containers Prohibited 09.01. A person shall not use nor cause nor suffer to be used any food container for the purpose of holding a poison.

010. Use and Disposal of Dangerous Drugs, Restricted Drugs and Poisons 010.01 (a) A person shall not place, discharge nor otherwise dispose of, nor cause, suffer nor permit to be placed, discharged or otherwise disposed of a dangerous drug, a restricted drug or a poison- (i) in or upon a street, alley, public place or public lands; (ii) in or upon any land, premises or place without the consent of the occupier of such land, premises or place or if there is no such occupier, then of the owner of such land, premises or place; (iii) upon or into a road, street, channel, drain, watercourse, creek, river, dam or other collection of water. (b) The provisions of this subregulation shall not apply to the laying of baits for the purposes of pest destruction by a person- (i) acting under a permit or authority of the Director-General or of a Local Authority; (ii) acting in pursuance of the provisions of "The Stock Routes and Rural Lands Protection Acts, 1944 to 1967"; or (iii) acting on behalf of a Cane Pest and Disease Control Board in pursuance of the provisions of the Sugar Experiment Stations Act 1900-1973. 010.02. Notwithstanding any other provision of these Regulations, a person shaU not in any place whatsoever or on ·any premises place, 76 The Poisons Regulations of 1973 discharge nor otherwise dispose of a dangerous drug, a restricted drug or a poison in such a manner as to- (a) endanger the life or safety of a person or domestic animal; (b) expose a food or a drug thereon to the risk of contamination.

011. Labels and Containers 011.01. A person shall not deface, change, cover nor remove a mark, statement, declaration, label or brand, which pursuant to these Regulations, is required to be affixed to or borne upon the container of a poison. 011.02. A person shall not have in his possession nor sell a package containing a poison if such package is damaged or cracked. A person in possession of such a package shall immediately empty it of its contents and destroy it. 011.03. A person shall not soak, wash nor otherwise treat a bottle or a container which- (a) has been used to hold a poison; or (b) is of a type commonly used to contain a poison; or (c) bears a brand, mark or label indicating that such bottle or container has been used to contain ,a poison. in the same tank or other receptacle in which bottles or other containers of a type commonly used to contain articles of food or drink for man or animal are soaked, washed or otherwise treated.

012. Advertising of Drugs and Poisons 012.01. (a) A person shall not publish nor suffer nor permit to be published an advertisement relating to a dangerous drug or a restricted drug or a Schedule 3 poison other than in a bona-fide professional or trade journal or price list intended for circulation only within the medical, veterinary, dental, and/or pharmaceutical professions or the wholesale drug trade. (b) A person shall not by an advertisement offer to obtain, sell nor procure a poison specified in Schedule 1, 2, 3 or 7 or in Appendix A to Schedule 6 unless he is licensed or authorised under these Regula tions to sell such poison. (c) A person shall not publish nor cause to be published an advertise ment which contravenes the provisions of clause (b) of this subregulation.

013. Fireworks 013.01. A person shall not manufacture nor sell fireworks containing arsenic. The Poisons Regulations of 1973 77

PART P-POWERS OF INSPECTORS AND POLICE Pl. Powers of Police P1.01. A member of the Police Force may- (a) at any time enter premises on which a person is in posses sion, or is reasonably suspected by him of being in possession for the purposes of sale of a poison specified in Schedule 1 or 7 or in Appendix A to Schedule 6; (b) require such person to produce for inspection a Poisons Sales Book and all documents in respect of the purchase and sa.le of such poison; and (c) inspect such book and such documents and may make copies of or take extracts therefrom.

P2. Powers of Inspectors, their Obligations P2.01. An inspector may with respect to any premises or place on which a person is in possession of a dangerous drug, a restricted drug or a poison or is reasonably suspected by him of being in possession of a dangerous drug, a restricted drug or a poison- ( a) enter such premises or place; (b) inspect or examine aU or ,any such dangerous drugs, restricted drugs or poisons found by him upon such entry; (c) inspect all books, prescriptions, orders, papers, entries, invoices and letters found by him upon such entry and which relate to the prescribing, dispensing, handling, ordering, purchase, sale, manufacture or having in possession a dangerous drug, a restricted drug or a poison, and make copies of or take extracts from all such books, prescriptions, orders, papers, entries, invoices and letters or any of them and for the purpose of facilitating the making of a copy or extract, remove all or any of such books, prescriptions, orders, papers, entries, invoices or letters temporarily from such premises or place; (d) seize and remove therefrom all or any of such books, prescriptions, orders, papers, entries, invoices and letters concerning which he has grounds for suspecting that a person has committed a breach of these Regulations; (e) remove therefrom for examination or analysis- (i) a dangerous drug, a rest!'icted drug or a poison, or an article which he believes to be or to contain a dangerous drug, a restricted drug or a poison; and (ii) a package enclosing a dangerous drug, a restricted drug or a poison or an article which he believes to be or to contain a dangerous drug, a restricted drug or a poison; and 78 The Poisons Regulations of 1973

(f) seize (i) a dangerous drug, a restricted drug or a poison or an article which he believes to be or to contain a dangerous drug, a restricted drug or a poison; .and (ii) a package enclosing a dangerous drug, a restricted drug or a poison or an artiele which he believes to be or to contain a dangerous drug, a restricted drug or a poison, found by him upon such entry and which he believes is had in possession by such person or upon such premises or place in contravention of a provision of these Regulations or which is packed or enclosed, or labelled, branded or marked in any manner contrary to or not in compliance with these Regula tions.

P2.02. (a) When an inspector, pursuant to the provisions of sub regulation P2.01, removes for examination or analysis or seizes a dangerous drug, a restricted drug or a poison or an article which he believes to be a dangerous drug, a restricted drug or a poison, or a package enclosing a dangerous drug, a restricted drug or a poison or an article which he believes to be or to contain a dangerous drug, a restricted drug or a poison, he shaH forthwith seal or fasten up such dangerous drug, restricted drug, poison, artiole or package as its nature permits and label it in such manner as to identify it. (b) In respect of a restricted drug or a poison, he shall either deliver it to a State analyst or retain it in safe keeping; and in respect of a dangerous drug, he sha.U, at the first opportunity, deliver or forward it to a State analyst.

P3. Service of Notices P3.01. An inspector may serve notice in writing, signed by him, upon a person who, in his opinion, has contravened or is contravening a provision of these Regulations, requiring him, within a time specified in such notice, to take such action or perform such work as he may consider necessary to correct such contraventibn. P3.02. A person who neglects to comply with such notice served on him by an inspector or who fails to comply therewith within the time specified therein shall be guilty of an offence against these Regulations.

P4. Obstruction P4.01. A person shall not obstruct nor delay an inspector or member of the Police Force, acting under the provisions of these Regulations in the exercise of his powers under these Regulations, nor refuse to permit him to exercise any such power under these Regulations; nor shaH a person conceal, nor fail nor refuse to produce, a book, prescription, order, paper, entry, invoice or letter when required to do so by an inspector or a member of the Police Force. The Poisons Regulations of 1973 79

PART Q-OFFENCES AND PENALTIES Ql. Offences Ql.Ol. Where a matter or thing is by these Regulations directed or forbidden to be done or where an authority is given by these Regulations to a person to direct or forbid a matter or thing to be done and such act directed to be done remains undone or such act forbidden to be done is done, or where a certificate, licence, approval, authority or permit is issued or granted subject to a condition, term or stipulation and a person fails in the performance or observance of such condition, term or stipulation, in every such case every person offending against such direction, prohibition, condition, term or stipulation shall be deemed to be guilty of an offence against these Regulations, although in a Regulation, certificate, licence, approval, authority or permit a breach thereof shall not be specifically stated to be an offence.

Q2. Penalties Q2.01. A person who is guilty of an offence against any of the provisions of Regulation D1 or of Regulation H1 or of Part N so far as such Regulations or Part relate to any of the matters prescribed pursuant to the provisions of sub-paragraphs (a), (b), (c), (d), or (e) of paragraph (xxviii) of subsection ( 1) of Section 152 of the Act shall be liable for a first offence to a penalty not exceeding one thousand dollars ( $1000) and for a second or subsequent offence, whether or not of the same nature or against the same provision, to a penalty not exceeding two thousand dollars ( $2000).

Q2.02. A person who is guilty of an offence against any of the provisions of these Regulations for which no other penalty is specifically provided shall be liable to a penalty not exceeding five hundred dollars ($500). Given under my hand at Brisbane, this second day of August, 1973. P. R. PATRICK, Director-General of Health and Medical Services.

The Poisons Regulations of 1973 81

SCHEDULE 1 POISONS Aconite (Root of aconitum napellus). Antimony, compounds of except:- ( a) antimony chlorides in polishes; (b) when included in Schedule 4. Atropine and substances containing more than 0 · 25 per cent of atropine, except:- (a) atropine methonitrate; and (b) when included in Schedule 6. Belladonna and substances containing more than 0 · 25 per cent of the alkaloids of belladonna calculated as hyoscyamine. Bromine (excluding its salts). Brucine except when used in concentrations of 0 · 02 per cent or less for the denaturation of alcohol. Coniine. Cotarnine. Croton Oil. Homatropine and substances containing more than 0 · 25 per cent of homatropine. Hydrocyanic acid and cyanides for therapeutic use in substances contain ing more than the equivalent of 0·15 per cent of hydrocyanic acid. Hyoscine and substances containing more than 0·25 per cent of hyoscine, except hyoscine butylbromide. Hyoscyamine and substances containing more than 0·25 per cent of hyoscyamine. Hyoscyamus and substances containing more than 0 · 25 per cent of the alkaloids calculated as hyoscyamine. Lobelia and substances containing more than 0 · 5 per cent of the alkaloids except preparations for smoking or burning. Mercuric chloride except:- ( a) in substances containing 0 · 5 per cent or less of mercuric chloride; (b) in batteries; and (c) when included in Schedule 7. Mercuric iodide except:- (a) in substances containing 2 per cent or less of mercuric iodide; and (b) when included in Schedule 6. 82 s. 1 The Poisons Regulations of 1973

Mercuric nitrate and substances containing more than the equivalent of 3 per cent of mercury (Hg), in such form. Mercuric potassium iodide and substances containing more than the equivalent of 2 per cent of mercuric iodide in such form. Mercuric thiocyanate except when included in Schedule 6. Mercury, organic compounds of, except:- ( a) in substances containing the equivalent of 0 · 5 per cent or less of mercury (Hg); (b) for therapeutic use; and (c) when included in Schedule 6 or Schedule 7. Nux vomica. Phosphorus, yellow (excluding its salts) and substances containing more than 0 · 5 per cent of free phosphorus. Savin, oil of. Stramonium and substances containing more than 0 · 25 per cent of the alkaloids ·calculated as hyoscyamine except preparations for smoking or burning. Tansy, oil of. Veratrum except for therapeutic use. The Poisons Regulations of 1973 83

SCHEDULE 2 POISONS Acetic Acid (excluding its salts) and substances containing more than 80 per cent of acetic acid, for therapeutic use. Acetyldihydrocodeine in compounded preparations containing 1 per cent or less of acetyldihydrocodeine. Antazoline- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. · Aspirin, whether or not compounded or combined with another substance, for internal use except where- (a) included in Schedule 4; or (b) not compounded or combined with a therapeutically active substance and- (i) in the form of a tablet or capsule containing not more than 325 milligrams of aspirin packed in a strip pack or other immediate container of a type or description approved by the Director-General with not more than 25 tablets or capsules in each such pack or container or in a primary pack; or (ii) in the form of a powder containing not more than 650 milligrams of aspirin each powder being packed in an immediate wrapper and if also packed in an immediate container such container being of a type or description approved by the Director-General with not more than 12 powders in each such container or in a primary pack; or (iii) in the form of granules, packed in an immediate wrapper containing not more than 650 milligrams of aspirin and if also packed in an immediate container such container being of a type or description approved by the Director General with not more than 12 immediate wrappers in each such container or in a primary pack. Atropine in substances containing 0 · 25 per cent or less of atropine except- (a) atropine methonitrate; and (b) when included in Schedule 6. Bamipine- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Belladonna in substances containing 0 · 25 per cent or less of the alkaloids of belladonna, calculated as hyoscyamine. 84 s. 2 The Poisons Regulations of 1973

Benzamine when included in- ( a) lozenges, pastilles, tablets and capsules containing 30 mg or less of benzamine in each; or (b) suppositories or bougies containing 200 mg or less of benzamine in each; or (c) substances for external use, other than eye drops, containing 10 per cent or less of benzamine. Benzocaine when included in- (a) lozenges, pastilles, tablets and capsules containing 30 mg or less of benzocaine in each; or (b) suppositories or bougies containing 200 mg or less of benzocaine in each; or (c) substances for external use, other than eye drops, containing 10 per cent or less of benzocaine. Benzoyl peroxide in substances for external human therapeutic use containing 5 per cent or less of Benzoyl peroxide. Bromodiphenhydramine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in· oral substances labelled and packed for the relief of coughs and colds. Bromhexine. Brompheniramine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Buclizine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in solid substances labelled and packed for the treatment of motion sickness in packs of 10 doses or less; or (c) in oral substances labelled and packed for the relief of coughs and colds. Bufexamac in substances containing 5 per cent or less of bufexamac for external human therapeutic use and in suppositories. Butylaminobenzoate when included in- (a) lozenges, pastilles, tablets and capsules containing 30 mg or less of butylaminobenzoate in each; or (b) suppositories or bougies containing 200 mg or less of butylaminobenzoate in each; or (c) substances for external use, other than eye drops, containing 10 per cent or less of butylaminobenzoate. The Poisons Regulations of 1973 s. 2 85

Cantharides (Cantharidin) in substances containing 0 · 01 per cent or less of cantharidin. Carbaryl in substances for external human therapeutic use containing 2 per cent or less of carbaryl. Carbenoxolone for topical oral use. Carbeta pentane citrate except in substances containing 0 · 5 per cent or less of carbetapentane citrate. Carbinoxamine- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Chloroform except- (a) in substances containing 10 per cent or less of chloroform where the chloroform content is declared on the label; and (b) when included in Schedule 4.

Chloropyriline- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Chlorpheniramine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Chlorphenoxamine- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Cinnamedrine. Cinnarizine- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in solid substances labelled and packed for the treatment of motion sickness in packs of 10 doses or less; or (c) in oral substances labelled and packed for the relief of coughs and colds. 86 s. 2 The Poisons Regulations of 1973

Clemastine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Clemizole- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Codeine- ( a) subject to paragraph (b), where compounded or combined in a preparation containing- (i) not more than 10 mg of codeine per dosage unit when in divided preparations; or (ii) not more than 0 · 5 per cent of codeine when in undivided preparations; (b) where compounded or combined with either aspirin or paracetamol or salicylamide in tablets or capsules containing not more than 10 mg of codeine per tablet or capsule whether with or without a substance or quantity of substance not included in a Schedule and with not more than 25 tablets or capsules in a primary pack. Cycliramine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Cyproheptadine- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Deptropine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Dexbrompheniramine- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. The Poisons Regulations of 1973 s. 2 87

Dexchlorpheniramine- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Dextromethorphan in compounded preparations containing 1 per cent or less of dextromethorphan. Dextrorphan in substances containing 1 per cent or less of dextrorphan. Diamines, phenylene, toluene and all other alkylated benzene diamine derivatives, except when included in Schedule 6. Dicophane (DDT) in substances for human therapeutic use. Dicyclomine in substances containing 0 · 1 per cent or less of dicyclomine. Dihydrocodeine in compounded preparations containing 1 per cent or less of dihydrocodeine. Dimenhydrinate- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in solid substances labelled and packed for the treatment of motion sickness in packs of 10 doses or less; or (c) in oral substances labelled and packed for the relief of coughs and colds. Dimethindene- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Dimethisoquin in substances for external use, other than eye drops, containing 10 per cent or less of dimethisoquin. Dimethothiazine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Diphemanil methylsulphate in substances for topical use. Diphenhydramine- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in solid substances labelled and packed for the treatment of motion sickness in packs of 10 doses or less; or (c) in oral substances labelled and packed for the relief of coughs and colds. 88 s. 2 The Poisons Regulations of 1973

Diphenylpyraline- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Doxylamine- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Embramine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Ephedrine- ( a) in compounded preparations containing more than 10 mg of ephedrine per dosage unit; or (b) in substances for external use containing more than 1 per cent of ephedrine. Erythrityl tetranitrate and other nitric esters of polyhydric alcohols. Etafedrine. Ether and substances containing more than 10 per cent of ether except when included in Schedule 4, Schedule 5 or Schedule 6. Ethoheptazine in substances containing 1 per cent or less of ethoheptazine. Ethylmorphine in compounded preparations containing 1 per cent or less of ethylmorphine. Ferrous sulphate and other iron preparations for human internal use, except in substances containing 5 per cent or less of iron. Fluorides- ( a) Sodium fluoride in substances for human ingestion containing 2 · 2 mg or less of sodium fluoride per dosage unit; and (b) other metallic fluoride substances including ammonium fluoride for therapeutic use except- (i) in dentifrices containing 1000 mg/kg or less of fluoride ion; or (ii) in substances containing 15 mg/kg or less of fluoride ion. Gelsemium. Glyceryl trinitrate except when included in Schedule 4. Guaiphenesin- (a) in liquid substances containing 2 per cent or less of guai phenesin; or (b) in solid dose substances containing 120 mg or less of guaiphenesin in each dosage unit. The Poisons Regulations of 1973 s. 2 89

Halopyramine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Hexachlorophane in substances for skin cleansing purposes containing 3 per cent or less of hexachlorophane except- (a) in preparations for use on infants; or (b) in preparations for the treatment of animals. Histapyrrodine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Homatropine in substances containing 0 · 25 per cent or less of homatro pine. Human chorionic gonadotrophin in pregnancy test kits. Hydrocyanic acid and cyanides in substances containing the equivalent of 0·15 per cent or less of hydrocyanic acid. Hydroxyquinoline and its derivatives, for human therapeutic use, except ( a) non-halogenated derivatives, containing 1 per cent or less of 8-hydroxyquinoline for external use; and (b) when included in Schedule 4. Hyoscine in substances containing 0 · 25 per cent or less of hyoscine, except hyoscine butylbromide. Hyoscyamine in substances containing 0·25 per cent or less of hyoscya mine. Hyoscyamus in substances containing 0 · 25 per cent or less of the alkaloids calculated as hyoscyamine. Iodine (excluding its salts) except- ( a) when included in Schedule 6; or (b) in iodophors in substances containing 1 · 5 per cent or less of available iodine; or (c) in solid or semi-solid substances containing 2 · 5 per cent or less of available iodine. Isopropamide in substances containing 2 per cent or less of isopropamide for cutaneous use. Isosorbide dinitrate. Lead, salts and compounds of, when prepared for medical or cosmetic use. 90 s. 2 The Poisons Regulations of 1973

Lignocaine when included in- ( a) Lozenges, pastilles, tablets and capsules containing 30 mg or less of lignocaine in each; or (b) suppositories or bougies containing 200 mg or less of ligno caine in each; or (c) substances for external use, other than eye drops, containing 10 per cent or less of lignocaine. Lindane in substances for external human therapeutic use containing two per cent or less of lindane. Lobelia in substances containing 0 · 5 per cent or less of the alkaloids of lobelia, except preparations for smoking or burning. Maldison in substances for external human therapeutic use containing 2 per cent or less of maldison. Mebendazole for human therapeutic use. Mebhydrolin- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Mepyramine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Mercuric ammonium chloride (ammoniated mercury). Mercuric chloride in substances containing 0 · 5 per cent or less of mercuric chloride, except- (a) in batteries; and (b) when included in Schedule 7. Mercuric iodide in substances containing 2 per cent or less of mercuric iodide, except when included in Schedule 6. Mercuric nitrate in substances containing the equivalent of 3 per cent or less of mercury (Hg), in such form. Mercuric oxide and all oxides of mercury.

Mercuric potassium iodide in substances containing the equivalent of 2 per cent or less of mercuric iodide, in such form.

Mercury, metallic (excluding its salts), except in scientific instruments. The Poisons Regulations of 1973 s. 2 91

Mercury, organic compounds of, in substances containing the equivalent of 0 · 5 per cent or less of mercury (Hg) except- (a) when included in Schedule 4, Schedule 6 or Schedule 7; and (b) as a preservative in substances containing 0 · 01 per cent or less of mercury. Methdilazine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Methoxamine except- ( a) substances containing 0 · 5 per cent or less of methoxamine; or (b) substances for external use containing 1 per cent or less of methoxamine. Methoxyphenamine. Methylephedrine. N aphazoline. Niclosamide for human therapeutic use. Nicocodine in compounded preparations containing 1 per cent or less of nicocodine. Nicodicodine in compounded preparations containing 1 per cent or less of nicodicodine. Norcodeine in compounded preparations containing 1 per cent or less of norcodeine. Noscapine. Octyl nitrite. Oxethazaine in substances for internal use only. Oxolamine. Oxymetazoline. Papaverine. Paracetamol, whether or not compounded or combined with another substance, for internal use except where- ( a) included in Schedule 4; or (b) not compounded or combined with a therapeutically active substance and- (i) in the form of a tablet or capsule containing not more than 500 milligrams of paracetamol packed in a strip pack or 92 s. 2 The Poisons Regulations of 1973

other immediate container of a type or description approved by the Director-General with not more than 25 tablets or capsules in each such pack or container or in a primary pack; or (ii) in the form of a powder containing not more than 1000 milligrams of paracetamol each powder being packed in an immediate wrapper and if also packed in an immediate container such container being of a type or description approved by the Director-General with not more than 12 powders in each such container or in a primary pack; or (iii) in the form of granules, packed in an immediate wrapper containing not more than 1000 milligrams of paracetamol and if also packed in an immediate container, such con tainer being of a type or description approved by the Director-General with not more than 12 immediate wrappers in each such container or in a primary pack. Phedrazine. Phenamazoline. Phenazone for external use. Phenindamine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Pheniramine- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in solid substances labelled and packed for the treatment of motion sickness in packs of 10 doses or less; or (c) in oral substances labelled and packed for the relief of coughs and colds. Phenol and any homologue of phenol boiling below 220°C, creosote, and substances containing more than 3 per cent of such substances or homologues, for therapeutic use. Phenylephrine except- (a) substances containing 0·5 per cent or less of phenylephrine; or (b) substances for external use containing 1 per cent or less of phenylephrine.

Phenyltoloxamine~ (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. The Poisons Regulations of 1973 s. 2 93

Pholcodine in compounded preparations containing 1 per cent or less of pholcodine. Potassium chlorate and substances containing more than 10 per cent of potassium chlorate. Procyclidine in substances containing 5 per cent or less of procyclidine for cutaneous use. Promethazine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in solid substances labelled and packed for the treatment of motion sickness in packs of 10 doses or less; or (c) in oral substances labelled and packed for the relief of coughs and colds. Propantheline in substances for topical use. Propoxur in substances for external human >therapeutic use containing 0·2 per cent or less of propoxur. Propylhexedrine in appliances for inhalation in which the substance is absorbed upon an inert solid material. Propyphenazone. Pseudoephedrine except- (a) substances containing 20 mg or less of pseudoephedrine per dosage unit; or (b) substances for external use containing 1 per cent or less of pseudoephedrine. Pyrantel for human ·therapeutic use. Pyrrobutamine- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Salicylamide, whether or not compounded or combined with another substance, for internal use except where- (a) included in Schedule 4; or (b) not compounded or combined with a ·therapeutically active substance and- (i) in ·the form of a tablet or capsule containing not more than 500 milligrams of salicylamide packed in a strip pack or other immediate container of a type or description approved by the Director-General with not more than 25 tablets or capsules in each such pack or container or in a primary pack; or 4 94 s. 2 The Poisons Regulations of 1973

(ii) in the form of a powder containing not more than 1000 milligrams of salicylamide each powder being packed in an immediate wrapper and if also packed in an immediate container such container being of a type or description approved by the Director-General with not more than 12 powders in each such container or in a primary pack; or (iii) in the form of granules, packed in an immediate wrapper containing not more than 1000 milligrams of salicylamide and if also packed in an immediate container, such con tainer being of a type or description approved by the Director-General with not more than 12 immediate wrappers in each such container or in a primary pack. Silver nitrate. Sodium nitrite for therapeutic use. Sorbide nitrate. Staphisagria except in substances containing 0 · 2 per cent or less of staphisagria. Stramonium in substances containing 0 · 25 per cent or less of the alkaloids calculated as hyoscyamine, except preparations for smoking or burning. Tetrahydrozoline. Thenalidine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Thenyldiamine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds.

Tolpropamine~ (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Tramazoline. Trimeprazine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. The Poisons Regulations of 1973 s. 2 95

Trimethobenzamide- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Trimizoline. Tripelennamine- ( a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Triprolidine- (a) in substances labelled and packed as eye drops or as nasal preparations for topical use; or (b) in oral substances labelled and packed for the relief of coughs and colds. Tymazoline. Xylometazoline. Zinc pyridinethione and substances containing more than 2 per cent of zinc pyridinethione.

The Poisons Regulations of 1973 97

SCHEDULE 3 POISONS Adrenaline, natural or synthetic, in substances containing more than 0 · 01 per cent but not more than 1 per cent of adrenaline. Amyl nitrite. Antazoline in oral substances except when included in Schedule 2. Bamipine in oral substances except when included in Schedule 2. Benzoyl peroxide in substances for external human therapeutic use con taining 10 per cent or less of benzoyl peroxide except when included in Schedule 2. Bromodiphenhydramine in oral substances except when included in Schedule 2. Brompheniramine in oral substances except when included in Schedule 2. Buclizine in oral substances except when included in Schedule 2. Butyl nitrite. Carbinoxamine in oral substances except when included in Schedule 2. Chloropyrilene in oral substances except when included in Schedule 2. Chlorpheniramine in oral substances except when included in Schedule 2. Chlorphenoxamine in oral substances except when included in Schedule 2. Cholestyramine for human therapeutic use. Cinnarizine in oral substances except when included in Schedule 2. Clemastine in oral substances except when included in Schedule 2. Clemizole in oral substances except when included in Schedule 2. Codeine where compounded or combined with either aspirin or para cetamol or salicylamide in tablets or capsules containing not more than 10 mg of codeine per tablet or capsule except when included in Schedule 2. · Colestipol for human therapeutic use. Cycliramine in oral substances except when included in Schedule 2. Cyproheptadine in oral substances except when included in Schedule 2. Deptropine in oral substances except when included in Schedule 2. Dexbrompheniramine in oral substances except when included in Schedule 2. 98 s. 3 The Poisons Regulations of 1973

Dexchlorpheniramine in oral substances except when included in Schedule 2. Dimenhydrinate in oral substances except when included in Schedule 2. Dimethindene in oral substances except when included in Schedule 2. Dimethothiazine in oral substances except when included in Schedule 2. Diphenhydramine in oral substances except when included in Schedule 2. Diphenylpyraline in oral substances except when included in Schedule 2. Dithranol for human therapeutic use. Doxylamine in oral substances except when included in Schedule 2. Embramine in oral substances except when included in Schedule 2. Ephedrine except- (a) substances containing 10 mg or less of ephedrine per dosage unit; or (b) substances for internal use containing 1 per cent or less of ephedrine; or (c) when included in Schedule 2. Fenoterol in metered aerosols delivering 200 micrograms or less of fenoterol per metered dose. Flavoxate. Folic acid in substances for human use expect in substances contammg 500 micrograms or less of folic acid per recommended daily dose. Folinic acid in substances for human use except in substances containing 500 micrograms or less of folinic acid per recommended daily dose. Halopyramine in oral substances except when included in Schedule 2. Histapyrrodine in oral substances except when included in Schedule 2. ldoxuridine in substances containing 0 · 5 per cent or less of idoxuridine for cutaneous use. Insulin and substances containing the specific hypoglycaemic principle of the pancreas. Isoprenaline- ( a) in solutions for inhalation containing 1 per cent or less of isoprenaline, or (b) in metered dose aerosols delivering 100 micrograms or less of isoprenaline per metered dose. Mebhydrolin in oral substances except when included in Schedule 2. The Poisons Regulations of 1973 s. 3 99

Mefenamic acid in packs of 30 capsules or less when labelled for treatment of spasmodic dysmenorrhea. Mepyramine in oral substances except when included in Schedule 2. Methdilazine in oral substances except when included in Schedule 2. Nitrofurazone in substances for cutaneous use containing 0 · 2 per cent or less of nitrofurazone. Orciprenaline in metered aerosols delivering 750 micrograms or less of orciprenaline per metered dose. Phenindamine in oral substances except when included in :Schedule 2. Pheniramine in oral substances except when included in Schedule 2. Phenyltoloxamine in oral substances except when included in Schedule 2. Promethazine in oral substances except when included in Schedule 2. Pyrrobutamine in oral substances ·except when included in Schedule 2. Quinine for human therapeutic use. Salbutamol in metered aerosols delivering 100 micrograms or less of salbutamol per metered dose. Santonin. Sodium Cromoglycate in nasal substances for topical use. Terbutaline in metered aerosols delivering 250 micrograms or less of terbutaline per metered dose. Thenalidine in oral substances except when included in Schedule 2. Thenyldiamine in oral substances except when included in Schedule 2. Theophylline and its derivatives in oral liquid substances. Tolpropamine in oral substances except when included in Schedule 2. Tretinoin for external human therapeutic use. Trimeprazine in oral substances except when included in Schedule 2. Trimethobenzamide in oral substances except when included in Schedule 2. Tripelennamine in oral substances except when included in Schedule 2. Triprolidine in oral substances except when included in Schedule 2.

The Poisons Regulations of 1973 101

SCHEDULE 4 RESTRICTED DRUGS Acetanilide and alkyl acetanilides, for human therapeutic use. Acetazolamide. Acetohexamide. Acetylcholine and other choline esters. Acetylcysteine. Acetyldihydrocodeine in compounded preparations:- (a) in tablet or capsule form containing 100 milligrams or less of acetyldihydrocodeine in each tablet or capsule; or (b) in any other form containing 2 · 5 per cent or less of acetyldi hydrocodeine, except when included in Schedule 2. Acetyl methyl dimethyl oximido phenyl hydrazine. Adiphenine. Adrenalin, natural or synthetic, in substances containing more than 1 per cent of adrenalin. Alcuronium. AHylisopropylacetylurea. Alphadolane. Alpha-receptor blocking agents including phentolamine and phenoxybenzamine. Alphaxolone. Amantadine. Ambenonium. Ambucetamide. Ambut:onium. Amethocaine. Amidopryine and its derivatives. Amikacin. Amiloride. Aminometradine. Amino rex. 102 s. 4 The Poisons Regulations of 1973

Amiphenazole. Amisometradine. Amitryptyline and other compounds structurally derived therefrom by substitution in the side chain .. Amodiaquine. AmoxyciUin. Amphomycin. Amphotericin. Ampicillin. Amylocaine. Anabolic steroidal agents. Anaesthetics, local, except when included in Schedule 2. Angiotensin amide. Aniazoline except when included in Schedule 2 or Schedule 3. Antibiotics not elsewhere specified except- (a) Avoparcin when intended for use as an animal feed additive; (b) Nisin. Antifolic acid substances including aminopterin, teropterin and orthopterin. Antihistamines not elsewhere specified. Antimalarial substances not elsewhere specified. Antimony, organic compounds of, for therapeutic use. Antitubercular substances including isoniazid and its derivatives, para- aminosalicyclic acid and thiacetazone. Apomorphine. Aprotinin. Arsenic, organic compounds of, for human therapeutic use. Aspirin in a compounded or combined preparation for internal use which contains any caffeine, paracetamol or salicylamide. AtenoloL Atropine methonitrate. Azaperone. Azapetine. Azatadine. The Poisons Regulations of 1973 s. 4 103

Bacitracin except:- (a) when included in Schedule 6; (b) in animal feedstuffs for growth promotion in concentrations of 50 mg/kg or less of the total active antibiotic principle; (c) in milk replacers for calves and rations for pigs up to 12 weeks of age in concentrations of 100 mg/kg or less of the total active antibiotic principle. Baclofen. Bamipine except when included in Schedule 2 or Schedule 3. Barbituric acid and its derivatives. Beclamide. Bemegride. Benactyzine and other substances structurally derived from diphenylmethane with ataractic properties, for therapeutic use. Benserazide. Benzamine except when included in Schedule 2. Benzhexol. Benzilonium. Benzocaine except when included in Schedule 2. Benzoyl peroxide in substances for external human therapeutic use except when included in Schedule 2 or Schedule 3. Benzphetamine and other substances structurally derived from beta aminopropylbenzine or beta-aminoisopropylbenzene by substitution in the side chain or by ring closure therein (or by both such substitution and such closure) except:- ( a) when included in Schedule 2 or Schedule 3 or Schedule 8; and (b) ephedrine, pseudoephedrine and phenylephrine in substances excepted from Schedule 2 or Schedule 3. Benztropine. Benzydamine. Benzylpenicillin (including procaine penicillin) except when included in Schedule 6. Betahistine. Beta-receptor blocking agents including alprenolol and propranolol. Bethanidine. Biperiden. 104 s. 4 The Poisons Regulations of 1973

Bismuth subgallate for oral use in humans. Bleomycin. Boron compounds for human therapeutic or cosmetic use except:- ( a) in preparations for external use containing 1 per cent or less of boron; and (b) in unit dose preparations for periodontal disease containing 100 mg or less of boron. Brety.Iium. Bromhexine. Bromides, inorganic, for therapeutic use. Bromocriptine. Bromodiphenhydramine except when included in Schedule 2 or Schedule 3. Bromo£orm for therapeutic use. Brompheniramine except when included in Schedule 2 or Schedule 3. Bromvaletone. Buclizine except when included in Schedule 2 or Schedule 3. Bufexamac except when included in Schedule 2. Bufotenine. Bumetanide. BuniodyJ sodium. Busulfan. Butacaine. Butylaminobenzoate except when included in Schedule 2. Butyl chloral hydrate. Calamus for human therapeutic use. Calcitriol. Calcium carbimide for therapeutic use. Calicitonin. Camphetamide. Camphorated oil. Cantharides and substances containing more than 0 · 01 per cent of cantharidin. Capreomycin. Captodiame. The Poisons Regulations of 1973 s. 4 105

Capuride. Caramiphen. Carbachol. Carbamazepine. Carbaryl for human therapeutic use except when included in Schedule 2. Carbazochrome. Carbenoxolone except when included in Schedule 2. Carbidopa. Carbimazole. Carbinoxamine except when included in Schedule 2 or Schedule 3. Carbocromen. Carbromal. Cardiac glycosides not elsewhere specified in these Schedules. Carindacillin. Cefoxitin. Cephacetrile. Cephalexin. Cephaloridine. Cephalothin. Cephamandole. Cephapirin. Cephazolin. Cephradine. Chenodeoxycholic acid. Chiniofon and other halogenated 8-hydroxyquinoline derivatives for internal human. use. Chloral formamide. Chloral hydrate. Chloramphenicol. Chlorazanil. Chlorbutol in substances for human oral use, except in preparations containing 0 · 5 per cent or less of Chlorbutol as a preservative. 106 s. 4 The Poisons Regulations of 1973

Chlorcyclizine. Chlordiazepoxide and other substances structurally derived from benzodiazepine with ataractic properties, for therapeutic use. Chlormerodrin. Chlormethiazole. Chlormezanone. Chloroform when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. 1- ( 4-Chlorophenoxy )-1-imidazol-1-1-yl-3-3-dimethyl-2-butanone for human use. Chloropyrilene except when included in Schedule 2 or Schedule 3. Chloroquine. Chlorothiazide and other substances structurally derived from benzothiadiazine for therapeutic use. Chlorpheniramine except when included in Schedule 2 or Schedule 3. Chlorphenoxamine except when included in Schedule 2 or Schedule 3. Chlorphentermine. Chlorpromazine and other substances structurally derived from phenothiazine with ataractic properties, for therapeutic use. Chlorpropamide. Chlorprothixene. Chlortetracycline except:- (a) when included in Schedule 6; (b) in animal feedstuffs containing 80 to 100 milligrams per kilogram of chlortetracycline when prepared solely for the prevention of disease in calves and pigs up to 12 weeks of age. Chlor·thalidone. Chlorzoxazone. Cimetidine. Cinchocaine. Cinnarizine except when included in Schedule 2 or Schedule 3. Cisplatin. Clemastine except when included in Schedule 2 or Schedule 3. Clemizole except when included in Schedule 2 or Schedule 3. The Poisons Regulations of 1973 s. 4 107

Clidinium. Clindamycin. Clobetasone-17 -butyrate. Clofenamide. Clofibrate. Clomiphene, cyclofenil and other substances specifically prepared to stimulate ovulation. Clomocycline. Clonazepam. Clonidine. Clopamide. Clorazepate. Clorexolone. Clotrimazole. Cloxacillin. Clozapin. Codeine in compounded preparations:- (a) in tablet or capsule form containing 30 milligrams or less of codeine in each tablet or capsule; or (b) in any other form containing one per cent or less of codeine, except when included in Schedule 2 or Schedule 3. Colaspase. Colchicine. Colistin. Cortisone and steroid suprarenal cortical hormones, either natural or synthetic, and their derivatives. Coumarin derivatives and phenylindanedione derivatives for therapeutic use. Curare, tubocurarine, d-tubocurarine, d-tubocurarine dimethyl ether, and all synthetic quaternary ammonium compounds and other compounds having curarising properties. Cyclandelate. Cycliramine except when included in Schedule 2 or Schedule 3. 108 s. 4 The Poisons Regulations of 1973

Cyclizine. Cyclopentolate. Cyclopropane when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Cycloserine. Cycrimine. Cyproheptadine except when included in Schedule 2 or Schedule 3. Dacarbazine. Danazol. Dapsone and all derivatives of 4,4-diaminodiphenylsulphone. Deanol. Demecarium bromide. Demecolocycline. Deptropine except when included in Schedule 2 or Schedule 3. Desipramine. Desmopressin (D.D.A.V.P.). Dexbrompheniramine except when included in Schedule 2 or Schedule 3. Dexchlorpheniramine except when included in Schedule 2 or Schedule 3. Dextromethorphan except when included in Schedule 2. Dextropropoxyphene. Dextrorphan except when included in Schedule 2. Diazepam. Dibenzepin. Diohloralphenazone. Dichlorphenamide. Diolofenac. Dicyclomine except in substances containing 0·1 per cent or less of dicyclomine. Diethazine. Diethylcarbamazine for human therapeutic use. Diethylpropion. N,N-Diethyltryptamine (DET). The Poisons Regulations of 1973 s. 4 109

Difenoxin in preparations containing, per dosage unit, 0 · 5 milligram or less of difenoxin and a quantity of atropine sulphate equivalent to not less than 5 per cent of the dose of difenoxin. Diflunisal. Digitalis and its glycosides. Dihydrallazine. Dihydrocodeine in compounded preparations:- ( a) in tablet or capsule form containing 100 milligrams or less of dihydrocodeine in each tablet or capsule; or (b) in any other form containing 2 · 5 per cent or less of dihydrocodeine, except when included in Schedule 2. Dihydrostreptomycin except when included in Schedule 6. Diisopropylamine dichloracetate. Dimenthydrinate except when included in Schedule 2 or Schedule 3. Dimethindene except when included in Schedule 2 or Schedule 3. Dimethisoquin except when included in Schedule 2. Dimethothiazine except when included in Schedule 2 or Schedule 3. Dimethoxanate. 2,5-dimethoxy-4-methylamphetamine (DOM or STP). Dimethyl sulphoxide for therapeutic use. N ,N -Dimethyltryptamine. Dinitrocresols for therapeutic use. Dinitronaphthols for therapeutic use. Dinitrophenols for therapeutic use. Dinitrothymols for therapeutic use. Diperodon. Diphemanil methylsulphate except in substances for external use. Diphenhydramine except when included in Schedule 2 or Schedule 3. Diphenidol. Diphenoxylate in preparations containing, per dosage unit, 2 · 5 miH:igrams or less of diphenoxylate and a quantity of atropine sulphate equiv alent to not less than 1 per cent of the dose of diphenoxylate. Diphenylpyraline except when included in Schedule 2 or Schedule 3. Dipivefrin. Dipyridamole. 110 s. 4 The Poisons Regulations of 1973

Disophenol. Disopyramide. Disulfiram for therapeutic use. Dithiazanine except in substances containing 2 per cent or less of dithiazanine for veterinary use. Dobutamine. Dopamine. Dothiepin. Doxapam. Doxepin. Doxorubicin. Doxycycline. Doxylamine except when included in Schedule 2 or Schedule 3. Droperidol. Drostanolone. Embramine except when included in Schedule 2 or Schedule 3. Emetine except in substances containing 0 · 2 per cent or less of emetine. Enfl.urane when specifically prepared and packed as a therapeutic agent for .the induction of inhalation anaesthesia. Epidllin. Ergot. Erythromycin except:- ( a) when included in Schedule 6; (b) in animal feedstuffs for growth promotion in concentrations of 50 mg/kg or less of tile total active antibiotic principle; (c) in milk replacers for calves or rations for pigs up to 12 weeks of age in concentrations of 100 mg/kg or less of the total active antibiotic principle. Eethacrynic acid. Ethambutol. Ethamivan. Ethchlorvynol. Ether when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Ethinamate. The Poisons Regulations of 1973 s. 4 111

Ethoglucid. Ethoheptazine and substances containing more than 1 per cent of ethoheptazine. Bhopropazine. Ethoxozolamide. Ethyl Chloride when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Ethylene when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Ethylmorphine in compounded preparations:- (a) in tablet or capsule form containing 100 milligrams or less of ethylmorphine in each tablet or capsule; or (b) in any other form containing 2 · 5 per cent or less of ethyl morphine, except when included in Schedule 2. Ethyloestrenol. Etidocaine. Fencamfamin. Fenfturamine. Fenoprofen. Fenoterol except when included in Schedule 3. Fenpipramide. Fenpiprane. Flavophospholipol except:- (a) when included in Schedule 6; (b) in animal feedstuffs for growth promotion in concentrations of 50 mg/kg or less of the tntal active antibiotic principle. Flucloxacillin. Flufenamic acid. Flunitrazepam. 5-ftuorocystosine. Fluorouracil and other substances structurally derived from uracil with cytotoxic properties, for therapeutic use. Fluoxymesterone. Flurazepam. 112 s. 4 The Poisons Regulations of 1973

Fluroxene when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Fluspirilene. Framycetin. Frusemide. Fusidic Acid. Galanthamine. Gallamine. Gentamycin. Glibomuride. Gliclazide. Glucagon. Glutethimide. Glyceryl Trinitrate in substances for injection. Glycopyrronium. Glymidine. Gramicidin. Griseofulvin. Guanacline. Guanethidine. Halcinonide. Haloperidol and other substances structurally derived from butyrophenone with ataractic properties, for ther~peutic use. Halopyramine except when included in Schedule 2 or Schedule 3. Halothane whne specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Heparin. Hetacillin. Hexachlorophane in preparations for use on infants and in all other preparations except when included in Schedule 2 or Schedule 6. Hexamethonium. Hexocyclium. Histapyrrodine except when included in Schedule 2 or Schedule 3. The Poisons Regulations of 1973 s. 4 113

Hydrallazine. Hydroquinone for human therapeutic use except in substances containing 2 per cent or less of hydroquinone. Hydroxychloroquine. 1-hydroxy-pyrido (3,2,a)-5-phenoxazone-3-carboxylic acid. Hydroxyurea. Hydroxyzine. Hygromycin except:- (a) when included in Schedule 6; and (b) in substances containing 50 ppm or less of hygromycin. Hyoscine butylbromide. Hypothalmic releasing factors when used for diagnostic purposes. lbufenac. Ibuprofen. ldoxuridine except ,when included in Schedule 3. Imipramine. Indomethacin. Inositol Nicotinate for internal use. Ion exchange resins, anionic and cationic-for internal human use. Ipratropium bromide. Iron compounds, in injectable preparations for therapeutic use. Isoaminile. Isoetharine. Isometheptene. Isoprenaline except when included in Schedule 3. Isopropamide except when included in Schedule 2. Isoxuprine. Kanamycin. Ketamine. Ketoprofen. Khellin. Kitasamycin except:- (a) when included in Schedule 6; 114 s. 4 The Poisons Regulations of 1973

(b) in animal feedstuffs for growth promotion in concentrations of 100 mg per kg or less of the total antibiotic principle. Labetalol. Laudexium methylsulphate. Lefetamine. Leptazol. Levamisole for human therapeutic use. Levodopa. Lidoflazine. Lignocaine except when included in Schedule 2. Lincomycin. Lithium salts for therapeutic use except in substances containing 0 · 01 per cent or less of lithium. Lorazepam. Lysergic acid. Lysergic acid diethylamide (lysergide). Maphenide. Mazindol. Mebeverine. Mebhydroline except when included in Schedule 2 or Schedule 3. Mecamylamine. Meclofenoxate. Meclozine. Medazepam. Mefenamic acid except when included in Schedule 3. Mefruside. Mepacrine. Mepenzolate. Mephenesin and its derivatives except guaiphenesin when included in Schedule 2. Mephentermine. Mepivacaine. Meprobamate. The Poisons Regulations of 1973 s. 4 115

Mepyramine except when included in Schedule 2 or Schedule 3. Mercaptopurine and other substances structurally derived therefrom with cytotoxic properties, for therapeutic use. Mercurous Chloride for therapeutic use. Mercury, organic compounds of, for therapeutic use, except substances for external use containing 0 · 5 per cent or less of mercury. Mescaline and other substances structurally derived from methoxyphenylethylamine having hallucinogenic properties. Metaraminol. Metformin. Methacycline. Methadienone. Methandriol. Methantheline. Methapyrilene. Methazolamide. Methdilazine except when included in Schedule 2 or Schedule 3. Methenolone. Methicillin. Methimazole. Methixene. Methocal'bamol. Methotrexate. Methoxsalen. Methoxyflurane when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Methylandrostanolone. Methyl cincophen (methyl ester of phenylcinchoninic acid). Methyldopa. Methylpentynol and other substituted alkynes for internal use. Methyprylone. Methysergide. Metoclopramide. 116 s. 4 The Poisons Regulations of 1973

Metolazone. Metoprolol. Metronidazole. Metyrapone. Mexiletine Hydrochloride. Mezlocillin. Mibolerone. Miconazole. Minocycline. Minoxidil. Mithramycin. Mitobronitol. M1tomycin. Monensin except in animal feeds containing 120 ppm or less of monensin. Monoamine oxidase inhibitors, including iproniazid, isocarboxazid, nialamide, phenelzine, pheniprazine and other substances for which monoamine oxidase inhibition is claimed, except triparanol. Monobenzone for human therapeutic use, except substances containing 2 per cent or less of monobenzone. Moperone. Morphine antagonists including nalorphine, naloxone and levallorphan. Mustine and other substances structurally derived therefrom with cytotoxic properties, for therapeutic use. Nalidixic acid. Nandrolone. Naproxen. Natamycin. Neomycin except when included in Schedule 6. Neostigmine. Nicocodine in compounded preparations:- (a) in tablet or capsule form containing 100 milligrams or less of nicocodine in each tablet or capsule; or (b) in any other form containing 2 · 5 per cent or less of nicocodine, except when included in Schedule 2. The Poisons Regulations of 1973 s. 4 117

Nicodicodine in compounded preparations:- (a) in tablet or capsule form containing 100 milligrams or less of nicodicodine in each tablet or capsule; or (b) in any other form containing 2 · 5 per cent or less of nicodicodine, except when included in Schedule 2. Nicotine in chewing tablets containing 4 milligrams or less of nicotine per tablet when labelled for use as an aid in withdrawal from tobacco smoking. Nicotinic Acid, when the recommended daily dose exceeds 250 mg. Nicotinyl alcohol for internal use. Nifenazone. Nikethamide. Niridazole. Nitrazepam. Nitrofuran and its derivatives for human therapeutic use except when included in Schedule 3. Nitrous Oxide when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Noradrenaline excluding its derivatives. Norcodeine in compound preparations:- ( a) in tablet or capsule form containing 100 milligrams or less of norcodeine in each tablet or capsule; or (b) in any other form containing 2 · 5 per cent or less of norcodeine, except when included in Schedule 2. Norethandrolone. Nortriptyline. Novobiocin except when included in Schedule 6. Octamylamine. Octatropine. Oleandomycin except:- (a) when included in Schedule 6; (b) in animal feedstuffs for growth promotion in concentrations of 50 mg/kg or less of the total active antibiotic principle. Orciprenaline except when included in Schedule 3. 118 s. 4 The Poisons Regulations of 1973

Organo-phosphorus compounds with anticholinesterase activity for human therapeutic use, except when included in Schedule 2. Ornidazole. Ornipressin. Orphenadrine. Orthocaine. Oxacillin. Oxandrolone. Oxazepam. Oxprenolol. Oxybuprocaine. Oxymesterone. Oxymetholone. Oxyphenbutazone. Oxyphencyclimine. Oxyphenisatin for human therapeutic use. Oxyphenonium. Oxytetracycline except:- (a) when included in Schedule 6; (b) in animal feedstuffs containing 80 to 100 milligrams per kilogram of oxytetracycline when prepared solely for the prevention of disease in calves and pigs up to 12 weeks of age. Pamaquine. Pancuronium. Paracetamol in a compounded or combined preparation for internal use which contains any caffeine asprin or salicylamide. Paraldehyde. Paramomycin. Pemoline. Pempidine. D-Penicillamine. Pentamethonium. The Poisons Regulations of 1973 s. 4 119

Penthienate. Pentolinium. Perhexilene. Phenacemide and other substances structurally derived from acetylurea with anti-convulsant properties, for therapeutic use. Phenacetin. Phenazone for internal use. Phenazopyridine. Phenetheicillin except when included in Schedule 6. Phenformin. Phenglutarimide. Phenindamine except when included in Schedule 2 or Schedule 3. Pheniramine except when included in Schedule 2 or Schedule 3. Phenoxybenzamine. Phenoxymethylpenicillin except when included in Schedule 6. Phensuximide and other substances structurally derived from succinamide with anti-convulsant properties, for therapeutic use. Phentermine. Phenthimentonium. Phenyapin. Phenylbutazone. Phenylpropanolamine. Phenyltoloxamine except when included in Schedule 2 or Schedule 3. Phenytoin and other substances structurally derived from hydantoin with anti-convulsant properties, for therapeutic use. Pholcodine in compounded preparations:- (a) in tablet or capsule form containing 100 milligrams or less of pholcodine in each tablet or capsule; or (b) in any other form containing 2 · 5 per cent or less of phol codine, except when included in Schedule 2. Physostigmine. Picrotoxin. 120 s. 4 The Poisons Regulations of 1973

Pilocarpine except in substances containing 0 · 025 per cent or less of pilocarpine. Pimozide. Pindolol. Pirpenzolate. Piperidolate. Pipobroman. Pipradrol. Pituitary, its e:1rtracts, its active principles and their synthetic substitutes except when included in Schedule 7. Pizotifen. Polymethylene bistrimethyl ammonium compounds. Polymyxin. Potassium perchlorate for therapeutic use. Prazepam. Pregnenolone acetate except in substances for external use. Prenylamine. Prilocaine. Primaquine. Primidone. Probenecid. Procainamide. Procaine. Procarbazine. Prochlorperazine. Procyclidine except when included in Schedule 2. Proguanil. Prolintane. Promethazine except when included in Schedule 2 or Schedule 3. Propanidid. Propantheline except in substances for external use. Propylhexedrine except when included in Schedule 2. The Poisons Regulations of 1973 s. 4 121

Proquazone. Prostaglandins. Prothi,onamide. Proxymethacaine. Psilocin. Psilocybin. Pyridostigmine. Pyrimethamine. Pyrrobutamine except when included in Schedule 2 or Schedule 3. Quinethazone. Quinidine. Rauwolfia. Rifampicin. Ritordrine. Roliteracycline. Salbutamol except when included in Schedule 3. Salicylamide in a compounded or combined preparation for internal use which contains any caffeine, aspirin or paracetamol. Selenium except:- (a) when included in Schedule 5 or Schedule 6; (b) in prepared stockfeeds containing 0 · 1 grams per tonne or less of selenium; (c) in compressed pellets for control of selenium responsive conditions in sheep. Sex Hormones, natural or synthetic, their substitutes, in all preparations including cosmetics except:- (a) their derivatives and their substitutes without sex hormonal activity; (b) testosterone propionate and testosterone dipropionate when included in Schedule 6; and (c) oestradiol-17-ibeta when included in Schedule 6. Sodium Cromoglycate except when included in Schedule 3. Sodium Fluoride in substances for human ingestion except when included in Schedule 2. Sodium Nitroprusside for human therapeutic use. 122 s. 4 The Poisons Regulations of 1973

Sodium Valproate. Sontoquine. Sparteine. Spectinomycin. Spiramcyin. Spironolactone. Stanolone. Stanozolol. Streptomycin except when included in Schedule 6. Strophanthus and its glycosides. Strychnine in substances containing 1 · 5 per cent or less of strychnine for the treatment of animals. Sulphanilamide and its derivatives except: (a) when included in Schedule 6; (b) sulphaquinoxaline when incorporated in baits for the destruc tion of vermin and in animal feedstuffs containing 200 ppm or less of sulphaquinoxaline; (c) oryzaEn; (d) in animal feedstuffs containing 80 to 100 milligrams per kilogram of sulphanilamide substance when prepared solely for the prevention of disease in calves and pigs up to 12 weeks of age. Sulphinpyrazone. Sulphomyxin. Sulphonal and alkyl sulphonals. Sulthiame. Suxamethonium. Tacrine. Tamoxifen. Temazepam. Terbutaline except when included in Schedule 3. Tetracycline except when included in Schedule 6. Thalidomide. Thenalidine except when included in Schedule 2 or Schedule 3. Thenyldiamine except when included in Schedule 2 or Schedule 3. The Poisons Regulations of 1973 s. 4 123

TheophyUine and derivatives therefrom except when included in Schedule 3. Thiambutosine. Thiazosulfone. Thiotepa and other substances structurally derived therefrom with cytotoxic properties, for theapeutic use. Thiothixene. Thiouracil and substances structurally derived therefrom with anti-thyroid properties, for therapeutic use. Thiourea for therapeutic use. Thyroid and its extract. Tiamulin. Ticarcillin. Tiemonium. Tigloidine. Timolol. Tinidazole. Tipepidine. Tolazamide. Tolazoline for internal use. Tolbutamide. Tolpropamine except when included in Schedule 2 or Schedule 3. Tranexamic acid. Tretamine. Trimaterene. Triaziquone. Triazolam. Trichloroethylene when specifically prepared and packed as a therapeutic agent for the induction .. of inhalation anaesthesia. Triclofos. Tricyclamol. Tridihexethyl. Trifluperidol. 124 s. 4 The Poisons Regulations of 1973

Trimeprazine except when included in Schedule 2 or Schedule 3. Trimetaphan. Trimethobenzamide except when included in Schedule 2 or Schedule 3. Trimethoprim. Trimipramine and other compounds structurally derived therefrom by substition in the side chain. Trimustine. Trioxsalen. Triparanol. Tripelennamine except when included in Schedule 2 or Schedule 3. Triprolidine except when included in Schedule 2 or Schedule 3. Troxidone and other substances structurally derived from oxazolidinone with anti-convulsant properties, for therapeutic use. Tylosin except:- (a) when included in Schedule 6; (b) in animal feedstuffs for growth promotion in concentrations of 50 mg/kg or less of the total active anti:biotic principle. (c) in milk replacers for calves or rations for pigs up to 12 weeks of age in concentrations of 100 mg/kg or less of the total active antibiotic principle. Urethane (excluding its salts) for therapeutic use. Urethanes and ureides having or purporting to have soporific, hypnotic or narcotic properties, not specifically included in this or any other Schedule. Vaccines, sera, toxoids, antitoxins and antigens for human parenteral use. Vaccines, veterinary live virus, except those included in Schedule 6. V alnoctamide. Veratrum for therapeutic use. Vinca alkaloids including semi-synthetic derivatives. Vinyl Ether when specifically prepared and packed as a therapeutic agent for the induction of inhalation anaesthesia. Viprynium. Virginiamycin except:- (a) when included in Schedule 6; (b) in animal feedstuffs for growth promotion in concentrations of 50 mg/kg or less of the total active antibiotic principle. The Poisons Regulations of 1973 s. 4 125

Visnadine. Vitamin A in substances for human use containing more than 3 milligrams (10 000 International Units) per recommended daily dosage. Vitamin D in substances for human use containing more than 25 micrograms ( 1 000 International Units) per recommended daily dosage. Xanthine oxidase inhibitors including allopurinol. Xantinol nicotinate. Xylazine. Yohimba. Zeranol except when included in Schedule 6.

The Poisons Regulations of 1973 127

SCHEDULE 5 POISONS Acetic acid (excluding. its salts) in substances cOntaining 80 per cent. or less and more than 30 per cent. of acetic acid, except for therapeutic use. Acetic anhydride (excluding its salts) in substances containing 80 per cent. or less and more than 30 per cent. of acetic anhydride, except for therapeutic use. Acetone when packed in containers of 20 litres or less, except:- (a) in substances containing 25 per cent. or less of acetone; and (b) in substances packed in containers each containing 60 milli litres or less of acetone. Aklomide. Alachlor. Alkaline salts, being sodium carbonate, sodium orthosilicate, sodium metasilicate and trisodium phosphate or any combination, except:- ( a) in preparati<.'ns containing 10 per cent or less of combined substances; or (b) in solid preparations whose pH in 1 per cent. (w/v) aqueous solution is 11· 5 or less; or (c) in liquid· preparations having a pH of 11 · 5 or less. Alpha-(2-chlorophenyl )-alpha-( 4-chlorophenyl) -5-pyrimidinemethanol. Amitrole. Ammonia (excluding its salts other than ammonium hydroxide) in sub stances containing' 5 per cent~ or less of free ammonia except:- ( a) in medicinal preparations for internal use; (b) in appliances for inhalation in which the substance is absorbed upon an inert solid material; and (c) in substances containing 0 · 5 per cent. or less of free ammonia. Ammonium thiocyanate. Arsenic, organic compounds of, other than copper aceto-arsenite, in herbicides and defoliants containing 3 per cent. or less of arsenic. Barium silicofluoride when coated on paper in an amount not exceeding 8 milligrams per square centimetre. Bendiocarb in substances containing 2 per cent. or less of bendiocarb. Bentazon. 12·8 s. 5 The Poisons Regulations of. 19?,3

Benzoyl peroxide except:- (a) when included in Schedule· 3 or Schedule 4; (b) when used as an approved food additive. S-Benzyl N, N-di-(sec-butyl)-thiolocarbamate. BHC in substances containing 10 per cent. or less of BHC. Bio allethrin except in sU!bstances containing 10 per cent. or less of bio allethrin. Boron compounds except:- (a) in substances containing 1 per cent. or less of boron; (b) in soap powders, powder detergents and bleaches; (c) in unit dose preparations for periodontal disease containing 100 mg or less of boron; (d) when included in Schedule 4. Buthidazole. Cadmium sulphide in substances containing 2 · 5 per cent. or less .. of cadmium sulphide, for human therapeutic use. Camphor and substances containing more than 10 per cent. of camphor except when included in Schedule 4. Captafol. Carbaryl:- (i) when impregnated in plastic resin strip material containing 20 per cent. or less of carbaryl; (ii) in other substances containing 10 per cent. or less of carbaryl; and (iii) except when included in Schedule 2 or 4. Chlordecone in substances containing 5 per cent. or less of chlordecone. Chlorethalin. Chlorfenac. Chlorfenson. Chlorinating compounds and bleaches containing more than 4 per cent. of available chlorine, except when included in Schedule 7. Chlomidine. Chlorocresol. 1-(4-Chlorophenoxy)-1-imidazol-1-yl-3, 3-dimethyl-2-butanone in sub stances containing more than 2 per cent. of 1-(4-chlorophenoxy)-1- imidazol-1-yl-3, 3-dimethyl-2-hutanone except when included in Schedule 4 or Schedule 6. The Poisons Regulations of 1973 s. 5 129

Chloropropylate. Copper sulphate except for internal human therapeutic use. 4-CPA. Cuprimyxin for the treatment of animals. Cyanatryn. Cyanuric acid (excluding its salts). Cyclohexanone peroxide. 3-cyclohexyl-6-(dimethylamino)-1-methyl-1, 3, 5-triazine, 2, 4(1H, 3H)- dione. Cypermethrin in substances containing 10 per cent. or less of cypermethrin. 2,4-D. 2,4-DB. 2,4-DES. N, N-Diallyldichloroacetamide, except in substances containing 10 per cent. or less of N, N-diallyldichloroacetamide. Dicamba. Dichlone. Dichloroisocyanurates. 1-12 (2, 4-Dichlorophenyl)-2-(2-propenlyloxy) ethyll-1h-imidazole. 3-6-Dichloropicolinic acid. Dichlorvos :- (i) when impregnated in plastic resin strip material containing 20 per cent. or less of dichlorvos; (ii) in sustained release resin pellets for veterinary use containing 20 per cent. or less of dichlorvos; or (iii) in aerosol packs containing 10 grams or less of dichlorvos. Dicloran. Dicofol. Dicophane in substances containing 10 per cent. or less of dicophane, except for human therapeutic use. Dimethirimol. Dimethylformamide, in substances containing 10 per cent. or less of dimethylformamide. 1, 1-Dimethylpiperidinium ion. Dinitramine. 130 s. 5 The Poisons Regulations of 1973

Diphenamid. Dodine. Epoxy resins, liquid, and all amines and organic anhydrides used as curing agents for epoxy resins. EPTC. Ethephon (excluding its salts). Ether preparations for use in internal combustion engines. Ethofumestate. Ethoxyquin except in substances containing 10 per cent. or less of ethoxyquin. Ethylene glycol, when packed and labelled as a boiling point and/or freezing point modifier and containing 10 milligrams per kliogram of denatonium benzoate as a· bittering agent. N-( 1-ethylpropyl)-3,4-dimethyl-2,6-dinitroaniline. Eucalyptus oil except in in substances containing 25 per cent ..or .less of eucalyptus oil. Fenbutatin-oxide. Fenoprop. Fenson. Fenthion in substances containing 20 per cent. or less of fenthion packed in single use containers having a capacity of 0 · 3 rnillilitre or less. Flam prop-methyl. Formic acid (excluding its salts). Fospirate when impregnated in plastic resin strip material containing 20 per cent. or less of fospirate. Glyphosate. Hydrocarbons, liquid, distilling under 300° C when tested according to method 086-61 of the American Society for Testing and Materials when packed in containers of 20 litres or less, except:- (a) when included in Schedule 6 or 7; (b) in substances containing 25 per cent. or less of such liquid hydrocarbons; (c) in solid or semi-solid cleaning and polishing preparations; (d) in preparations packedin pressurised aerosol containers; and (e) in adhesives packed in containers each containing 50 grams or less of adhesive. The Poisons Regulations of 1973 s. 5 131

Hydrochloric acid (excluding its salts) in substances containing 10 per cent. or less of hydrochloric acid (HCl) except:- ( a) in substances containing 0 · 5 per cent. or less of hydrochloric acid (HCI); and (b) for therapeutic use. Hydrofluoric acid and hydrosilicofluoric acid in substances containing 0· 5 per cent. or less of hydrofluoric acid or hydrosilicofluoric acid except in substances containing 15 mg/kg or less of fluoride ion. Hydrogen peroxide (excluding its salts) and substances containing more than 6 per cent. weight in volume (20 vol.) of hydrogen peroxide. Iodofenphos. 2-Iso-buty lamino-4-ethylamino-6-methoxy-1 ,3 ,5 ,-triazine. lsopropyl-N-( 3-N-ethyl-N-phenylcarbamoyloxy) phenylcarbamate. Kerosene and substances containing more than 25 per cent. of kerosene when packed in containers of 20 litres or less. Levamisole in substances containing 15 per cent. or less of levamisole for the treatment of animals. Lindane in substances containing 10 per cent. or less of lindane except when included in Schedule 2. · Maldison in substances containmg 10 per cent. or less of maldison, except for human therapeutic use. Mancozeb. Maneb. MCPA. MCPB. Mecoprop. Metaldehyde in substances containing 2 per cent. or less of metaldehyde. Methabenzthiazuron. Methazole. Methiocarb in pelleted preparations containing 2 per cent. or less of methiocarb. Methoxychlor. Methylated Spirit, Industrial as defined by the Commonwealth Spirits Act 1906-1973, excluding its admixtures and preparations when packed in containers of 5 litres or less. Methylene chloride except in preparations packed in pressurised aerosol containers. 134 s. 5 The Poisons Regulations of 1973

Methyl ethyl ketone and substances containing more than 25 per .cent. of ketones to which this Schedule applies when packed in containers of 20 litres or less. Methyl ethyl ketone peroxide. Methyl N-(furo-2-yl)-N-(2,6 xylyl) alaninate. Methyl iso-amyl ketone and substances containing more than 25 per cent. of ketones to which this Schedule applies when packed in containers of 20 litres or less. Methyl isobutyl ketone and substances containing more than 25 per cent. of ketones to which this Schedule applies when packed in containers of 20 litres or less. Methyl N-(methoxyacetyl)-N-(2, 6-xylyl) alaninate. 3-(Methylsulfonyl) butanon-0-methylcarbamoyloxim in solid substances containing 10 per cent. or less of 3-(methylsulfonyl) butanon-0- methylcarbamoyloxim. Metiram. Metolachlor. Metribuzin. Mezineb. Mineral turpentine and substances containing more than 25 per cent. of mineral turpentine when packed in containers of 20 litres or less. Naled when impregnated in plastic resin strip material containing 20 per cent. or less of naled. Naphthalene (excluding its salts). Naphthalene acetic acid except in substances containing 25 per cent. or less of naphthalene acetic acid. Nitric acid (excluding its salts) in substances containing 10 per cent. or less W/W of nitric acid (HNOa), except substances containing 0·5 per cent. or less of nitric acid (HNOa). Norbormide. Oil of turpentine and substances containing more than 25 per cent. of oil of turpentine when packed in containers of 20 litres or less. Organo-tin compounds in substances containing 1 per cent. or less of such compounds. Ortho phenylphenol. Oxycarboxin. Oxythioquinox. Para-dichlorobenzene. Pebulate. The Poisons Regulations of 1973 s. 5 133

Petrol and substances containing more than 25 per cent. of petrol when packed in containers of 20 litres or less. Phosphoric acid, excluding its salts except:- ( a) when packed in containers with a capacity of not less than 10 litres and labelled with the word "CORROSIVE", in bold face sanserif capital letters of a height of not less than 1 em; (b) in substances containing 350 g per litre or less of phosphoric acid; (c) in solid and semi-solid preparations; (d) in professional dental kits. Pirimicarb in substances containing 0 · 5 per cent. or less of pirimicarb. Poly (hexamethylene biguanide) hydrochloride. Potassium hydroxide (excluding its salts) in substances containing 5 per cent. or less of potassium hydroxide except:- ( a) substances containing 0 · 5 per cent. or less of potassium hydroxide; and (b) in accumulators and batteries. Prometryne. Propanil. Propionic acid (excluding its salts) in substances containing 80 per cent. or less and more than 30 per cent. of propionic acid, except for therapeutic use. Propoxur in dust preparations containing 3 per cent. or less of propoxur. Prynachlor. Pyrethrins and related compounds in substances containing more than 10 per cent. of such compounds. N-3-pyridylmethyl-N1-p-nitrophenylurea in substances containing 10 per cent. or less of N-3-pyridylmethyl-Nl-p-nitrophenylurea. Quaternary ammonium compounds and substances containing more than 10 per cent. of quaternary ammonium compounds, except when included in another Schedule. Quintozene. Salicylanilide. Selenium sulphide in substances containing 2 · 5 per cent. or less of selenium sulphide for therapeutic use. Sodium acid sulphate. Sodium chlorate. 6 134 s. 5 The Poisons Regulations of 1913

Sodium hydrogen sulphate. Sodium hydroxide (excluding its salts) in substances containing 5 per cent. or less of sodium hydroxide, except substances containing 0 · 5 per cent. or less of sodium hydroxide. Sodium nitrite except:- (a) in substances containing 1 per cent. or less of sodium nitrite; and (b) for therapeutic use. Styrene (excluding its salts) when packed in containers of 20 litres or less. Sulphamic acid, except in substances containing 10 per cent. or less of sulphamic acid. 2.3.6-TBA. TDE in substances containing 10 per cent. or less of TDE. Terbuthylazine. Terbutryne. 2-Tert butylamino-4-ethylamino-6-methoxy-1 ,3,5-triazine. Tetrachlorvinphos. Thiobencarb. Triadimenol. Triallate. Trichloroacetic acid (alkali salts of). 1,1, 1-trichloroethane when packed in containers of 20 litres or less except:- ( a) in substances containing 25 per cent. or less of 1,1,1- trichloroethane; (b) in substances packed in pressurised aerosol containers; and (c) when packed in containers of 50 millilitres or less. Trichloroisocyanuric acid when compressed in block form for use in swimming pools. Trietazine. Vernolate. White spirit and substances containing more than 25 per cent. of white spirit when packed in containers of 20 litres or less. Zinc pyridinethione in substances containing 2 per cent. or less of zinc pyridinethione. Zineb. Ziram. The Poisons Regulations of 1973 135

SCHEDULE 6

POISONS Acephate. Acetic acid (excluding its salts) except:- ( a) in substances containing 80 per cent. or less of acetic acid; and (b) for therapeutic use. Acetic anhydride (excluding its salts) except:- ( a) in substances containing 80 per cent. or less of acetic anhydride; and (b) for therapeutic use. Allidochlor. Alpha-chlorohydrin. Alpha-chloralose when prepared for use as a pesticide .. Ametryne. Amidithion. 2-amino-butane. Aminocarb in substances containing 25 per cent. or less of aminocarb. 2-Amino-5-diethylamino toluene. 2-Amino-5-N-ethyl-(B hydroxy ethyl) amino toluene. 2-Amino-5-N-ethyl-N-(B methane sulphonamide ethyl) amino toluene. 2-Amino-5-N-ethyl-N B methoxyethyl amino toluene di-p-toluene. Amitraz. Ammonia (excluding its salt's other than ammonium hydroxide) except: (a) in substances containing 5 per cent. or less of free ammonia; (b) in medicinal preparations for internal use; and (c) in appliances for inhalation in which the substance is absorbed upon an inert solid material. Aniline (excluding its salts and derivatives) except in preparations con taining 1 per cent. or less of aniline. 136 s. 6 The Poisons Regulations of 1973

Arecoline. Arprinocid. Arsenic and all compounds of arsenic, except:- ( a) when included in Schedule 4, Schedule 5 or Schedule 7; and (b) in animal feedstuffs containing 7 5 ppm or less of arsenic. Atropine sulphate 0 · 5 milligram tablets, in packs of 6 labelled for the treatment of organo-phosphorus poisoning. Azobenzene. Azocyclotin. Bacitracin in animal feedstuff premixes for growth promotion purposes containing concentrations greater than 50 ppm but not more than 20,000 ppm of the total antibiotic principle. Barban. Barium, salts of (except barium sulphate) except: (a) in paint containing barium metaborate; and (b) when included in Schedule 5. Bendiocarb- (a) in wettable powders containing 80 per cent. or less of bendiocarb and when packed in containers or primary packs containing not less than 100 grams of bendiocarb; (b) in insoluble granular substances containing 5 per cent. or less of bendiocarb; (c) except when included in Schedule 5. Benquinox. Bensulide. Benzylpenicillin including procaine penicillin in substances for intra mammary infusion in animals, containing not more than 100,000 international units per dose of benzylpenicillin or procaine penicillin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker and when packed in applicator devices specially designed for the purpose. Beryllium. BHC and substances containing more than 10 per cent. of BHC. Binapacryl. Bithionol for the treatment of animals. 3-(3-(4'-Bromodiphenyl-4-yl)-3-hydroxy-1-phenylpropyl)-4- hydroxycoumarin in substances containing 0·1 per cent. or less of 3-( 3-( 4'-Bromodiphenyl-4-yl) 3-hydroxy~ 1-phenylpropyl) -4- hydroxycoumarin. The Poisons Regulations of 1973 s. 6 137

3-{3-( 4'-Bromodiphenyl-4-yl)-1,2,3,4,-tetrahydronaphthyl)-4- Hydroxycoumarin in substances containing 0·25 per cent. or less of 3-(3-( 4'-Bromodiphenyl-4-yl)-1,2,3,4-tetrahydronaphthyl-4- hydroxycoumarin. Bromoform, except for therapeutic use. Bromophos. Bromophos-ethyl. Bromoxynil. Brotianide. Bunamidine. Butacarb.

2-butoxy-21- thiocyano-diethylether. Butynorate. Cadmium, compounds of, except when included in Schedule 5. Cambendazole. Carbadox except in animal feedstuffs containing 50 milligrams per kilogram or less of the total active principle. Carbaryl except when included in Schedules 2, 4 or 5. Carbon bisulphide. Chlordane. Chlordecone except when included in Schedule 5. Chlorfenethol. Chlormequat. N-5-CChloro-4-( ( 4-chlorophenyl) -cyanomethyl) -2-methyl-phenyl-2- hydroxy-3,5-diiodobenzamide. Chloromethiuron. 2-Chloro-N-( 4-methoxy-6-methyl-1 ,3 ,5-triazin-2-yl) aminocarbonyl ben zene sulfonamide. S- ( 6-Chloro-2-oxo-oxozolo ( 4,5-b) -pyridin-3-ylmethyl) -0,0-dimethyl phosphorothioate. Chlorophacinone. 1- ( 4-Chlorophenoxy) -1-imidazol-1-yl-3, 3-dimethyl-2-butanone in sub stances containing more than 40 per cent of 1- ( 4-Chlorophenoxy) -1- imidazol-1-yl-3, 3-dimethyl-2-butanone except when included in Schedule 4. 138 The Poisons Regulations of 1973

Chloropicrin in substances containing 5 per cent or less of chloropicrin. 5- ( 2-chloro-4( trifluoromethyl) phenoxy)-2-Nitrobenzoate. Chlorpyrifos. Chlorpyrifos-methyl. Chlortetracycline in substances:- (a) for topical application to animals for ocular use only; (b) for intramammary infusion in animals, containing not more than 100,000 international units per dose of chlortetracycline when suitably coloured with Brilliant Blue FCF or other approved colour as a marker and when packed in applicator devices specially designed for the purpose; (c) for feedstuff premixes for the prevention of disease in calves and pigs up to 12 weeks of age containing 2 per cent. or less of antibiotic substance when labelled for the preparation of feeds containing 80 to 100 milligrams per kilogram of antibiotic substance. Chlorthiamide. Chromates and dichromates. Chromium trioxide (excluding its salts). Coumaphos in preparations containing 5 per cent. or less of coumaphos. Coumarin derivatives and phenylindanedione derivatives not otherwise included in any Schedule. Coumatetralyl. Crotoxyphos. Crufomate. Cyanazine. Cyclosulfyne. Cyhexatin. Cypermethrin except when included in Schedule 5. Cythioate. Dazomet. Demeton-0-methyl and demeton-S-methyl in substances containing 50 per cent. or less of one or both demeton-0-methyl and demeton-S methyl. Di-allate. Diazinon. Dibromochloropropane. The Poisons Regulations of 1973 s.6 139

Dichlofenthion. Dichloroethyl ether. 1-2-( 2,4-Dichlorophenyl) -4-ethyl-1 ,3-dioxolan-2-:Y1-methyl-1h-1 ,2,4- triazole. 0-( 2, 4-Dichlorophenyl) -0-ethyl-S-propylophosphorodithioate. Dichloropropane. Dichloropropene. Dichlorvos in substances containing 50 per cent. or less of dichlorvos except when included in Schedule 5. Diclofop-methyl. Dicophane and substances containing more than 10 per cent. of dicophane except for human therapeutic use. Diethylene dioxide. N, N-Diethyl-p-phenylene diamine. Difenzoquat. Dihydrostreptomycin in substances for intramammary infusion in animals containing not more than 100,000 international units per dose of dihydrostreptomycin when suitably coloured with Brilliant Blue FCF or other approved colour as a marker and when packed in applicator devices specially designed for the purpose. Dimethanonaphthalene and all substitution and/or addition products of, including aldrin and dieldrin. Dimethoate. i ,3-di ( methoxycarbonyl) -1-propen-2-yl-dimethyl phosphate in substances containing 25 per cent. or less of 1,3-di (methoxycarbonyl)-1- propen-2-yl-dimethyl phosphate. Dimethyl-formamide. 2- ( 2', 4'-Dimethyl-phenylimino) -3-methyl-4-thiazoline. Dimethyl Sulphoxide except for therapeutic use. Dimetilan in substances containing 25 per cent. or less .of Dimetilan. Dimetridazole. Dinitrocresols, dinitrophenols and their homologues, in substances con taining 5 per cent. or less of such compounds, except for therapeutic use. Dinocap. 140 s. 6 The Poisons Regulations of 1973

Dioxacarb. Diphacinone. Diquat. Disulfiram except for therapeutic use. Disulphoton in granular preparations containing 5 per cent. or less of disulphoton. Dithianon. Dithiazanine in substances containing 2 per cent. or less of dithiazanine for veterinary use. Dithiocarbamates when packed for use for agricultural, pastoral or horticultural purposes, except when included in Schedule 5. 3,3' Di(trifluoromethyl)-4, 4'-dichloro-n n' -diphenyl-urea. Diuredosan. DSMA when prepared for use as a herbicide except when included in Schedule 5. Econazole, for external animal use. Endosulfan. Endothal. Epichlorohydrin except in substances containing 2 per cent. or le.ss of epichlorohydrin. Erythromycin- ( a) in substances for intramammary infusion in animals, contain ing not more than 100,000 international units per dose of erythromycin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker and when packed in applicator devices specially designed for the purpose; (b) in animal feedstuff premixes for growth promotion purposes containing concentrations greater than 50 ppm but not more than 20 000 ppm of 1the total antibiotic principle. - Ether, solvent. Ethiofencarb. Ethoate-methyl. Ethoprophos in granular formulations containing 10 per cent. or less of ethoprophos. 5-ethoxy-3-trichloromethyl-1 ,2,4-thiadiazole. Ethyl bromide. The Poisons Regulations of 1973 s.6 141

Ethylene chlorohydrin. Ethylene dibromide. Ethylene Glycol when packed and labelled as a boiling point and/ or freezing point modifier except when included in Schedule 5. Famphur in substances containing 20 per cent. or less of famphur. Fenaminosulph in substances containing 10 per cent. or less of fenamino sulph when labelled and packed as dry seed dressing. Fenamiphos in granular preparations containing 5 per cent. or less of fenamiphos. Fenazaflor. Fenchlorphos. F enitrothion. Fenthion except when included in Schedule 5. Fenvalerate. Ferbam. Flavophospholipol in animal feedstuff premixes for growth promotion purposes containing concentrations greater than 50 ppm but not more than 20,000 ppm of the total antibiotic principle. Formaldehyde and substances containing more than 5 per cent. of formaldehyde. Formothion. Fospirate except when included in Schedule 5. Fumagillin. Furalaxyl. Guazatine. HCB. Heptachlor. Hexachlorobenzene. Hexachlorophane in substances for the treatment of animals. Hydrazine. Hydrochloric acid (excluding its salts) and substances containing more than 10 per cent. by weight of hydrochloric acid (HCl) as such. Hydrofluoric acid and hydrosilicofluoric acid and other fluorine com pounds except:- ( a) when used for human therapeutic purposes; 142 S• 6 The Poisons Regulations of 1973

(b) in dentifrices containing 0 · 5 per cent. or less of flouride ion; (c) in substances containing 3 per cent. or less of sodium fluoride or sodium silcofluoride when used as preservatives; (d) when included in Schedule 2, Schedule 4, Schedule 5 or Schedule 7; {e) in substances containing 15 mg/kg or less of fluoride ion; (f) Ammonium fluosilicate in substances containing 3 · 2 per cent. or less of ammonium fluosilicate for pesticide purposes. Hygromycin in animal feedstuff premixes for use as an anthelmintic containing concentrations greater than 50 ppm but not more than 20,000 ppm of hygromycin. Imidocarb. Iodine (excluding its salts):- (a) in iodophors except in susbstances containing 1· 5 per cent. of available iodine; or (b) in other liquid substances containing 2 · 5 per cent. or less or less of available iodine; or (c) in substances for animal treatment only, except in iodophors containing 1· 5 per cent or less of available iodine or in solid or semi-solid substances containing 2 · 5 per cent. or less of available iodine. Ioxynil. Iron compounds in substances for the treatment of animals. Isocyanates, free organic. Kitasamycin in animal feedstuff premixes for growth promotion purposes containing concentrations greater than 100 mg/kg but not more than 20,000 mg/kg of the total antibiotic principle. Lasalocid. Laurylisoquinolinium bromide. Lead, salts and compounds of, except for medical or cosmetic use. Lindane except when included in Schedule 5. Maldison except:- (a) for human therapeutic use; and (b) when included in Schedule 5. Mebendazole for veterinary use. Meclofenamic acid for veterinary use. Menazon. The Poisons Regulations of 1973 s. 6 143

Mercuric iodide when packed for use for agricultural, industrial, pastoral or horticultural purposes. Mercuric thiocyanate when packed for photographic purposes. Mercurous chloride except substances for therapeutic use. Mercury, organic compounds of, when packed for use for agricultural, pastoral, industrial or horticultural purposes, except when included inSchedule 7. Metacresolsulphonic acid and formaldehyde condensation product for animal use. Metaldehyde except when included in Schedule 5. Metham-sodium. Methiocarb except when included in Schedule 5. Methomyl in fly-baits containing one per cent or less of methomyl and not less than 0 . 002 per cent of denatonium benzoate as a bittering agent. 0-2-Methoxycarbonylprop-1-enyl-0, 0-dimethylphosphorothioate. Methyl alcohol (exCluding its salts) except in methylated spirit. Methyl chloride. Methylene bisthiocyanate except in substances containing one per cent. or less of methylene bisthiocyanate. Methyl isothiocyanate. 3- (Methysulfonyl) butanon-0-methylcarbamoyloxin except when included in Schedule 5. 1-(B Methyl sulphonamide ethyl)-2-amino-3-N, N-diethylamino benzene. Metoxanine. Molinate. N aled except when included in Schedule 5. Naphthalophos when specially prepared and packed as a sheep drench. Neomycin in preparations for veterinary use for topical application for ocular use only. Nicotine in substances for veterinary use containing 3 per cent. or less of nicotine, except tobacco in any form. Nimidane in substances containing 25 per cent. or less of nimidane. Nithiamide, except in substances containing 20 per cent or less of nithiamide. 144 s. 6 The Poisons Regulations of 1973

Nitric acid (excluding its salts) and substances containing more than 10 per cent. of nitric acid (HNOa). Nitrobenzene except:_. (a) in solid or semi-solid polishes; (b) in soaps containing 1 per cent. or less of nitrobenzene; and (c) in substances containing0·1 per cent. or less of nitrobenzene. Nitrofuran and its derivatives, when packed and labelled for treatment of ornamental caged birds or ornamental fish only. Nitrophenols, ortho, meta, para. N itroscanate. Nitroxynil. Novobiocin in substances for intramammary infusion in animals, con taining not more than 100,000 international units per dose of novobiocin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker and when packed in applicator devices specially designed for the purpose. 2-n-Octyl-4-Isothiazolin-3-one. Oestradiol-17-beta in ear implants for use as a growth promotant in bovine cattle. Olaquindox when intended for use as a growth promotant in pigs, except in animal feedstuff containing 100 mg/kg or less of the total active principle. Oleandomycin in animal feedstuff premixes for growth promotion purposes containing concentrations greater than 50 ppm but not more than 20,000 ppm of the total antibiotic principle. Omethoate in substances containing 50 per cent. or less of omethoate. Organo-tin compounds, being di-alkyl, tri-alkyl and tri-phenyl tin com pounds where the alkyl group is methyl, ethyl, propyl or butyl not elsewhere included in thes·e Schedules except:- ( a) in plastics; (b) in other substances containing 1 per cent. or less of such compounds. Ortho-dichlorobenzene. Oxalic acid (excluding its salts) and soluble oxalates. Oxantel pamoate for the treatment of animals. Oxfendazole. Oxyclozanide. Oxytetracycline in substances:- ( a) for topical application to animals for ocular use only; The Poisons Regulations of 1973 s. 6 145

(b) for intramammary infusion in animals, containing not more than 100,000 international units per dose of oxytetracycline, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker and when packed in applicator devices specially designed for the purpose; (c) for feedstuff premixes for the prevention of disease in calves and pigs up to 12 weeks of age containing 2 per cent. or less of antibiotic substance when labelled for the preparation of feeds containing 80 to 100 milligrams per kilogram of antibiotic substance. Paraquat in granular preparations containing 3 per cent. or less of paraquat. Parbendazole. Pentaclorophenol except in substances containing 0 · 5 per cent. or less pentachlorophenol. Perfluidone. Permanganates. Phenethicillin in substances for intramammary infusion in animals, con taining not more than 100,000 international units per dose of phenethicillin, when suitably coloured with Brilliant BJue FCF or other approved colour as a marker and when packed in applicator devices specially designed for the purpose. Phenkapton in substances containing 50 per cent. or less of phenkapton. Phenol and any homologue of phenol boiling below 220·c, and creosote, except:- ( a) substances containing 3 per cent. or less by weight of such substances or homologues; and (b) for therapeutic use. Phenoxymethyl penicillin in substances for intramammary infusion in animals, containing not more than 100,000 international units per dose of phenoxymethyl penicil

Phosalone. Phosmet. Phosphides, metallic. Phosphorus yellow (excluding its salts) in substances containing 0 · 5 per cent. or less of free phosphorus. Phoxim. Picric acid and substances containing more than 5 per cent. of picric acid. Pindone. Piperophos. Pirimicarb except when included in Schedule 5. Pirimiphos-ethyl. Pirimiphos-methyl. Potassium bromate and substances containing more than 0 · 5 per cent. of potassium bromate. Potassium cyanate. Potassium hydroxide (excluding its salts) and substances containing more than 5 per cent. of potassium hydroxide. Profenofos. Progesterone in a silicon rubber elastomer when used as a controlled- release implant for synchronisation of oestrus in cattle. Promacyl. Promecarb in substances containing 50 per cent. or less of promecarb. Propachlor. Propionic acid (excluding its salts) except:- ( a) in substances containing 80 per cent. or less of propionic acid; and (b) for therapeutic use. Propoxur except when included in Schedules 2 or 5. Pyrazophos. N-3-pyridlymethyl-N1-p-nitrophenylurea except when included in Schedule 5. Rafoxanide. The Poisons Regulations of 1973 s. 6 147

Selenium, compounds of- ( a) in substances containing 2 · 5 per cent. or less of selenium (i) when packed and labelled for the blueing of gun barrels; (ii) when packed and labelled for photographic purposes; (b) in substances containing 0 · 1 per cent. or less of selenium when packed and labelled as vaccines, drenches or pastes for treatment of animals; (c) in substances containing 0 · 5 per cent. or less of selenium when packed and labelled as other injections for treatment of animals; (d) in premixes containing 2 per cent. or less of selenium when packed and labe1led for incorporation into animal feeds to provide 0 · 1 g/tonne or Jess of selenium. Sodium bromate and substances containing more than 0· 5 per cent. of sodium bromate. Sodium hydroxide (excluding its salts) and substances containing more than 5 per cent. of sodium hydroxide. Streptomycin in substances for intramammary infusion in animals, con taining not more than 100,000 international units per dose of streptomycin when suitably coloured with Brilliant Blue FCF or other approved colour as a marker and when packed in applicator devices specially designed for the purpose. Sulfallate. Sulphonamides- (a) in substances packed and. labelled for the treatment of footrot in animals in packs containing 250 grams or less of sulphonamide substance; (b) sulphadimidine in feedstuff premixes for the prevention of disease in calves and pigs up to 12 weeks of age containing 2 per cent. or less of sulphonamide substance when labelled for the preparation of feeds containing 80 to 100 milligrams per kilogram of sulphonamide substance; (c) sulphaquinoxaline when packed and labelled for use as a coccidiostat in poultry except substances containing 200 mg/kg O'f less of sulphaquinoxaline; (d) in substances packed and labelled for the treatment of ornamental caged birds or ornamental fish only. Sulphuric acid (excluding its salts) except:- ( a) in accumulators, batteries or fire extinguishers; and (b) in substances containing 0 · 5 per cent. or less W /W of sulphuric acid (H2S04). Sulprophos. 148 s. 6 The Poisons Regulations of 1973

2,4,5-T. TCA (excluding its salts). TCMTB (2-( thiocyanomethylthio) benzothiazole). TDE except when included in Schedule 5. Temephos. Terpenes, chlorinated. Testosterone propionate, testosterone dipropionate and testosterone enanthate in substances label·led solely for the treatment of pizzle and sheath rot in wethers. Tetrachloroethylene except:- ( a) for therapeutic use; and (b) when packed in containers of 50 millilitres or less. Tetracycline in substances:- (a) for .topical application to animals for ocular use only; (b) for intramammary infusion in animals, containing not more than 100,000 international units per dose of tetracycline, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker and when packed in applicator devices specially designed for the purpose; (c) when packed and •labelled for treatment of ornamental fish only. Tetradifon. Tetramisole, including Levamisole, in substances for veterinary use, except when included in Schedule 5. Thallium in prepared baits containing 0 · 25 per cent. or less of thallium. Thiazafluron. Thiometon. Thiourea except for therapeutic use. Tbiram. o-Tolidine when packed and labelled in concentrations of 0 ·1 per cent. or less of o-tolidine for the testing of water. Toluene and xylene when packed in containers of 20 litres or less except:- (a) substances containing 50 per cent. or less of one or both toluene and xylene when tested according to method 01019-67 of the American Society for Testing and Materials; and (b) when packed in containers of 50 millilitres or less. The Poisons Regulations of 1973 s. 6 149

Triadimefon. S,S,S-tributylphosphorothiolate. Trichlorfon. Trichloroethylene except (a) when packed in containers of 50 mls or less; and (b) when included in Schedule 4.

Trichlorophenol. Triethyl phosphate. Tylosin in animal feedstuff premixes for growth promotion purposes containing concentrations greater than 50 ppm but not more than 20,000 ppm of the total antibiotic principle.

Vaccines, veterinary live virus, the following only Bovine wart vaccine, Contagious ecthyma (scabby mouth) vaccine, Fowl pox vaccine, Pigeon pox vaccine, Tick fever vaccine (babesia and anaplasma), Turkey pox vaccine.

Vamidothion.

Virginiamycin in animal feedstuff premixes for growth promotion purposes containing concentrations greater than 50 ppm but not more than 20,000 ppm of the total antibiotic principle. Warfarin except for therapeutic use. Zeranol in implants for use as a growth promotant in steer cattle. Zinc chloride and substances containing more than 5 per cent. of zinc chloride. Zinc phenolsulphonate and substances containing more than 5 per cent. of zinc phenolsulphonate. Zinc sulphate except for human therapeutic use and in preparations containing 5 per cent. or less of zinc sulphate.

APPENDIX A TO SCHEDULE 6 Arsenic and all compounds of arsenic except:- ( a) when included in Schedule 4 or Schedule 7; (b) in animal feedstuffs containing 75 ppm or less of arsenic; and (c) organic compounds of arsenic, other than copper aceta- arsenite, in herbicides, defoliants, veterinary medicines, and animal feed additives and premixes. Beryllium. Carbon bisulphide. Ethylene dibromide. Mercury, organic compounds of, when packed for use for agricultural, pastorcll, or horticultural purposes, except when included in Schedule 7. Pentachlorophenol in substances containing more than 10 per cent. of pentachlorophenol. Phosphides, metallic.

The Poisons Regulations of 1973 151

SCHEDULE 7 POISONS Acrolein. Aldicarb. Allyl alcohol. Aminocarb except when included in Schedule 6. 4-aminopyridine. Amiton. Amygdalin. ANTU. Arsenic and compounds of arsenic in ant poisons, liquid weedkillers, and liquid preparations for the destruction of termites, except:- ( a) ant poisons containing 0 · 5 per cent. or less of arsenic trioxide; and (b) organic compounds of arsenic in herbicides and defoliants. Azinphos-ethyl. Azinphos-methyl. Bendiocarb except when included in Schedules 5 or 6. Benzene (excluding its derivatives) except:- (a) substances containing 1·5 per cent. v/v or less of benzene; (b) petrol containing 5 per cent. v/v or less of benzene. Beta-hydroxyethylhydrazine. Bithionol except when included in Schedule 6. 5-bromo-4-chlorosalicylanilide. 3-( 3-( 4' Bromodiphenyl-4-yl) -3-hydroxy-phenylpropyl) -4-hydroxy courmarin except when included in Schedule 6. 3-(3-( 4' Bromodiphenyl-4-yl)-1, 2, 3, 4-tetrahydronaphthyl)-4-hydroxycoumarin except when included in Schedule 6. Buclosamide. 4-n-Butyl-4H-1 ,2,4-triazole. Camphechlor. Carbofuran. Carbon tetrachloride. Carbophenothlon. 152 s. 7 The Poisons Regulations of 1973

~hlordinrrefofDl.

~hlorfenvinphos.

~hlorine (excluding its salts). 5-Chloro-3-methyl-4-nitropyrazole. 5-(2-Chloro-1-phthalinrridoethyl) -0, 0-diethylphosphorodithioate.

~hloropicrin and substances containing more than 5 per cent. of chloropicrin. Coumaphos except when included in Schedule 6. Denrreton. Denrreton-0-nrrethyl and Denrreton-S-nrrethyl except when included m Schedule 6. Dichlorvos except when included in Schedule 5 or Schedule 6. Dicrotophos. 0,0-Diethyl-0-(2,4,5-dichloro (methylthio) phenyl) thionophosphate. Dinrrefox. 1, 3-di (nrrethoxycarbonyl )-1-propen-2-yl-dinrrethyl phosphate except when included in Schedule 6. Dinrretilan except when included in Schedule 6. Dinitrocresols, dinitrophenols and their homologues and substances con taining more than 5 per cent. of such compounds, except for therapeutic use. Dioxathion. Disulphoton except in granular preparations containing 5 per cent. or less of disulphoton. Dulcin. Ethion. Ethoprophos except when included in Schedule 6. Ethoxyethyl nrrercury chloride. Ethyl mercury chloride. Famphur and substances containing more than 20 per cent. of famphur. Fenaminosulph except when included in Schedule 6. Fenamiphos except when included in Schedule 6. Fensulphothion. F enthion-ethyl. The Poisons Regulations of 1973 s. 7 153

Fenticlor. Fluoroacetamide. Fluoroacetic acid. Formetanate. Halofuginone except in prepared stockfeeds containing 3 grams per tonne or less of haJofuginone. Hydrocyanic acid and cyanides except:- (a) in substances containing the equivalent of 0·15 per cent. or less of hydrocyanic acid; and (b) for therapeutic use. Isocarbophos. Leptophos. Mazidox. Mecarbam. Mercuric chloride when packed for agricultural, pastoral, horticultural or industrial use. Methamidophos. Methidathion. Methomyl. Methyl bromide. Mevinphos. Mipafox. Mirex. Monocrotophos. N aphthalophos except when specially prepared and packed as a sheep drench. Nicotine except:- (a) when included in Schedule 4 or Schedule 6; (b) tobacco in any form. Nimidane except when included in Schedule 6. Nitrilotriacetic acid and all substances containing nitrilotriacetic acid when labelled and packed for use as detergents or washing preparations. Nitro fen. Omethoate except when included in Schedule 6. 154 s. 7 The Poisons Regulations of 1973

Oxamyl. Paraquat except when included in Schedule 6. Parathion. Parathion-methyl. Phenkapton except when included in Schedule 6. Phorate. Phosfolan. Phosphamidon. Polychlorinated biphenyls. Promecarb except when included in Schedule 6. Schradan. Strychnine. Sulphotep. Tepp. Terbufos. Tetrachloroethane. Tetrachlorosalicylanilide. Thallium except in prepared baits containing 0 · 25 per cent. or less of thallium. Thiofanox. o-Tolidine except when included in Schedule 6 and in solid state diagnostic therapeutic reagents. Tljamiphos. Trichloroisocyanuric acid except:- ( a) in substances containing 4 per cent. or less of available chlorine; (b) when included in Schedule 5. 1, 1, !-trichloroethane in aerosols for therapeutic use. Vinyl chloride (monomer). The Poisons Regulations of 1973 155

SCHEDULE 8 DANGEROUS DRUGS Acetorphine (OS-acetyl-7, 8 dihydro-7a (1 (R)-hydroxy-1-methylbutyl)- 06methyl-6, 14-endoetheno-morphine). Acetyldihydrocodeine except when included in Schedule 2 or Schedule 4. Acetylmethadol ( 3-acetoxy-6-dimethylamino-4,4-diphenylheptane). Allylprodine ( 3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine). Alphacetylmethadol ( a-3-acetoxy-6-dimethylamino-4,4-diphenylheptane). Alphameprodine ( a-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine). Alphamethadol ( a-6-dimethylamino-4,4-diphenyl-3-heptanol). Alphaprodine ( a-1 ,3-dimethyl-4-phenyl-4-propionoxypiperidine). Amphetamine. Anileridine ( 1-para-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester). Benzethidine ( 1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester). Benzylmorphine ( 3-benzylmorphine). Betacetylmethadol (,8-3-acetoxy-6-dimethylamino-4,4-diphenylheptane). Betameprodine (,8-3-ethyl-1 methyl-4-phenyl-4-propionoxypiperidine). Betamethadol (,8-6-dimethylamino-4,4-diphenyl-3-heptanol). Betaprodine (,8-1 ,3-dimethyl-4-phenyl-4-propionoxypiperidine). Bezitramide ( 1-( 3-cyano-3,3-diphenylpropyl) -4-(2-oxo-3-propionyl-1- benzimidazolinyl) -piperidine). Cannabis and cannabis resin and extracts and tinctures of cannabis. Clonitazene (2-para-chlorbenzyl-1-diethylaminoethyl-5-nitrobenzimida- zole). Cocaine (methyl ester of benzoylecgonine). Coca leaf. Codeine ( 3-methylmorphine) except when included in Schedule 2, Schedule 3 or Schedule 4. Codeine-N-oxide. Codoxime ( dihydrocodeinone-6-carboxymethyloxime). 156 s. 8 The Poisons Regulations of 1973

Concentrate of poppy straw (the material arising when poppy straw has entered into a process for concentration of its alkaloids). Desomorphine ( dihydrodesoxymorphine). Dexamphetamine. Dextromoramide (( +) -4- (2-methyl -4-oxo-3, 3-diphenyl -4- (1- pyrrolidinyl) butyl) morpholine). Diacetylmorphine (heroin). Diampromide (N-(2- (methylphenethylamino) propyl) propionanilide). Diethylthiambutene ( 3-diethylamino-1, 1-di-( 2'-thienyl) -1 butene). Difenoxin ( 1- ( 3-cyano-3,3-diphenylpropyl) -4-phenylisonipecotic acid) except when included in Schedule 4. Dihydrocodeine except when included in Schedule 2 or Schedule 4. Dihydromorphine. Dimenoxadol ( 2-dimethylaminoethyl-1-ethoxy-1, 1-diphenylacetate). Dimepheptanol (methadol) ( 6-dimethylamino-4, 4-diphenyl -3-heptanol). 3-(1,2-Dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H -dibenzo (b,d) pyran (DMPH). Dimethylthiambutene ( 3-dimethylamino-1, 1-di-(2'thienyl-1-butene). Dioxaphetyl butyrate (ethyl 4-morpholino-2,2-diphenylbutyrate). Diphenoxylate ( 1-(3-cyano-3, 3-diphenylpropyl) -4-phenylpiperidine-4- carboxylic acid ethyl ester) except when included in Schedule 4. Dipipanone ( 4,4-diphenyl-6-piperidine-3-h_eptanone). Drotebanol ( 3,4-dimethoxy-17-methylmorphinan-6,8, 14-diol). Ecgonine, its esters and derivatives which are convertible to ecgonine and cocaine. Ethylmethylthiambutene (3-ethylmethylamino-1, 1-di-(2'-thienyl)-1-butene ). Ethylmorphine (3-ethylmorphine) except when included in Schedule 2 or Schedule 4. N-Ethyl-1-phencyclohexylamine (PCE). Etonitazene ( 1-diethylaminoethyl-2-para-ethoxybenzyl-5-nitrobenzimida- zole).

Etorphine ( 7. 8-dihydro-7 a- ( 1 ( R) -hydroxy-1-methyl-butyl-06-methyl-6, 14-endoethenomorphine). Etoxeridine ( 1- (2-(2-hydroxyethoxy) ethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester). The Poisons Regulations of 1973 s. 8 157

Fentanyl (1-phenethyl 4-N-propionyl-anilino piperidine). Furethidine ( 1-( 2-tetrahydrofurfuryloxyethyl) -4-phenylpiperidine -4- carboxylic acid ethyl ester). Heptane derivatives having addiction properties, not specifically included in this Schedule. 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo (b,d) pyran (parahexyl). H ydrocodone ( dihydrocodeinone). H ydromorphinol ( 14-hydroxydihydromorphine). Hydromorphone ( dihydromorphinone). Hydroxypethidine ( 4-meta-hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester). Isomethadone ( 6-dimethylamino-5-methyl-4, 4-diphenyl-3-hexanone). Ketobemidone. Levomethorphan ( (-) -3-methoxy-N-methylmorphinan). Levomoramide ( (-) -4- (2-methyl-4-oxo-3, 3-diphenyl-4-(1-pyrrolidinyl) butyl) morpholine). Levophenacylmorphan ( (-)-3-hydroxy-N-phenacylmorphinan). Levorphanol ( (-)-3-hydroxy-N-methylmorphinan). Mecloqualone 3- ( 0-Chlorophenyl) -2-methyl-4-( 3h) quinazolinone. Metazocine ( 2'-hydroxy-2,5 ,9-trimethyl-6, 7-benzomorphan). Methadone ( 6-dimethylamino-4,4-diphenyl-3-heptanone). Methadone-Intermediate ( 4-cyano-2-dimethylamino-4,4-diphenylbutane). Methaqualone. Methylamphetamine. Methyldesorphine ( 6-methyl-6. 6-desoxymorphine). Methyldihydromorphine ( 6-methyldihydromorphine). Methylphenidate. 1-methyl-4-phenylpiperidine-4-carboxylic acid esters. Metopon ( 5-methyldihydromorphinone). Moramide-Intermediate (2-methyl-3-morpholino-1, 1-diphenylpropane carboxylic acid). Morpheridine ( 1-( 2-morpholinoethyl) -4-phenylpiperidine-4-carboxylic acid ethyl ester). 158 s. 8 The Poisons Regulations of 1973

Morphine. Morphine derivatives not specifically included in this Schedule. Morphine methobromide and other pentavalent nitrogen morphine derivatives. Morphine-N-oxide. Morphine substitutes not specifically included in this Schedule. Myrophine (myristylbenzylmorphine). Nicocodine ( 6-nicotinylcodeine) except when included in Schedule 2 or Schedule 4. Nicodicodine except when included in Schedule 2 or Schedule 4. Nicomorphine (3,6-dinicotinylmorphine). Noracymethadol ( ( + )-a-3-acetoxy-6-methylamino-4,4-diphenylheptan). Norcodeine (N-demethylcodeine) except when included in Schedule 2 or Schedule 4. Norlevorphanol ( (-)-3-hydroxymorphinan). Normethadone ( 6-dimethylamino-4,4-diphenyl-3-hexanone). Normorphine (N-demethylated morphine). Norpipanone (4,4-diphenyl-6-piperidine-3-hexaone ). Opium in any form except the alkaloids noscapine and papaverine. Oxycodone ( 14-hydroxydihydrocodeinone). Oxymorphone ( 14-hydroxydihydromorphinone) . Pentazocine. Pethidine ( 1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester). Pethidine-Intermediate A ( 4-cyano-1-methyl-4-phenylpiperidine). Pethidine-Intermediate B ( 4-phenylpiperidine-4-carboxylic acid ethyl ester). Pethidine-Intermediate C ( 1-methyl-4-phenylpiperidine-4-carboxylic acid). Phenadoxone ( 6-morpholino-4,4-diphenyl-3-heptanone). Phenampromide (N (1-methyl-2-piperidinoethyl) propionanilide). Phenazocine ( 2-hydroxy-5 ,9-dimethyl-2'-phenethyl-6, 7 -benzomorphan). Phencyclidine. Phenmetrazine. Phenomorphan ( 3-hydroxy-N-phenethylmorphinan). The Poisons Regulations of 1973 s. 8 159

Phenoperidine ( 1-( 3-hydroxy-3-phenylpropyl) -4-phenylpiperidine-4- carboxylic acid ethyl ester). 1-(1-Phenylcyclohexyl) pyrrolidine (PHP or PCPY). Pholcodine (morpholinylethyl morphine) except when included in Schedule 4 or Schedule 2. Piminodine ( 4-phenyl-1-( 3-phenylaminopropyl) piperidine-4-carboxylic acid ethyl ester). Piperidine derivatives having addiction properties, not specifically included in this Schedule. Piritramide ( 1-( 3-cyano-3 diphenylpropyl) -4-( 1-piperidino) piperidine-4- carboxylic acid amide). Proheptazine ( 1 ,3-dimethyl-4-phenyl-4-propionoxyazacyloheptane). Properidine ( 1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester). Propiram. Racemethorphan ( ( + )-methoxy-N-methylmorphinan). Racemoramide ( ( + )-4-(2-methyl-4-oxo-3,3-diphenyl-4-( 1-pyrrolidinyl) butyl) morpho line). Racemorphan ( ( + )-3-hydroxy-N-methylmorphinan). Tetrahydrocannabinols. Thebacon (acetyl dihydrocodeinone). Thebaine. 1-1-(2-Thienyl}cyolohexyl piperidine (TCP). Trimeperidine ( 1 ,2,5-trimethyl-4-phenyl-4-proprionoxy-piperidine).

The Poisons Regulations of 1973 161

SCHEDULE 9

[Form A QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973

APPLICATION FOR A GENERAL LICENCE TO SELL POISONS To the Director-General of Health and Medical Services, Brisbane. SIR, 1. *!/We hereby apply for a licence under Regulation All of "The Poisons Regulations of 1973" to sell the poisons specified in Schedules 1, 2 and 7 and in Appendix A to Schedule 6 of the said Regulations at the premises described in paragraph 5 of this application. 2. *I!We intend to conduct a bona-fide business as a seller of the poisons referred to in paragraph 1. 3. Full name(s) of person(s) or company applying for licence: 4. Address of Applicant(s): 5. Description and location of premises at which it is desired to sell poisons: 6. Is the business conducted under a Registered Business Name? If so, state name: 7. Is the applicant a company registered in Queensland? If so state position in the company held by signatory: 8. Are the premises described in paragraph 5 within twenty-five kilometres by the nearest practicable road of a place at which a pharmaceutical chemist conducts and maintains an open chemist's shop? 9. Are you familiar with the provisions of Regulations All, C1, C2, C3, C4 and C5 of "The Poisons Regulations of 1973"? 10. *!/We declare that all the statements contained in this application are true. Signature(s): Date: • 19 *Strike out whichever is not applicable.

N.B.-This application must be accompanied by the prescribed fee of Thirty two dollars fifty cents ($32.50). 162 The Poisons Regulations of 1973 QUEENSLAND [Form B Health Act 1937-1979 The Poisons Regulations of 1973 APPLICATION FOR A STRYCHNINE PERMIT To the Director-General of Health and Medical Services, George Street, Brisbane. Sir, 1. *I/We hereby apply for a permit under Regulation CS of "The Poisons Regulations of 1973" to purchase strychnine from persons authorised to sell strychnine under "The Poisons Regulations of 1973". 2. The strychnine will be stored at the premises described in paragraph 5 below. It will not be re-sold. It will be used for the following purposes: 3. Full name of person(s) or Company applying for permit: 4. Address of Applicant: 5. Description and location of premises where it is intended to store .the strychnine: 6. What quantity and description of strychnine is required? 7. Length of time stychnine is required for: Date: 19 . Signature of Applicant. * Strike out whichever is not applicable.

QUEENSLAND [Form Bl Health Act 1937-1979 The Poisons Regulations of 1973 STRYCHNINE PERMIT The Director-General of Health and Medical Services hereby grants to , of , a permit under Regulation CS of "The Poisons Regulations of 1973" to purchase, be in possession of, and use the following amount of strychnine-namely: This permit is ·issued subject .to the following conditions: (1) The strychnine will be stored at (2) It will not be re-sold. (3) It will be used for the following purposes only: Dated at Brisbane, this day of , 19 . Director-General of Health and Medical Services. Valid until , 19

QUEENSLAND [Form C Health Act 1937-1973 The Poisons Regulations of 1973 GENERAL LICENCE TO SELL POISONS The Director-General of Health and Medical Services hereby grants t.o , of (address of licensee(s) ), a licence under Regulation All of "The Poisons Regulations of 1973" to sell the poisons specified in Schedules 1, 2 and 7 and in Appendix A to Schedule 6 of the said Regulations at (description and location of premises), under and subject to the provisions of the said Regulations during the period from the date hereof until the thirtieth day of September then next following. Dated at Brisbane the day of , 19 Director-General of Health and Medical Services. N.B.-If a pharmaceutical chemist should commence business at a place within twenty-five kilometres by the nearest practicable road of the premises specified in this licence, such licence will not be renewed after expiration. -..j

[Form D DRuos BooK Full Description of Class of Dangerous Drug: Unit of Measure ·----- ~ Person from whom obtained or to whom supplied (1:> (or description of transaction) Quantity Prescription, Name of Remarks Date of Order, or Person Initials of and ~ Pre- Dispenser, Transaction Invoice Marginal ~- IN OuT BALANCE Number scribing or &c. Notes Name Address Obtained, Supplied, Stock on Ordering ~ &c. &c. hand ~ _._.... ~ Balance of stock brought forward from [ --- c;·

1;:;

.Q_

...... \0 -...) ~

...... 0\ ~ 164 The Poisons Regulations of 1973

[Form F QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973 APPLICATION FOR A LICENCE TO MANUFACTURE AND/OR SELL BY WHOLESALE POISONS To the Director-General of Health and Medical Services, Brisbane. SIR, 1. *I/We hereby apply for a licence under Regulation A10 of "The Poisons Regulations of 1973" to manufacture and/or sell by wholesale the poisons specified in Schedules 1, 2, 3 and 7 and in Appendix A to Schedule 6 of the said Regulations at the premises described in paragraph 5 of this application. 2. *I/We intend to conduct a bona-fide business ·as a manufacturer and/or wholesale seller of the poisons referred to in paragraph 1. 3. Full name(s) of person{s) or company applying for licence: 4. Address of Applicant(s): 5. Description and location of premises at which it is desired to manufacture and/or sell poisons: 6. Is the business conducted under a Registered Business Name? If so, state name: 1. Is the applicant a company registered in Queensland? If so state position in the company held by signatory: 8. Will the actual manufacture ·and/or sale of such poisons be at all times under the personal supervision of a competent and responsible person? 9. Are you familiar with the provisions of Parts A, B, and C of "The Poisons Regulations of 1973"? 10. *I/We declare that all the statements contained in this application are true. Signature(s): Date: ' 19 . *Strike out whichever is not applicable.

N.B.-This application must be accompanied by the prescribed fee of Fifty seven dollars fifty cents ($57.50).

[Form G QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973 LICENCE TO MANUFACTURE AND/OR SELL BY WHOLESALE POISONS The Director-General of Health and Medical Services hereby grants to , of (address of licensee(s) ), a licence under Regulation A10 of "The Poisons Regulations of 1973" to manufacture and/or sell by wholesale the poisons specified in Schedules 1, 2, 3 and 7 and in Appendix A to Schedule 6 of the said Regulations at (description and location of premises), under and subject to the provisions of the said Regulations during the period from the date hereof until the. thirtieth day of September then next following. Dated at. Brisbane the day of , 19 . Director-General of Health and Medical Services. The Poisons Regulations of 1973 165

[Form H QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973 APPLICATION FOR A LICENCE TO SELL POISONS FOR PHOTOGRAPillC PURPOSES To the Director-General of Health and Medical Services, Brisbane. SIR, 1. *1/We hereby apply for a licence under Regulation A12 of "The Poisons Regulations of 1973" to sell the poisons specified in Schedules 1, 2 and 7 and in Appendix A to Schedule 6 of the said Regulations for photographic purposes only at the premises described in paragraph 5 of this application. 2. *1/We intend to conduct a bona-fide business as a dealer in photographic materials. 3. Full name(s) of person(s) or company applying for licence: 4. Address of Applicant(s): 5. Description and location of premises at which it is desired to sell~. poisons: 6. Is the business conducted under a Registered Business Name? If so, state name: 7. Is the applicant a company registered in Queensland? If so state position in the company held by signatory: 8. Are you familiar with ,fhe provisions of Regulations A12, C1, C2, C3, C4 and C5 of "The Poisons Regulations of 1973"? 9. *I/We declare that all the statements contained in this application are true. Signature ( s) :

Date: ' 19 0 *Strike out whichever is not applicable.

N.B.-This application must be accompanied by the prescribed fee of Twelve dollars fifty cents ($12.50).

[Form I QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973 LICENCE AS A SELLER OF POISONS FOR PHOTOGRAPillC PURPOSES The Director-General of Health ·and Medical Services hereby grants to , of (address of licensee(s) ), a licence under Regulation Al2 of "The Poisons Regulations of 1973" to sell the poisons specified in Schedules i, 2 and 7 and in Appendix A to Schedule 6 of the said Regulations for photographic purposes only at (description and location of premises), under and subject to the provisions of the said Regulations during the period from the date hereod' untH the thirtieth day of September then next following. Dated at Brisbane the day of , 19 • Director-General of Health and Medical Services. 166 The Poisons Regulations of 1973

[Form J QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973 APPLICATION FOR A LICENCE TO SELL POISONS FOR PURPOSES OTHER THAN HUMAN THERAPEUTIC USB To the Director-General of Health and Medical Services, Brisbane. SIR, 1. *1/We hereby apply for a licence under Regulation Al3 of "The Poisons Regulations of 1973" to sell the poisons specified in Appendix A to Schedule 6 and in Schedule 7 of the said Regulations for purposes other than human therapeutic use at the premises described in paragraph 5 of this application. 2. *1/We intend to conduct a bona-fide business as a seller of the poisons referred to in paragraph 1. 3. Full name(s) of person(s) or company applying for licence: 4. Address of Applicant(s): 5. Description and location of premises at which it is desired to sell poisons: 6. Is the business conducted under a Registered Business Name? If so state name: 1. Is the applicant a company registered in Queensland? If so state position in the company held by signatory: 8. Are you familiar with the provisions of Regulations Al3, Cl, C2, C3, C4 and C5 of "The Poisons Regulations of 1973"? 9. *1/We declare that all the statements contained in this application are true. Signature ( s) : Date: ' 19 * Strike out whichever is not applicable. N.B.-This application must be accompanied by the prescribed fee of Twenty one dollars fifty cents ($21.50).

[Form K QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973 LICENCE TO SELL POISONS FOR PURPOSES 0nrnR THAN HUMAN THERAPEUTIC USE The Director-General of Health and Medical Services hereby grants to , of (address of licensee(s) ), a licence under Regulation A13 of "The Poisons Regulations of 1973" to sell the poisons specified in Appendix A to Schedule 6 and in Schedule 7 of the said Regulations for purposes other than human therapeutic use at (description and location of premises), under and subject to the provisions of the said regulations during the period from the date hereof until the thirtieth day of September then next following. Dated at Brisbane the day of ' 19 Director-General of Health and Medical Service~. The Poisons Regulations of 1973 167

[Form L QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973 LICENCE RENEWAL NOTICE The licence described below will expire on 30th September, next. If you desire the licence to be renewed for a further year, application may be made on this form, which should be forwarded, together with the renewal fee, to reach the Director-General by 29th September. Name and Address of Licensee: Location of Licensed premises: Licence No. Renewal Fee, $

APPLICATION FOR RENEWAL OF A LICENCE To the Director-General of Health and Medical Services, 63-79 George Street, Brisbane, 4000. SIR, 1. *I/We hereby apply for the licence described above to be renewed for a period of one year. 2. *IIWe enclose for the prescribed renewal fee. 3. Has there been any change in name or ownership of the business conducted under this licence from that shown above? If so give details. 4. Has there been any change in location or description of the licensed premises? If so give details. Signature(s) of Applicant(s): Date: ' 19 '''Strike out whichever is not applicable.

[Form M QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973 RENEWAL OF LICENCE The Director-General of Health and Medical Services, in pursuance of the provisions of ''The Poisons Regulations of 1973" hereby renews the licence numbered , granted to , until the thirtieth day of September, 19 , in relation ·to which renewal a fee of $ has been paid. Dated at Brisbane the day of , 19 Director-General of Health and Medical Services. 168 The Poisons Regulations of 1973

[Form N QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973 APPLICATION FOR A. CYANIDE. PERMIT To the Director-General: of Health and Medical Services, George Street, Brisbane. SIR, 1. *I/We hereby apply for a permit under Regulation C3 of "The Poisons Regulations of 1973" to purchase cyanide from persons authorised to sell cyanide under "The Poisons Regula~ii0ns of 1973". 2. The cyanide will be stored at the premises described in paragraph 5 below. It will not be re-sold. It will be used for the following purposes:- 3. Full name of person(s.) or Company applying for permit: 4. Address of Applicant: 5. Description and location of premises where it is intended to store the cyanide: 6. What quantity and description o.f cyanide is required? 7. Length of time cyanide is required for: Date: , 19 Signature of Applicant: *Strike out whichever is not applicable.

[Form Nl QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973 CYANIDE PERMIT The Director-General of Health and Medical Services hereby grants to , of , a permit under Regulation C3 of "The Poisons Regulations of 1973" to purchase;. be in possession of and use the following amount of cyanide-namely: This permit is issued subject to the following conditions: (1) The cyanide will be stored at (2) It will not be re-sold. (3) It will be used for the following purposes only: Dated at Brisbane this day of , 19 . Director-General of Hea!tfu and. Medical Services. Valid until ' 19 The Poisons Regulations of 1973 169

[Form 0 QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1!17.3 APPLICATION FOR A WHOLESALE REPRESENTATIVE'S AUTHORITY To the Director-General of Health and Medical Services, Brisbane. Sir, 1. I hereby apply for a Wholesale Representative's Authority under Regulation F6 of "The Poisons Regulations of 1973". 2. Full name of Applicant: 3. Address of Applicant: 4. Are you familiar with the provisiOns of Regulations F4, FS and F6 of "The Poisons Regulations of 1973"? Signature of Applicant: Date: ' 19 Endorsement by Employer 5. Full N arne of Employer: 6. Employer's Licence No.: 7. Employer's Address (as shown on Licence): 8. I certify that the abovenamed applicant is employed in a capacity which requires him to be in possession of restricted drugs for the purpose of display and/ or supply to medical, veterinary, and/or dental practitioners. 9. I endorse and recommend this application. 10. Are you familiar with the provisions of Regulation F4, FS and F6 of "The Poisons Regulations of 1973"? Signature: Position held by Signatory: Date: ' 19

N.B.-This application must be accompanied by the prescribed fee of Twenty four dollars ($24).

[Form P QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973 WHOLESALE REPRESENTATIVE'S AUTHORITY The Director-General of Health and Medical Services hereby grants to , of (address of holder) who .is employed by (a licensed manufacturer of or a licensed wholesale seller of restricted drugs) a Wholesale Representative's Authority under Regulation F6 of "The Poisons Regula tions of 1973" to have in his possession restricted drugs under and subject to the pro visions of the said Regulations and to the conditions set forth hereunder, from the date hereof until the thirtieth day of September then next !following. Conditions 1. This Authority is valid only so long as the holder continues to be employed by the licensed manufacturer of or licensed wholesale seller of restricted dru<>s named herein, in a capacity which requires him to be in possession of restrict;d drugs f<)r the purpose of display and/or supply to medical, veterinary and/or dental practitioners. 170 The Poisons Regulations of 1973

2. The holder is authorised to be in possession of not more than four hundred primary packs of restricted drugs, of which not more than one hundred are of any one description, which restricted drugs have been supplied to him by his employer for the purpose set out in condition number 1. Dated at Brisbane the day of , 19 Director-General of Health and Medical Services.

N.B.-This authority is not renewable. Should an Authority be required for a further period beyond the expiry date, a fresh application should be submitted.

No NOTICE OF EXPIRY WILL BE ISSUED

[Form Q QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973 APPLICATION FOR A LICENCE TO SELL DANGEROUS DRUGS BY WHOLESALE To the Director-General of Health and Medical Services, Brisbane. Sir, 1. *I!We hereby apply for a licence under Regulation E2 of "The Poisons Regulations of 1973" to sell dangerous drugs by wholesale at the premises described in paragraph 5 of this application. 2. *I!We intend to conduct a bona-fide business as a wholesale seller of dangerous drugs. 3. Full name(s) of person(s) or company applying for licence:

4. Address of Applicant(s): 5. Description and location of premises at which it is desired to sell dangerous drugs: 6. Is the business conducted under a Registered Business Name? If so state name: 7. Is the applicant a company registered in Queensland? If so state position held in the company by signatory: . 8. Will the actual sale of dangerous drugs be at all times under the personal supervision of a competent and responsible person? 9. Are you familiar with the provisions of Parts A, B, D, E, G, K and N of "The Poisons Regulations of 1973"? 10. *I!We declare that all the statements contained in 1his application are true. Signature(s): Date , 19 * Strike out whichever is not applicable. N.B.-This application must be accompanied by the prescribed fee of One hundred and sixteen dollars ($116). The Poisons Regulations of 1973 171

[Form R QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973

LICE!\'CE TO SELL DANGEROUS DRUGS BY WHOLESALE The Director-General of Health and Medical Services hereby grants to , of (address of licensee(s) ), a licence under Regulation E2 of "The Poisons Regulations of 1973" to sell dangerous drugs by wholesale at (description and location of premises), under and subject to the provisions of the said Regulations during the period from the date hereof until the thirtieth day of September then next following. Dated at Brisbane the day of ·, 19 Director-General of Health and Medical Services.

[Form S QUEENSLAND ~Health Act 1937-1973 The Poisons Regulations of 1973

APPLICATION FOR A LICENCE TO MANUFACTURE DANGEROUS DRUGS To the Director-General of Health and Medical Services, Brisbane. Sir, 1. q;we hereby apply for a licence under Regulation E1 of "The Poisons Regulations of 1973" to manufacture dangerous drugs at the premises described in paragraph 5 of this application. 2. *1/We intend to conduct a bona-fide business as a manufacturer of dangerous drugs. 3. Full namets) of person(s) or company applying for licence: 4. Address of Applicant(s): 5. Description and location of premises at which it is desired to manufacture dangerous drugs: 6. Is the business conducted under a Registered Business Name? If so state name: 7. Is the applicant a company registered in Queensland? If so state position in the company held by signatory: 8. Name and qualifications of the person under whose personal supervision the manufacture of dangerous drugs will be conducted: • 9. Description of dangerous drug(s) or class(es) of dangerous drugs to be manufactured: • 10. Are you familiar with the provisions of Parts A, B, D, E, G, K and N of "The Poisons Regulations of 1973"? 11. *1/We declare that all the statements contained in this application are true. Signature(s): Date: , 19 • * Strike out whichever is not applicable.

N.B.-This application must be accompanied by the prescribed fee of One hundred and sixteen dollars ($116). 172 The Poisons Regulations of 1973

[Form T QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973 LICENCE TO MANUFACTURE DANGEROUS DRUGS The Director-General of Health and Medical Services hereby grants to , of (address of licensee(s) ), a licence under Regulation E1 of ''The Poisons Regulations of 1973" to manufacture the dangerous drugs or class or classes of dangerous drugs specified in the Schedule hereto at (description and location of premises), under and subject to the provisions of the said Regulations and to the express condition that such manufacture is at all times under the personal super vision of during the period from the date hereof until the thirtieth day of September then next following. Dated at Brisbane the day of , 19 Director-General of Health and Medical Services.

THE ScHEDULE

[Form V QUEENSLAND Health Act 1937-1973 The Poisons Regulations of 1973 APPLICATION FOR A LICENCE TO SELL REsTRICTED DRUGS BY WHOLESALE To the Director-General of Health and Medical Services, Brisbane. SIR, 1. *1/We hereby apply for a licence under Regulation F2 of "The Poisons Regulations of 1973" to sell restricted drugs by wholesale at the premises described in paragraph 5 of this application. 2. *I/We intend to conduct a bona-fide business as a wholesale seller of restricted drugs. 3. Full name(s) of person(s) or company applying for licence: 4. Address of applicant(s): 5. Description 'and location of premises at which it is desired to sell restricted drugs: 6. Is the business conducted under a Registered Business Name? If so state name: 7. Is the applicant a company registered in Queensland? If so state position held in the company by signatory: 8. Will the actual sale of restricted drugs be at all times under the personal supervision of a competent and responsible person? 9. Are you familiar with the provisions of Parts A, B, C, D, F, G, K and N of "The Poisons Regulations of 1973"? 10. *1/We declare that all the statements contained in this application are true. Signature(s): Date: ' 19 *Strike out whichever is not applicable. N.B.-This application must be accompanied by the prescribed fee of One hundred and sixteen dollars ($116). The Poisons Regulations of 1973 173

QUEENSLAND {Form W Health Act 1937-1973 The Poisons Regulations ._of 19.73 LICENCE TO SELL RESTRICTED DRUGS BY WHOLESALE The Director-General of Health · and Medical Services hereby grants to , of (address of licensee(s) ), a 'licence under Regulation F2 of "The Poisons Regulations of 1973" to sell .restricted drugs by wholesale at (description and location of premises), under and subject to the ,provisions of the said Regulations during the period from the date hereof until the thirtieth day of September then next fo11owing. Dated at Brisbane the day of ' 19 .. Director-General of Health and Medical Services.

QUEENSLAND [Form X Health Act 1937-1973 The Poisons Regulations of 1973

APPLICATION FOR THE SCHEDULING OR A VARIATION IN '"IHE .SCHEDULING OF A THERAPEUTIC OR A NON-THERAPEUTIC Suns;r.ANCE To the Director-General of Health and Medical Services, :Brisbane. SIR, I (or We), herewith make application for *the scheduling f the *a variation in scheduling 0 following .preparation:- *Strike out whichever is not applicable. I (or We) submit the following information in respect of the above preparation:- 1. Applicant: Name: 1\lanufacturer: Address.: 2. Approv.ed :Gr Common Name: 3. Pr9Jlr1etary name: 4. Purpose: 5.. Chemical Name: .6. Chemical formula and stnicture: 7. ·Chemical and physical characteristics: 8. Formulation and presentation: 9. Standards: Tests for potency, purity and safety in manufacture and storage when applicable. 10. Uses: In the case of therapeutic substances; Dosage, route of administration, special precautions, claims regarding effect and antidote or antagonist. In the case of n.on-theraPt;utic substa~ces; Strength of preparations, methods of handlmg, special precautiOns and claims regarding effectiveness and antidote or antagonist. 11. Labelling and Packaging: Indicate proposed details. 174 The Poisons Regulations of 1973

12. Action by other Authorities: Evidence of approval or rejection by any other statutory body or authority. 13. Bibliography: Complete bibliography of any publications relating to pharm acological and therapeutic actions, including clinical trials, should be given. 14. Toxicity Studies: Show full details of investigations made with respect to the toxicity of the substance, including tests carried out by universities and/ or research institutions and clinical trials. NOTE-Full reports are required of adequate tests which will show whether or not the substance will be safe to the human. The reports shall include detail data derived from appropriate animal and other biological experiments in which the methods used and the results obtained are clearly set forth. Details of any reports which could bias an evaluation of the safety of the substance shall NOT be omitted. The dose levels at which the tests are carried out should always include a level based on the expected normal exposure of the human. In tests (i) (b) (ii) and (v) the dose level which produces toxic or physiological changes is specifically required. Toxicity data should also include tests conducted with the formulated substance. Toxicological data should also include the results of full histological examination. Information required should include: (i) ACUTE TOXICITY (a) L.D. 50 in two species by both the oral and parenteral routes. (b) Local and systemic toxicity by topical and inhalation routes. (ii) SUB-ACUTE TOXICITY 6-14 weeks administration to rats and dogs by each of oral, parenteral (and topical) routes. (iii) CHRONIC ToXICITY Daily administration for at least one year in the rat. Information should also be supplied regarding:- (iv) Uniformity of response within a species and among different species. (v) Behavioural, cardiovascular, neural, and respiratory effects in the cat or dog. (vi) Occurrence of unusual or alarming reactions, such as carcinogenesis, or teratogenesis. (vii) Occurrence of sensitivity tolerance or idiosyncrasy in response to the substance. (viii) Metabolism, rate, extent and mode of elimination of the substance in mammal or human. (ix) Any tendency towards accumulation in the body. (x) Any special incompatability. (xi) Method of assay. (xii) Known side effects (in the case of therapeutic substances.) The Poisons Regulations of 1973 175

QUEENSLAND [Form Y Health Act 1937-1973 The Poisons Regulations of 1973 APPLICATION FOR A LICENCE TO MANUFACTURE RESTRICTED DRUGS To the Director-General of Health and Medical Services, Brisbane. SIR, 1. *I/We hereby apply for a licence under Regulation F1 of "The Poisons Regulations of 1973" to manufacture restricted drugs at the premises described in paragraph 5 of this application. 2. *I/We intend to conduct a bona-fide business as a manufacturer of restricted drugs. 3. Full name(s) of person(s) or company applying for licence: 4. Address of applicant(s): 5. Description and location of premises at which it is desired to manufacture restricted drugs: 6. Is the business conducted under a Registered Business Name? If so state name: 7. Is the applicant a company registered in Queensland? If so state position in company held by signatory: 8. Name and qualifications of the person under whose personal supervision the manufacture of restricted drugs will be conducted: 9. Description of restricted drug(s) or class(es) of restricted drugs to be manufactured: 10. Are you familiar with the provisions of Parts A, B, C, D, F, G, K and N of "The Poisons Regulations of 1973"? 11. *I/We declare that all the statements contained in this application are true. Signature(s): Date: ' 19 *Strike out whichever is not applicable.

N.B.-This application must be accompanied by the prescribed fee of One hundred and sixteen dollars ($116).

QUEENSLAND [Form Z Health Act 1937-1973 The Poisons Regulations of 1973 LICENCE TO MANUFACTURE RESTRICTED DRUGS The Director-General of Health and Medical Services hereby grants to , of (address of licensee(s)), a licence under Regulation Fl of "The Poisons Regulations of 1973" to manufacture the restricted drugs or class or classes of restricted drugs specified in the Schedule hereto at (description and location. of premises), under and subject to the provisions of the said Regulations and to the express condition that such manufacture is at all times under the personal supervision of , during the period from the date hereof until the thirtieth day of September then next fo1Iowing. Dated at Brisbane the day of , 19 • Director-General of Health and Medical Services.

THE SCHEDULE

177

EXTRACTS FROM HEALTH ACT 1937-1982 5. Interpretation. In this Act, unless the context otherwise indicates, the following terms have the meanings set against them respectively:- "Advertisement"-Any method of conveying information or making any claim with regard to any food, drug or article, whether orally or by writing or pictorially, or by telephone, gramophone, or wireless broadcasting or television or any other means of transmitting images or sound or both in association, or by label, letter, circular, pamphlet, book, magazine, newspaper, sign, poster, or otherwise; "Authorised person"-A person authorised by this Act to do the act in relation to which the expression is used: the term except where otherwise provided includes a medical prac titioner, chemist, veterinary surgeon, or dentist; "Dentist"-A dentist within the meaning of "The Dental Acts, 1902 to 1935," or of any Act amending or in substitution for those Acts; "Director-General"-The Director-General of Health and Medical Services for the State of Queensland; "Drug addict"-Any person who has acquired, as a result of repeated administration, an overpowering desire for the continued administration of any dangerous drug or restricted drug, and in whom the cessation of the administration of any such drug so desired leads to definite symptoms of mental or physical distress or disorder, and who does not require the use of any such drug so desired for the relief of symptoms of organic disease; "Have in possession"-Includes having under control in any place whatever, whether for the use or benefit of the person of whom the term is used or of another person, and although another person has the actual possession or custody of the thing in question; "Licence"-A licence issued by the Minister or by the Director General and, where permitted by this Act, by. a Local Authority under the provisions of this Act and legally in force for the time being; "Local Authority"-A Local Authority constituted in accordance with the laws in force for the time being relating to local government: the term also includes a Joint Local Authority and the Brisbane City Council constituted under "The City of Brisbane Acts, 1924 to 1936," or any Act amending or in substitution for those Acts; "Medical practitioner"-A medical practitioner within the mean ing of "The Medical Acts, 1925 to 1935," or of any Act amending or in substitution for those Acts; "Official dose"-The term when used with reference to any drug or other article means the maximum dose (if any) stated in the British Pharmacopreia; 178 Extracts from the Health Act 1937-1982

"Opium"-The term includes raw opium, prepared opium, medicinal opium, smoking opium, opium charcoal, and every other morphine containing preparation of the juice of the opium poppy, also any admixture, preparation, or solution containing any of those substances; "Paint"-Without limiting the ordinary meaning, includes any substance of any kind whatsoever used or intended to be used for application as a colouring or protective coating to any surface: the term includes. oil paint, water paint, enamel, distemper, and any tinting substance for use in the composition of any paint or for adding to any paint; "Pesticide"-The term includes any insecticide, rodenticide, arachnidicide, pulicide, weedicide or fungicide; "Pharmacist"-A pharmacist within the meaning of the Pharmacy Act 1976; "Prohibited plant"-A plant or a species of a genus of plant declared under this Act to be a prohibited plant: the term includes, with respect to a plant so declared or a plant of a species so declared, the seeds (whether capable or incapable of germination) and all other parts thereof, whether attached thereto or detached therefrom; "Sale" (with its derivatives)-Includes barter, and also includes offering or attempting to sell, or receiving for sale, or having in possession for sale, or exposing for sale, or sending, forwarding, or delivering for sale, or causing or suffering or permitting or allowing to be sold or offered or exposed for sale: unless the context otherwise indicates, the term refers only to sale for consumption or use by man: the term also, so far as relates to any poison, or to any restricted drug, or to any dangerous drug, or to any biological preparation includes supplying, exchanging, lending, or giving away, and whether for consumption or use by man or for any other purpose whatsoever; the term also includes, in relation to any article of food or drink for consumption by man, supplying or giving away as a means of advertisement and, in relation to any article for use by man, permitting or allowing such use as a means of advertisement; "Veterinary surgeon"-A veterinary surgeon within the meaning of "The Veterinary Surgeons Act of 1936" or of any Act amending or in substitution for that Act. 130. Possession of and trafficking in dangerous dmgs restricted. (1) A person shall not- ( a) have in his possession a dangerous drug, or a prohibited plant, or procure for himself a dangerous drug or a prohibited plant or attempt so to do, save under and in accordance with the authority of a licence or other authorization provided by or under this Act; Extracts from the Health Act 1937-1982 179

(b) have in his possession a pipe, needle, syringe, or other utensil for use in connexion with the preparation, smoking, administration or consumption of a dangerous drug, or that he has used in connexion with such a purpose, save where that drug is in the possession of himself or of any other person in accordance with the authority of a licence or other authorization provided by or under this Act and he is in possession of the pipe, needle, syringe or other utensil for the purpose of using that drug to carry out the direction of the medical practitioner who prescribed the drug for the bona fide treatment of himself or any other person or any animal or to carry out the direction of the veterinary surgeon who prescribed the drug for the bona fide treatment of any animal. Penalty: Imprisonment with hard labour for two years or a fine of $2,000 or both such imprisonment and such fine. In no case shall the mere possession of a pipe, needle, syringe or other utensil give rise to a presumption that it is in such possession for use in connexion with the preparation, smoking, administration or consumption of a dangerous drug. (2) Save under and in accordance with the authority of a licence or other authorization provided by or under this Act a person shall not- ( a) produce, prepare, or manufacture a dangerous drug or attempt so to do; (b) cultivate a prohibited plant or attempt so to do; (c) sell, give, supply or procure, or attempt so to do, or offer to sell, give, supply or procure, to or for another person or otherwise deal or trade in a dangerous drug or a prohibited plant or attempt so to do; (d) have in his possession a dangerous drug, or a prohibited plant for a purpose specified in paragraph (c) of this subsection; (e) permit or suffer premises of which he is owner or occupier or in the management whereof he is concerned to be used for the production, preparation, manufacture, sale, supply, distribution, smoking, administration or consumption of a dangerous drug or for the cultivation of a prohibited plant. Penalty:- ( a) upon conviction on indictment, imprisonment with hard lab our for life or a fine of $100,000 or both such imprisonment and such fine; (b) upon conviction in summary proceedings, imprisonment with hard labour for two years or a fine of $2,000 or both such imprisonment and such fine. (2A) A person shall not have in his possession or at his order or disposition- ( a) money, marketable securities or other thing; or 180 Extracts from the Health Act 1937-1982

(b) any acknowledgement, note or other thing purporting or intended to entitle the bearer or any other person to money or money's worth, in any case had by him, whether directly or indirectly, by way of or for the purpose of the commission of an offence against a provision of subsection (2) of this section or as consideration for the com mission of such an offence. Penalty:- (a) upon conviction on indictment, imprisonment with hard labour for life or a fine of $100,000 or both such imprison ment and such fine; (b) upon conviction in summary proceedings, imprisonment with hard labour for two years or a fine of $2,000 or both such imprisonment and such fine. (3) A person shall not- ( a) administer, or attempt or offer to administer a dangerous drug to another person save-- (i) where he does so under and in accordance with the authority of a licence or other authorization provided by or under this Act; or (ii) where, he or such other person being lawfully in possession of the dangerous drug, he administers or attempts or offers to administer it to carry out the direction of the medical practitioner who prescribed the drug for the bona fide treatment of such other person; (b) have in his possession a dangerous drug for a purpose specified in paragraph (a) of this subsection that is unlawful. Penalty:- (a) upon conviction on indictment, imprisonment with hard labour for 10 years or a fine of $10,000 or both such imprisonment and such fine; (b) upon conviction in summary proceedings, imprisonment with hard labour for two years or a fine of $2,000 or both such imprisonment and such fine. ( 4) This section does not apply to a State botanist who, in the course of his duties as such, has in his possession, at premises approved for the purpose by the Director-General, a prohibited plant for the purpose of identification, storage or cultivation. 130I. Form of proceedings for offences. (a) A charge of an offence against any provision of section 130 of this ~ct may be p:osec~ted upon indictment or by way of summary proceedmgs before a st1pend1ary magistrate sitting alone. (b) Proceedings before the stipendiary magistrate shall be proceedings with a view to the committal of the defendant for trial or sentence or proceedings with a view to summary conviction, at the election of the prosecutor. Extracts from the Health Act 1937-1982 181

(c) Where proceedings are taken with a view to summary con viction of the defendant and the stipendiary magistrate forms the opinion that the matter should not be determined summarily, he shall abstain from determining the matter summarily and shall instead deal with the proceedings as proceedings with a view to the committal of the defendant for trial or sentence, as the case may be, arrd may exercise in respect of the defendant for the purpose of such proceedings all the powers conferred on him by law as though the proceedings were proceedings with a view to committal in the first instance. (d) Where the stipendiary magistrate abstains from determining a matter summarily pursuant to paragraph (c) of this section, the plea of the defendant taken at the outset of the summary proceedings shall be disregarded and, before committing the defendant for trial or for sentence, he shall address the defendant in accordance with the pro visions of section 104 of The Justices Acts 1886 to 1968.

130J. Matters of proof respecting possession of drugs. (1) In a pro ceeding brought for an offence in relation to possession of a dangerous drug, a person who, contrary to section 130 of this Act, has in his possession- ( a) a quantity of that drug in excess of a quantity prescribed under this Act for the purposes of this paragraph (a) in respect of that drug; or (b) a quantity of any substance containing that drug, which quantity exceeds the quantity prescribed under this Act for the purposes of this paragraph (b) in respect of that drug, shall be deemed to have possession of that drug for a purpose specified in paragraph (c) of subsection (2) of section 130 of this Act unless he shows the contrary. (2) In respect of a charge of an offence against any provision of section 130 of this Act, (a) it is not necessary to particularize the dangerous drug in respect of which the offence is alleged to have been committed; (b) proof that a dangerous drug was at the material time upon premises occupied by or under the control of any person is proof that ·the drug was then in his possession unless he shows that he then neither knew nor had reason to suspect that the drug was upon the premises; (c) the burden of proving any licence or other authorization provided by or under this Act lies on the defendant who claims the authority of such licence or authorization; (d) the operation of section 24 of The Criminal Code is excluded unless the defendant shows his honest and reason able belief in the existence of any state of things material to the charge. 182 Extracts from the Health Act 1937-1982

( 3) A person charged with an offence against any provlSlon of section 130 of this Act shall be liable to be convicted as charged notwithstanding that the identity of the dangerous drug to which the charge relates is not proved to the satisfaction of the court that hears the charge if the court is satisfied that the substance to which the charge relates was at the material time a dangerous drug. A person charged with an offence against paragraph (d) of sub section (2) of section 130 of this Act shall be liable to be convicted of the charge notwithstanding that the purpose for which the drug or plant was had in possession as alleged in or in connexion with the charge is not proved to the satisfaction of the court that hears the charge if the court is satisfied that the drug or plant was had in possession for a purpose specified in paragraph (c) of that subsection. Where a person is charged with an offence against paragraph (d) of subsection (2) of section 130 of this Act by reason only of the quantity of dangerous drug in his possession and there is no evidence of the purpose of the possession charged, a court shall not order par ticulars of such purpose to be supplied and the absence of such par ticulars shall in no way affect the taking of proceedings upon the charge. 130L. Forfeiture to Crown. ( 1) Where a person is convicted of an offence against any provision of section 130 of this Act any prohibited plant, dangerous drug, pipe, needle, syringe or other utensil in respect of which the offence was committed shall by virtue of such conviction be forfeited to Her Majesty. (2) Where a person charged with an offence against any provision of section 130 of this Act is not convicted of any offence on that charge the court before which he was charged may order that any prohibited plant or dangerous drug or any pipe, needle, syringe or other utensil capable of being u~;ed in connexion with the preparation, smoking, administration or consumption of any dangerous drug, found under his cultivation or in his possession at or about the time of his being charged with the offence be forfeited to Her Majesty and any such thing in respect of which the order is made shall thereby be forfeited accordingly. (2A) Where a person is convicted of an offence against subsection (2A) of section 130 of this Act the court before which he is convicted or a court of like jurisdiction shall, on application- ( a) in the case of a conviction on indictment, made on behalf of the Crown; or (b) in the case of a conviction in summary proceedings, made by or on behalf of the complainant, order that any money, security, acknowledgement, note or other thing in respect of which the offence was committed be forfeited to Her Majesty and upon the making of such order such forfeiture shall take effect. ( 3) Any thing forfeited pursuant to subsection (1) or ( 2) of this section may be taken and disposed of as the Minister directs, and for Extracts from the Health Act 1937-1982 183 that purpose a person authorized by the Director-General, either generally or in a particular case, may, with such assistants and by such means as he considers necessary, enter upon any premises upon which he knows or suspects the thing so forfeited to be. ( 4) All marketable securities forfeited pursuant to subsection (2A) of this section and all rights arising in connexion with the same and all rights conferred by any acknowledgement, note or other thing forfeited pursuant to that subsection shall by virtue of such forfeiture and without any transfer or assignment whatever vest in The Treasurer of Queensland who, for the purpose of taking, holding and dealing with the same, shall be by that name a corporation sole with power to sell, call in and convert into money any of the same and to exercise rights of every description in connexion therewith or in connexion with further securities acquired by him by reason of his holding the securities so vested in him. (5) All moneys forfeited to Her Majesty pursuant to subsection ( 2A) of this section and all moneys that from time to time vest in The Treasurer of Queensland as a result .of a forfeiture pursuant to that subsection shall be paid to the credit of the Consolidated Revenue Fund. (6) All moneys and marketable securities forfeited pursuant to subsection (2A) of this section and all rights vested in The Treasurer of Queensland pursuant to subsection ( 4) of this section by virtue of a forfeiture pursuant to subsection (2A) of this section and all moneys, securities and rights acquired by The Treasurer of Queensland as a result of a forfeiture pursuant to subsection (2A) of this section shall be held by the Crown or, as the case may be, The Treasurer of Queenland subject to the rights with respect thereto of any person who within 6 months of the date of the relevant forfeiture pursuant to subsection (2A) of this section satisfies the Treasurer that- ( a) he is the lawful owner of the moneys, marketable securities, acknowledgement, note or other thing so forfeited or has a proprietary interest or a charge in or in respect of the same; and (b) he was not privy to the commission of the offence against subsection (2A) of section 130 of this Act consequent on the conviction for which the moneys, marketable securities, acknowledgement, note or other thing were ordered to be forfeited to Her Majesty. Save as is provided by this subsection, no person shall have a claim for compensation or otherwise on account of the seizure, forfeiture, retention or dealing with any moneys, marketable securities, acknowledge .•nent, note or other thing referred to in subsection (2A) of section 130 of this Act. (7) A person charged with keeping any register or record required or authorized by law to be kept in which is recorded a registration or notification concerning any person in respect of any marketable securities, acknowledgement, note or other thing specified in subsection ( 4) of this section shall, upon being notified in writing by The Treasurer 184 Extracts from the Health Act 1937-1982 of Queensland of the forfeiture of such securities or the rights conferred by such acknowledgement, note or other thing and without payment of any fee, alter that registration or notification by substituting therein reference to The Treasurer of Queensland for a reference to the person registered or recorded therein.

130M. Power to detain, search, seize and arrest. ( 1) A member of the Police Force, or any person authorized by the Director-General in writing for the purposes of this section may- (a) detain any person whom he reasonably suspects- (i) to have in his possession or on any premises any dangerous drug, prohibited plant, or pipe, needle, syringe or other utensil for use in connexion with the preparation, smoking, administration or consumption of any dangerous drug; (ii) to have in his possession or at his order or disposition any money, security, acknowledgement, note or other thing, in contravention of any provision of section 130 of this Act; (b) search the person and possessions of any person so detained and anything carried by such person and any premises wherein such person is found and any premises wherein such person :has or is suspected of having any 1thing specified in the preceding paragraph (a) and for the purpose of such search open by such means as he finds necessary any room, package, container or receptacle; (c) seize and retain any thing specified in paragraph (a) of this subsection found in the course of such search; (d) arrest without 'Warrant any person who has or who he reasonably suspects has contravened any provision of section 130 of this Act and deal with him according to law. (lA) Without derogating from the provisions of subsection ( 1) of this section, where complaint is made before a justice on oath by a member of the Police Force or any person authorized by the Director General in writing for the purposes of this section that a person has or is reasonably suspected of having contravened any provision of section 130 of this Act, the justice may, upon the matter of complaint being substantiated to his satisfaction, issue a warrant for the apprehension of such person and for him to be dealt with according to law. ( 2) Where a person has been arrested on a charge of any offence against any provision of section 130 of this Act the member of the Police Force in charge of the police station, watch-house or lock-up to which the person is taken after arrest may take or cause to be taken all such particulars as he thinks necessary for the identification of the person including his photograph and finger prints and palm prints. If proceedings are not taken against the arrested person in respect of any offence against any provision of section 130 of this Act or if he is acquitted in respect of all offences of which he might be convicted Extracts from the Health Act 1937-1982 185 upon the charge made against him all photographs, finger prints and palm prints taken pursuant to this subsection shall be destroyed in his presence. ( 3) Any thing seized and retained pursuant to paragraph (c) of subsection ( 1 ) of this section may be retained for a period of 12 months, unless- (a) it is sooner established to the satisfaction of the Attorney General of the State that at the time of seizure and retention no offence against any provision of this Act in relation to that thing had been committed, in which case that thing shall be returned to the person from whom it was seized; or (b) within that period- (i) proceedings for an offence against this Act in relation to that thing; or (ii) proceedings for an offence against this Act in which that thing may be used as evidence, have been instituted, in which case that thing shall be retained until the final determination or other disposal of those pro ceedings (including all appeals therein duly instituted) if that period exceeds 12 months. 130N. Declaration of dangerous dmgs and prohibited plants. ( 1) The Governor in Council may, by Order in Council, (a) declare any article or substance other than a dangerous drug to be a dangerous drug for the purposes of section 130 of this Act; (b) declare any plant or any species of a genus of plant to be a prohibited plant for the purposes of this Act.

130o. Meaning of certain expressions in this Division. Save where the contrary appears, the following expressions when used as referred to in this section have the meanings respectively assigned to them by this section, that is to say- (a) "dangerous drug" or "dangerous drugs" when used in sections 130, 130B, 130J, 130K, 130L, 130M, 131A and 131B of this Act includes any dangerous drug and any article or substance declared to be a dangerous drug pursuant to section 130N of this Act. (b) "declared institution" when used in section 130F of this Act means an institution declared by the Governor in Council to be an institution for the purposes of section 130B of this Act. (c) "treatment" when used in sections 130A, 130B and 130F of this Act includes medical treatment, care, training, educa tion, supervision, social rehabilitation, help and advice. * * * * * 186 Extracts from the Health Act 1937-1982

131. Cyanide of potassium and other poisonous cyanides. (1) No person other than one licensed in such behalf under this Act, or otherwise authorised in such behalf under this Act, shall at any time have in his possession or upon any premises or place occupied by him any cyanide of potassium or any poisonous compound of cyanogen. The burden of proof that he is licensed or otherwise authorised under this Act shall in every case be on the defendant. (2) If any person acts in contravention of or fails to comply with any requirement of this section he shall be guilty of an offence against this Act. Penalty. Any person guilty of any such offence shall be liable on conviction to a penalty of not less than $200 nor more than $400, or to imprisonment with or without hard labour for a term not exceeding three months or to both such fine and imprisonment, and in the case of a second or subsequent conviction to a penalty of not less than $400, nor more than $1,000, or to imprisonment with or without hard labour for a term not exceeding six months or to both such fine and imprison ment, and the stipendiary magistrate dealing with the case may in r"ddition to any further punishment order the goods in respect of which the offence was committed to be forfeited to the Crown. Power of arrest, seizure, &c. Any member of the Police Force may without warrant arrest any person who has committed or attempted to commit, or is reasonably suspected by him of having committed or attempted to commit, an offence against this section, and any member of the Police Force may detain any person found in or upon any place, including any person found in any road, street, or other public place, or found travelling, whom he may reasonably suspect to have in his possession any cyanide of potassium, or any poisonous compound of cyanogen, or any substance which is reasonably suspected to be cyanide of potassium or any poisonous compound of cyanogen, contrary to the provisions of this section, and may search any place in or upon which such person may be, and may search such person and may open and search any package in the possession or apparent possession of or carried or conveyed by such person and may seize any cyanide of potassium, or poisonous compound of cyanogen, or any substance which is reasonably suspected to be cyanide of potassium, or any poisonous compound of cyanogen, found in the possession of such person or in any package in the possession or apparent possession of or carried or conveyed by such person or in or upon any such place, and may forthwith arrest such person without warrant and detain him in custody until he can be brought before the court to be dealt with according to law. 131A. Search warrant in respect of dangerous drugs and cyanide. Upon complaint on oath before any justice of the peace by any member of the Police Force that such member believes that- (i) Any dangerous drug or prohibited plant; (ii) Any cyanide of potassium or any poisonous compound of cyanogen Extracts from the Health Act 1937-1982 187 is, or is in the possession of any person, in or upon any premises or place contrary to the provisions of this Act, such justice may grant a warrant to any member of the Police Force with or without assistants, to enter, by force if necessary, and search such premises or place and all persons found therein or thereon. Such police officer may in respect of the premises or place in question and of any person or any dangerous drug, cyanide of potassium, poisonous compound of cyanogen, or any substance which is reasonably suspected to be any dangerous drug, cyanide of potassium or poisonous compound of cyanogen found therein or thereon, do and execute all of the powers and authorities conferred upon him by section 130M, or as the case may be, subsection two of section one hundred and thirty-one of this Act. 131B. Obstruction of officers. A person shall not assault or obstruct, or attempt so to do, a member of the Police Force or other person in the exercise by such member or other person, in relation to an offence or suspected offence concerning any dangerous drug, prohibited plant, pipe, needle, syringe or other utensil or any money, security, acknowledgement, note or other thing of any power or function permitted to or required of him by this Act. Penalty: $2,000. * * * * * 1311. Drugs and Poisons to be labelled. Every package containing any drug or poison for sale shall bear a label which complies in all respects with what is prescribed by the Director-General by regulations in relation thereto, it being hereby declared, without limiting any of the provisions of section 152, that such regulations may be made by the Director-General. A person shall not sell a package containing any drug or poison unless the package bears such a label complying in all respects as aforesaid. * * * * * 188 Extracts from the Health Act 1937-1982

152. Regulations. ( 1) The Director-General may from time to time make regulations with respect to all or any of the following matters, namely:- * * * * * (xvi) Defining or prescribing poisons, etc. Defining or prescribing poisons and/ or restricted drugs and/ or dangerous drugs and/or biological preparations; (xvii) Regulating and controlling and, as deemed necessary, prohibiting or restricting the ownership, possession, manu facture, cultivation, sale, distribution, supply, use, lending, dispensing, prescribing, or giving away of or forging and uttering of prescriptions for or any other dealing with poisons, restricted drugs, dangerous drugs, biological preparations, prohibited plants, or goods for therapeutic use under and within the meaning of the Therapeutic Goods Act 1966 of the Commonwealth or any Act amending the same or in substitution therefor; the licensing of persons or classes of persons to manufacture, pack, re-pack or sell, poisons or restricted drugs or dangerous drugs, or biological pre parations, or prohibited plants, or goods for therapeutic use under and within the meaning of the Therapeutic Goods Act 1966 of the Commonwealth or any Act amending the same or in substitution therefor; the siting, construction, lay-out, condition and registration of the premises of all such licensees as aforesaid, any of which regulations may differ in respect of different poisons, or restricted drugs, or dangerous drugs, or biological preparations, or pro hibited plants, or goods for therapeutic use under and within the meaning of the Therapeutic Goods Act 1966 of the Commonwealth or any Act amending the same or in sub stitution therefor; regulating the supply of drugs to drug addicts; providing for the inspection, sampling, seizure, and analysis of poisons, dangerous drugs, restricted drugs, bio logical preparations, prohibited plants, or goods for thera peutic use under and within the meaning of the Therapeutic Goods Act 1966 of the Commonwealth or any Act amending the same or in substitution therefor, which provisions may be in addition to or in lieu of the provisions contained in this Act in respect of inspection, sampling, seizure, and analysis; providing for the inspection of all or any books, prescriptions, papers and other writings relating to the prescribing, dispensing, handling, having in possession, ordering, purchasing, selling or manufacturing of poisons, dangerous drugs, restricted drugs, biological preparations, prohibited plants or goods for therapeutic use under and within the meaning of the Therapeutic Goods Act 1966 of the Commonwealth or any Act amending the same or in sub stitution therefor, providing for the taking of extracts from or copies of any of such books, prescriptions, papers and Extracts front the Health Act 1937-1982 189

other writings and the taking into and retention in, custody of an inspector of any of such books, prescriptions, papers and other writings and the circumstances in and conditions under which the same may be released from such custody; * * * * (xviiA) Registration of pharmacies. The registration by the Director-General of premises in which medicines, mixtures, compounds and drugs are dispensed (other than a dispensary in any hospital controlled by a Hospitals Board under the Hospitals Act 1936-1978 or premises in which medicines, mixtures, compounds or drugs are dispensed by a person (not being a pharmacist within the meaning of the Pharmacy Act 1976-1978) authorized so to do under this Act) or items of trade are sold or services in conjunction with such dispensing are provided; the siting, construction, layout and condition of such premises; (xviiB) Labelling and packaging dangerous substances. Requiring the packaging of dangerous substances, prescribing the mode of such packaging, .requiring the labelling of dangerous substances packaged for sale and prescribing the mode of labelling thereof and the matter to be contained or not contained in such labels; (xxviii) Penalties. Prescribing penalties not exceeding $500 for the breach of any regulation, save that penalties not exceeding $2,000 may be prescribed for breach of any regulation in respect of- (a) the obtaining, or doing any act or making any omission for or with a view to the obtaining, of any dangerous drug; (b) the failing to account for or concealing the whereabouts, possession or disposition of any dangerous drug; (c) the making of any false or untrue entry in any book or record prescribed by the regulations concerning any dangerous drug; (d) the prescribing of a dangerous drug; (e) dispensing a dangerous drug;

* * * * * 190

ORDER IN COUNCIL At the Executive Building, Brisbane, the thirteenth day of July, 1972 Present: His Excellency the Governor in Council HIS Excellency the Governor in Council, acting by and with the advice of the Executive Council and in pursuance of the provisions of the Health Act 1937-1971, doth hereby revoke the Order in Council dated the sixth day of May, 1971, declaring any plant or any species of a genus of plant therein specified to be a prohibited plant and doth hereby declare that the following plants or any species of a genus of such plants shall be prohibited plants for the purposes of this Act:- ( a) Indian Hemp (Cannabis sativa) ; (b) Mushroom (Psilocybe cubensis); and (c) Opium Poppy (Papaver somniferum) but excluding the seed thereof which seed has been rendered sterile by a means approved by the Minister. And the Honoura!ble the Minister for Health is to give the necessary directions herein accordingly. KEITH SPANN, Clerk of the Council. Gov. Gaz., 15th July, 1972, page 1305.

ORDER IN COUNCIL At the Executive Building, Brisbane, the eighteenth day of September, 1980. Present: The Deputy Governor, for and on behalf of His Excellency the Governm in Council THE Deputy Governor, for and on behalf of His Excellency the Governor acting by and with the advice of the Executive Council and in pursuance of the provisions of the Health Act 1937-1980 does hereby- ( a) rescind the Order in Council dated the sixth day of May 1971 and published in the Government Gazette of the eighth day of May 1971; and 191

(b) declare that each of the foHowing substances shaH be a dangerous drug under and for the purposes of section 130 of the said Health Act: N, N-dimethyltry:ptamine; N, N-diet!hyltryptamine; Bufotenine; Psilocin; Psilocybin; Lysergic acid; Lysergamide; Lysergide and other N-alkyl derivatives of lysergamide; Mescaline; 2,5-dimethoxy-4-methylamphetamine (DOM or STP); 4-bromo-2,5-dimethoxyamphetamine (BDMA); Any ~bstance (except methoxyphenylamine) having haUucino genic properties and being structurally related, by substitution in the ring to any extent with alkyl, alkoxy, alkalene-dioxy or hallide substituents, whether or not further substituted in the ring by one or more univalent substituents, to any of the following substances- (a) phenylethylamine; (b) an N-alkylphenylethylamine; (c) a-methylphenylethylamine; (d) an N-alkyl-a-methyl-phenylethylamine; (e) a-ethylphenylethylamine; or (f) an N-alkyl-a-ethylphenylethylamine; Sources and chemical precursors from which any of the above specified substances may be derived; Barbituric acid, its salts, and any 5,5 disubstituted derivatives of barbituric acid, whether or not further substituted at position 1 of the ring, and their salts. And the Honourable the Minister for Health is to give the necessary directions herein accordingly. KEITH SPANN, Clerk of the Council. Gov. Gaz., 20th September, 1980, page 282

Alphabetical Substance Index 193 ALPHABETICAL INDEX TO SUBSTANCES THE POISONS REGULATIONS OF 1973 Including Amendments to 6th August, 1983

Substance Schedule Substance Schedule

Acephate (organo-phos) 6 I Alpha-chlorohydrin 6 Acetanilide, etc., human therapeutic 4 I Alpha-(2-chlorophenyl)-alpha-(4- 5 chlorophenyl)-5-pyrimidinemeth Acetazolamide 4 a no! Alphadolane .. 4 Acetic acid 2,5and6 Alphameprodine 8 Acetic anhydride 5 and 6 Alphamethadol 8 Acetohexamide 4 Alphaprodine .. Acetone 5 Alpha-receptor blocking agents 4 Acetorphine 8 Alphaxolone .. 4 Acetylcholine, etc. 4 Alprenolol (see Beta-receptor) 4 Acetylcysteine .. 4 Amantadine 4 Acetyldihydrocodeine 2,4and8 Ambenonium 4 Acetyl dihydrocodeinone (see 8 Thebacon) Ambucetamide 4 Acetylmethadol 8 Ambutonium 4 Acetyl methyl dimethyl oximodo 4 Amethocaine 4 phenyl hydrazine Ametryne 6 Acetylurea derivatives (see 4 Phenacemide) Amidithion (organo-phos) 6

Aconite . Amidopyrine, etc. 4 Acrolein 7 1 Amikacin .. 4 Adiphenine 4 1 Amiloride . . • . . . . . 4 1 Adrenaline 3 and 4 II Amines, as curing agents (see Epoxy 5 resins) Aklomide 5 Amines, aromatic, in hair dyes see 2 and 6 Alachlor 5 II Alcuronium 4 ~~2-am:::_:~:nes 6 Aldicarb (N-methyl carbamate) 7 1 Aminocarb (N-methyl carbamate) 6 and 7 Aldrin (see Dimethanonaphthalene) 6 I 2-Amino-5-diethylamino toluene 6 Alkaline salts .. 5 2-Amino-5-N-ethyl-(B hydroxy ethyl) 6 amino toluene Akaloids (see substance names) 2-Amino-5-N-ethyl-N-(B methane 6 Alkyl acetanilides (see Acetanilide) .. 4 I ~~~~~~.:'amide ethyl) amino Alkyl sulphonals (see Sulphonal) .. 4 I 2-Amino-5-N-ethyl-N B methoxyethyl 6 Alkynes, substituted (see Methyl- ' 4 I1 amino toluene di-p-toluene pentynol) Allidochlor 6 I A mmometra . d" 1ne . . . . 4

Allopurinol (see Xanthine) 4 1 Aminopterin (see Antifolic) 4 Allyl alcohol .. 7 4-aminopyridine 7 Allylisopropylacetylurea 4 Aminorex 4 Allylprodine Amiphenazole .. 4 Alphacetylmethadol 8 Amisometradine 4 Alpha-chloralose 6 Ami ton (organo-phos) 7 194 Alphabetical Substance Index

Substance Schedule II il Substance Schedule ! Amitraz 6 Aspirin ...... 2 and 4 Amitrole 5 I Ataractic substances (see Benactyzine, 4 Chlordiazepoxide, Chlorproma- Amitryptaline, etc. 4 1 zine, Haloperidol) Ammonia 5 and 6 II Atenolol 4 Ammoniated mercury (see Mercuric 2 l Atropine . . . . I, 2 and 6 amon. chlor.) Atropine Methonitrate 4 Ammonium Fluoride (see Fluoride•) 2, 4, 6 and 7 Atropine Sulphate 0·5 mg tablets. 6 Ammonium, quaternary compounds 4 and 5 III special pack

Ammonium thiocyanate 5 1 Azaperone 4 Amodiaquin (see Antimalarial) 4 Azapetine 4 Amoxycillin 4 Azatadine 4 Amphetamine 8 Azinphos-ethyl and methyl (organo 7 phos) Amphomycin 4 Azobenzene 6 Amphotericin 4 ~~ 6 Ampicillin 4 ~~ Azocyclotin

Amygdalin 7 Bacitracin 4 and 6 Amyl nitrite I Baclofcn 4 Amylocaine 4 \ Bamipine 2, 3 and 4 Anabolic steroidal agents (see Zeranol) 4 II Barban .. 6 Anaesthetics, inhalation 4 Barbituric acid, etc. 4 Anaesthetics, local 2 and 4 Barium salts 5 and 6 Angiotensin amide 4 I Beclamide 4 Anhydrides, organic, as curing agents! 5 Belladonna I and 2 (see Epoxy resins) 1[ Bemegride 4 Anileridine I I Benactyzyne, etc., therapeutic 4 6 Aniline.. I' I 5, 6 and 7 Antazoline 2, 3 and 4 I ::::~~::: (N-methyl carbamate) 6 Antibiotics 4 and 6 Benseyazide 4 Antifolic acid substances 4 I 1 Bensulide (organo-phos) 6 Antigens, human parenteral (see 4 Vaccines) Bentazon 5 Antihistamines 2, 3 and 4 I Benzamine (sec> Anaesthetics, local) .. 2 and 4 Antimalarial substances 4 II Benzene 7 Antimony I and 4 II [ Benzene hexachloride-(see BHC) 5 and 6 Antithyroid substances (see Thiouraci 1) 4 ' 1 Benzethidine Antitoxins, human parenteral (see 4 11 Vaccines) !I Benzhexol 4 Antitubercular substances 4 4 ANTU .. il' Benzilonium ...... Benzocaine (see Anaesthetics, local) .. 2 and 4 Apomorphine 4 Benzodiazepine derivatives (see 4 Aprotinin 4 II Chlordiazepoxide) 1 Arecoline 6 1 Benzothiadiazine derivatives (see 4 I Chlorothiazide) Arprinocid 6 I !I Benzoyl peroxide 2, 3, 4 and 5 Arsenic 4, 5, 6, 6A and 7 l! Bcnzphetamine, etc. 2, 3, 4 and 8 Alphabetical Substance Index 195

Substance Schedule Substance Schedule

Benztropine 4 Bromophos-ethyl (organo-phos) 6 Benzydamine 4 Bromoxynil 6 Benzylmorphine 8 Brompheniramine 2, 3 and 4 S-Benzyl N, N-di-(sec-butyl)-thiolo 5 Bromvaletone 4 carbamate Brotianide 6 Benzyl penicillin 4 and 6 Brucine Beryllium 6A Buclizine 2,3and4 Beta-aminopropylbenzene and beta- 2, 3, 4 and 8 aminoisopropylbenzene der- Buclosamide 7 ivatives not elsewhere listed (see Benzphetamine) Bufexamac 2 and 4 Betacetylmethadol 8 Bufotenine 4 Betahistine 4 Bumetanide 4 Beta-hydroxyethylhydrazine .. 7 Bunamidine 6 Betameprodine 8 Buniodyl sodium 4 Betamethadol 8 Busulfan 4 Betaprodine Butacaine 4 Beta-receptor blocking agents 4 Butacarb 6 Bethanidine 4 Buthidazole 5 Bezitramide 8 2-buto xy-2'-thiocyano-diethyl ether .. 6

BHC 5 and 6 Butylaminobenzoate (see Anaesthetics, 2 and 4 local) Binapacryl 6 Butylcaine and Butylcaine picrate 4 Bioallethrin 5 (see Anaesthetics, local) Biperiden 4 Butyl chloral hydrate 4 Bismuth subgallate, human oral use .. 4 Butyl nitrate •. 3 Bithionol 6 and 7 4-n-Butyi-4H-1 ,2,4-triazole 7 Bleaches (see Chlorinating compounds 5 and 7 Butynorate 6 Calcium hypochlorite, Sodium dichloroisocyanurate, Trichloro~ Butyrophenone derivatives (see 4 isocyanuric acid and its salts) Haloperidol) Bleomycin 4 Cadmium 5 and 6 Boron compounds 4 and S Calamus, human therapeutic 4 Bretylium 4 Calcium carbimide 4 Bromhexine 2 Calcium hypochlorite (see Chlorin- 5 Bromides, inorganic, therapeutic 4 ating compounds) Bromine Calcitonin 4 5-bromo-4-chlorosalicylanilide 7 Calomer (see Mercurous chloride) 4 Bromocriptine 4 Cambendazole 6 Bromodiphenhydramine 2,3and4 Camphechlor .. 6 3-(3-(4' Bromodiphenyl-4-yl)-3- 6 and 7 Camphetamide 4 hydroxy-phenylpropyl)-4- hydroxycourmarin Camphor 4 and 5 3-(3-(4' Bromodiphenyl-4-yl)-1,2,3,4- 6 and 7 Camphorated oil 4 tetrahydronaphthyl)-4- hydroxycoumarin Cannabis, etc•.• 8 Bromoform 4 and6 Cantharides 2 and4 Bromophos 6 Capreomycin 4 8 196 Alphabetical Substance Index

Substance Schedule Substance Schedule

Captodiame 4 Chlorbutal, oral preparations 4 Captafol 5 Chlorcyclizine . . 4 Captiride 4 Chlordane 6 Caramiphen 4 Chlordecone 5 and 6 Carbachol 4 Chlordiazepoxide, etc., therapeutic . . 4 Carbad ox 6 Chlordimeform 7 Carbamazepine 4 Chlorethalin 5 Carbaryl 2,4, 5 and6 Chlorfenac 5 Carbazochrome 4 Chlorfenethol 6 Carbenoxolone 2 and4 Chlorfenson 5 Carbetapentane 2 Chlorfenvinphos (organo-phos) 7 Carbidopa 4 Chlorinating compounds (see 5 and 7 Bleaches, Calcium hypochlorite, Carbimazole 4 Sodium dichloroisocyanurate, Trichloroisocyanuric acid and Carbinoxamine 2,3and4 its salts) Carbocromen 4 Chlorine 7 Carbofuran 7 Chlormequat 6 Carbon bisulphide 6A Chlormerodrin 4 Carbon tetrachloride 7 Chlormethiazole 4 Carbophenothion (organo-phos) 7 Chlormezanone 4 Carbromal 4 Chlornidine 5 Cardiac glycosides 4 N-5-Chloro-4-( (4-chlorophenyl)- 6 cyanomethyl)-2-methyl-phenyl-2- Carindacillin •• 4 hydroxy-3, 5-diiodobenzamide CDAA (see Allidochlor) 6 Chlorobenzyl disulphonamide (see 4 Clofenamide) CDEC (see Sulfallate) 6 Chlorocresol • • 5 Cefoxitin 4 NN-diallyl chloroacetamide (see 6 Cephacetrile 4 Allidochlor) Cephalexin 4 2-chloroethyl phosphonic acid (see 5 Ethephon) Cephaloridine 4 Chloroform 2 and 4 Cephalothin 4 Chloromethi uron 6 Cephamandole 4 2-Chloro-N-(4-methoxy-6-methyl- 6 Cephapirin 4 1,3,5-triazin-2-yl) aminocarbonyl benzene sulfonamide Cephazolin 4 5-Chloro-3-methyl-4-nitropyrazole . . 7 Cephradine 4 S-(6-Chloro-2-oxo-oxozolo (4,5-b) 6 Chenodeoxycholic acid 4 -pyridin-3-ylmethyl)-0,0-dimethyl phosphorothioate Chlorophacinone 6 Chiniofon, etc. 4 1-(4-Chlorophenoxy)-1-imidazol-1-yl- 4, 5 and 6 Chloral formam ide 4 3,3-dimethyl-2-butanone I

Chloral hydrate 4 5-(2-Chloro-1-phthalimidoethyl)-0, 0- 1 7 diethylphosphorodithioate Chlorallyldiethyldithiocarbamate 6 (see Sulfallate) Chloropicrin . . 6 and 7 Chloramphenicol 4 Chloropropylate 5 Chlorazanil 4 Chloropyrilene i 2, 3 and 4 Alphabetical Substance Index 197'

Substance Schedule Substance Schedule

Chloroquine (see Antimalarial) 4 Clotrimazole 4 Chlorothiazide, etc. .. 4 Cloxacillin 4 5-(2-chloro-4(trifluoromethyl) 6 Clozapin 4 phenoxy)-2-Nitrobenzoate Cocaine 8 Chlorphenamidine (see Chlordime- 7 form) Cocaine substitutes (see Anaesthetics, 2 and4 local) Chlorpheniramine 2,3and4 Coca leaf 8 Chlorphenoxamine 2,3and4 Codeine 2,3,4and8 Chlorphentermine 4 Codeine-N-oxide 8 Chlorpromazine, etc., therapeutic 4 Codoxime (dihydrocodeinone-6-car- 8 boxy-methyloxime) Chlorpropamide 4 Colaspase 4 Chlorprothixene 4 Colchicine 4 Chlorpyriphos (organo-phos) 6 Colestipol 3 Chlorpyrifos-methyl 6 Colistin 4 Chlortetracycline 4 and 6 Concentrate of poppy straw .. 8 Chlorthalidone 4 Coniine Chlorthiamide 6 Copper aceta-arsenite (see Arsenic) .. 6A Chlorzoxazone 4 Copper •ulphate 5 Cholestyrarnine Cortisone, etc. 4 Choline esters (see Acetylcholine) 4 Cotarnine Chromates and dichromates (see Pot- 6 assium chromate) Coumaphos (organo-phos) 6 and 7 Chromium trioxide 6 Coumarin derivatives, etc. 4 and 6 Cimetidine 4 Coumatetralyl .. 6 Cinchocaine 4 4-CPA .. 5 Cinnamedrine 2 Creosote and Cresol (see Phenol) 2 and 6 Cinnarizine 2, 3 and 4 Croton oil Cisplatin 4 Crotoxyphos (organo-phos) 6 Clemastine 2,3and4 Crufomate (organo-phos) 6 Clernizole 2,3and4 Cuprimyxin 5 Clidinium 4 Curare, etc. 4 Clindamycin 4 Curing agents for epoxy resins (see 5 Epoxy) Clobetasone-17-butyrate 4 Cyanatryn 5 Clofenamide 4 Cyanazine 6 Clofibrate 4 Cyanides (see Hydrocyanic acid) I, 2 and 7 Clomiphene, etc. 4 Cyanuric acid 5 Clomocycline 4 Cyclandelate 4 Clonazepam 4 Cycliramine 2,3and4 Clonidine 4 Cyclizine 4 Clonitazine Cyclofenil (see Clomiphene) .. 4 Clopamide 4 Cyclohexanone peroxide 5 Clorazepate 4 3-cyclohexyl-6-(dimethylarnino)-1-met- 5 I hyl-1,3,5-triazine, 2,4(1H, 3H)- Clorexolone 4 dione 198 Alphabetical Substance Index

Substance Schedule Substance l_s_c_h_e_d_ui_e_

Cyclopentolate 4 4,4-diaminodiphenylsulphone deri-1 4 vatives (see Dapsone) Cyclopropane 4 Diamorphine (see Diacetylmorphine) 8 Cycloserine 4 Diampromide .. 8 Cyclosulfyne 6 Diazepam 4 Cycrimine 4 Diazinon (organo-phos) 6 Cyhexatin 6 Dibenzepin 4 Cypermethrin 5 and 6 Dibromochloropropane 6 Cyproheptadine 2, 3 and 4 Dicamba Cythioate 6 Dichlone Cytotoxic substances (see Fluorour 4 acil, Mercaptopurine, Mustine, Dichlofenthion (organo-phos) 6 Thiotepa) Dichloralphenazone •. 4 Dichloran (see Dicloran) 5 2,4-D 5 o-dichlorobenzene (under " 0 " in 6 Schedule) Dacarbazine 4 p-dichlorobenzene (under " P ") 5 Danazol 4 Dichloroethyl ether 6 Dapsone, etc. 4 Dichloroisocyanurates 5 Dazomet 6 Dichloronitroaniline (see Dicloran) . . 5 2,4-DB 5 1-2-(2,4-Dichlorophenyl)-4-ethyl- 6 DDT (see Dicophane) 2, 5 and 6 1,3-dioxolan- 2-yl-methyl-:h- 1,2,4-triazole Deanol .. 4 0-(2,4-Dichlorophenyl)-0-ethyi-S 6 Demecarium bromide 4 prophylphosphoro-dithioate Demeclocycline 4 1- [2(2,4-Dicblorophenyl)-2-(2- propenyloxy) ethyl]-lh-imidazole Demeton (organo-phos) 7 Demeton-0-methyl (organo-phos) 6 and 7 3-6-Dichloropicolinic acid 5 Demeton-S-methyl (organo-phos) 6 and 7 Dichloropropane 6 Deptropine 2,3and4 Dichloropropene 6 2,4-DES 5 Dichlorophenamide 4 Desipramine 4 Dichlorvos 5, 6 and 7

Desmopressin (D.D.A.V.P.) .. 4 Dichromates (see Chromates) 6 Desomorphine 8 Diclofenac 4 Dexamphetamine 8 Diclofop-methyl 6 Dexbrompheniramine 2,3and4 Dicloran 5 Dexchlorpheniramine 2,3and4 Dicofol 5 Dextromethorphan 2 and 4 Dicophane (DDT) 2, 5 and 6 Dextromoramide 8 Dicrotophos (organo-phos) 7 Dextropropoxyphene 4 Dicyclomine 2 and 4 Dextrophan 2 and4 Dieldrin (see Dimethanonaphthalene) 6 Diacetylmorphine (see Heroin) 8 Diethazine 4 Di-allate 6 2-(diethoxypbosphinylimino)-1,3- 7 dithiolane (see Phosfolan) N,N-Diallyldichloro-acetamide 5 Diethylcarbamazine for human thera- 4 Diamines (see Amines) 2 and 6 peutic use Alphabetical Substance Index 199

------~------1

Substance '1 ------Schedule Substance Schedule 0,0-Diethyl-0-(2,4,5-dichloro (meth-1 7 2(-2' ,4' -Dimethyl-phenylimino)-3- 6 ylthio) phenyl) tbionophosphate methyl-4-thiazoline Diethylene dioxide . . . . . ·I 6 1, 1-Dimethylpiperidinium ion 5 N, N-Diethyl-p-phenylene diamine .. ! 6 Dimethyl sulphoxide 4 and 6 Diethylpropion i 4 Dimethylthiambutene 8 i Diethyltbiambutene I 8 N, N-Dimethyltryptamine 4 N, N-Diethyltryptamine (DET) 4 Dimetilan 6 and 7 I Difenoxin 4 and 8 Dimetridazole . . 6 Difenzoquat ::I 6 Dinitramine 5 Diflunisal 4 Dinitrocresols, dinitrophenols, etc. 4, 6 and 7 (see Dinoseb, DNOC) Digitalis, etc. 4 Dinitronaphthols, therapeutic 4 Dihydrallazine 4 I Dinitrothymols, therapeutic 4 Dihydrocodcine 2, 4 and 8 Dinocap 6 Dihydrocodeinone (see Hydrocodone) 8 Dinoseb (see Dinitrophenols) 6 and 7 Dihydrocodeinone-6-carboxymethyl- 8 oxime (see Codoxime) Dioxacarb 6 Dihydrodesoxymorphine (see Deso Dioxaphetyl butyrate 8 morphint!) Dioxathion (organo-phos) 7 Dihydromorphine 8 Diperodon 4 Dihydromorphinone (see Hydromor- 8 phone) Diphacinone 6 Dihydrostreptomycin 4 Diphemanil methylsulphate 2 and 4 Diisopropylamine dichloroacetate 4 Diphenamid 5 Dirnefox (organo-phos) 7 Diphenhydramine 2, 3 and 4 Dimenhydrinate 2, 3 and 4 Diphenidol 4 Dimenoxadol . . 8 Diphenoxylate 4 and 8

Dimepheptanol Diphenylmethane derivatives (see 4 Benactyzine) Dimethanonaphthalene, etc. (see 6 Dieldrin, Aldrin) Diphenylpyraline 2, 3 and 4 Dimethindene 2, 3 and 4 Dipipanone 8 Dimethirimol 5 Dipivefrim 4 Dimethisoquin (see Anaesthetics, 2 and 4 Dipyridamole 4 local) Diquat 6 Dimethoate (organo-phos) 6 Disodiurn methyl arsonate (DSMA) 5, 6 and 6A Dirnethothiazine 2, 3 and 4 Disophenol .. 4 Dimethoxanate 4 I Disopyramide 4 l ,3-di(rnethoxycarbonyl)-l-propen-2- 6 and 7 yl-dimethyl phosphate (organo Distillate (see Hydrocarbons, liquid) 5 phos) 2,5-dirnethoxy-4-methylamphet 4 Disulfiram 4 and 6 amine (see DOM and STP) Disulphoton (organo-phos) 6 and 7 Dimethylamino-benzene-diazo 6 and 7 sodium sulphonate (see Fen Dithianon 6 amino sulph) I Dithiazanine 4 and 6 Dimethyl-formamide .. 5 and 6 Dithiocarbamates, agricultural, etc. 5 and 6 3-( l ,2-Dimethylheptyl)-l-hydroxy-7, 8 (see Mancozeb, Maneb, Metiram, 8,9, l O-tetrahydro-6,6,9-trime ) Mezineb, Zineb, Ziram) thyl-6H-dibenzo (b, d) pyran (DMPH) I1 Dithranol 200 Alphabetical Substance Index

Substance Schedule Substance Schedule

3,3' Di(trifiuoromethyl)-4, 4'- 6 Ethchlorvynol . . 4 dichloro-n n' -diphenylurea Ethephon ( =(2-chloroethyl) phos- Diuredosan 6 phonic acid) DNOC (dinitro-o-cresol) 6 and 7 Ether 2, 4, 5 and 6 Dobutamine 4 Ethinamate 4 Dodine 5 Ethiofencarb 6 DOM (see 2,5-dimethoxy-4- 4 Ethion (organo-phos) 7 methylamphetamine) Ethoate-methyl (organo-phos) 6 Dopamine 4 Ethofumesate 5 Dothiepin 4 Ethoglucid 4 Doxapan 4 Ethoheptazine . . 2 and 4 Doxepin 4 Ethopropazine 4 Doxorubicin 4 Ethoprophos (organo-phos) .. 6 and 7 Doxycycline 4 Ethoxy ethyl mercury chloride 7 Doxylamine 2, 3 and 4 Ethoxyquin Droperidol 4 5-ethoxy-3-trichloromethyl-1,2,4- 6 Drostanolone 4 thiadiazole Drotebanol 8 Ethoxzolamide 4 DSMA (Disodium methyl arsonate) 5, 6 and 6A Ethyl Bromide 6 Dulcin . . 7 Ethyl chloride .. 4 Ethylene 4 Ecgonine, etc. 8 Ethylene chlorohydrin 6 Econazole 6 Ethylene dibromide 6A EDB (see Ethylene dibromide) 6A Ethyleneglycol 5 and 6 Embramine 2, 3 and 4 Ethyl mercury chloride 7 Emetine 4 Ethylmethylthiambutene Endosulfan 6 Ethyl 4-(methylthio)-m-tolyl- 6 and 7 isopropylphosphoramidate (see Endothal ( =7-oxabicyclo-(2,2,1)-hep- 6 Fenamiphos) tane-2,3-dicarboxylic acid) Ethylmorphine. . 2, 4 and 8 Endrin (see Dimethanonaphthalene) 6 Ethyloestrenol 4 Enfiurane 4 N-Ethyl-1-phencyclohexylamine Ephedrine 2 and 3 (PCE) Epichlorohydrin 6 N-(1-<0tbylpropyl)-3, 4-dimethylC2, 6- dinitroaniline Epicillin 4 Etidocaine 4 Epoxy resins, liquid, etc. 5 Etonitazine 8 EPTC Etorphine Ergot 4 Etoxeridinc Erythrityl tetranitrate, etc. 2 Eucalyptus Oil Erythromycin 4 and 6 Etafedrine 2 Ethacrynie acid 4 Famphur (organo-phos) 6 and 7 Ethambutol 4 Fenaminosulph 6 and 7 Ethamivan 4 Fenamiphos (organo-phos) 6 and 7 Alphabetical Substance Index 201

Substance Schedule Substance Schedule

Fenazaflor 6 Fospirate (organo-'Phos) 5 and6 Fenbutin-oxide (organo-tin) .. 5 Framycetin 4 Fencamfamin .. 4 Frusemide 4 Fenchlorphos (organo-phos) 6 Fumagillin 6 Fenfiuramine .. 4 Furalaxyl 6 Fenitrothion (organo-phos) 6 Furethidine 8 Fenoprofen 4 Fusidic Acid 4 Fenoprop 5 Fenoterol 3 and 4 Galanthamine .. 4 Fenpipramide 4 GaT! amine 4 Fenpiprane 4 Ge1semium 2 Fenson .. 5 ' Gentamycin 4 Fensulphothion (organo-phos) 7 Glacial acetic acid (see Acetic) 2 and 6 Fentanyl 8 Glibornuride 4 Fenthion (organo-phos) 5 and 6 Gliclazide 4 Fenthion-ethyl (organo-phos) 7 Glucagon 4 Fenticlor 7 Glutethimide 4 Fenvalerate 6 Glyceryl trinitrate 2 and4 Ferbam 6 Glycopyrronium 4 Ferrous sulphate 2,4and6 Glycosides-- Flamprop-methyl 5 Of Digitalis (see Digitalis) •• 4 Of Strophanthus (see Strophan- 4 Flavophospholipol 4 and 6 thus) Cardiac, other (see Cardiac) 4 Flavoxate 3 Glymidine 4 Flucloxacillin 4 Glyphosate 5 Flufenamic acid 4 Gramicidin 4 Flunitrazepam 4 Griseofulvin 4 Fluorides 2, 4, 6 and 7 Guaiphenesin (see Mephenesin) 2 and4 Fluoroacetamide 7 Guanacline 4 Fluoroacetic acid 7 Guanethidine 4 5-fluorocystosine 4 Guazatine 6 Fluorouracil, etc. 4

Fluoxymesterone 4 Halcinonide 4 Flurazepam 4 Halofuginone 7 Fluroxene 4 Haloperidol, etc. 4 Fluspirilene 4 Halopryamine .. 2, 3 and 4 Folic acid 3 Halothane 4 Folinic acid 3 Heparin 4 Formaldehyde 6 Heptachlor 6 Formetanate 7 Heptane derivatives, addictive 8 Formic acid 5 Heroin (see Diacetylmorphine) 8 Formothion (organo-phos) ti Hetacillin 4 202 Alphabetical Substance Index

Substance Schedule . Substance Sshedule . Imido~·-a_r_b______----6-~ Hexachlorobenzene 6 I Hexachlorophane 2, 4 and 6 Indian hemp (see Cannabis) . . ~ 8 Hexamethonium 4 Indomethacm ...... I 4

Hexocyclium .. 4 I Inositol nicotinate (see Mesoinositol) jl 4 1 3-Hexyl-1-hydroxy-7,8,9,10-tetrahy Insulin, etc. dro6,6,9-trimethyl-6H-dibenzo (b,d) pyran (parahexyl) Iodine .. 2 and 6 Histapyrrodine 2, 3 and 4 Iodofenphos (organo-phos) Homatropine .. 1 and 2 Iodophors (see Iodine) 6 Human clorionic gonadotrophin ;~I 2 Ion exchange resins, internal human 4 pregnancy test kits I use Hydantoin derivatives (see Phenytoin) 4 Ioxynil 6 Hydrallazine 4 Ipecacuanha and opium powder (see opium) Hydrazine 6 lpratropium bromide 4 Hydrocarbons, liquid 5, 6 and 7 Iproniazid (see Monoamine) 4 Hydrochloric acid 5 and 6 I Iron preparations (see Ferrous sui- 2, 4 and 6 Hydrocodone .. 8 ' phate) Hydrocyanic acid and cyanides 1,2and7 Isoaminile 4 Hydrofluoric acid 2, 4, 5, 6 2-Iso-butylamino-4-ethylamino-6- and 7 methoxy-1, 3, 5,-triazine Hydrogen peroxide 5 Isocarbophos (organo-phos) 7

Hydromorphinol 8 Isocarboxazid (see Monoamine) 4 Hydromorphone Isocyanates, free organic 6 Hydroquinone, human therapeutic .. 4 Isoetharine 4 Hydrosilicoftuoric acid 2, 4, 6 and 7 Isomethadone Hydroxychloroquine 4 Isometheptene 4

Hydroxypethidine 8 Isoniazid (see A ntitubcrcular) 4 1-hydroxy-pyrido (3,2,a)-5- 4 Isoprenaline 3 and 4 phenoxazone-3-carboxylic acid Isopropamide 2 and 4 8-hydroxyquinolinc (see Chiniofon, 2 and 4 etc.) Isopropyl-N-(3-N-ethyl-N-phenylcarbamoyloxy) phenylcarbamate Hydroxyurea 4 lsosorbidedinitrate 2 Hydroxyzine 4 Isoxuprine 4 Hygromycin 4 and 6 Hyoscine 1 and 2 Hyoscine butylbromide 4 Kanamycin 4 Hyoscyamine, hyoscyamus (see also 1 and 2 Belladonna and Stramonium) Kerosene Hypothalmic releasing factors 4 Ketamine 4 Ketobemidone 8 Ketones (see Acetone, Methylethyl, 5 Methyl iso-amyl, Methyl-iso Ibufenac 4 butyl) Ibuprofen 4 Ketoprofen 4 ldoxuridine 3 and 4 Khellin .. 4 Imipramine 4 Kitasamycin 4 and 6 Alphabetical Substance Index 203

Substance Schedule Substance Schedule

Labetalol 4 Meclofenamic acid, veterinary 6 Lasalocid 6 Meclofenoxate 4 Laudexium methylsulphate 4 Meclogualone 8 Laurylisoquinolinium bromide 6 Meclozine 4 Lead arsenate .. 6A Mecoprop Lead salts and compounds 2 and 6 Medazepam 4 Lefetamine 4 Mefenamic acid 3 and 4 Leptazol 4 Mefruside 4 Leptophos (organo-phos) 7 Menazon (organo-phos) 6

Levallorphan (see Morphine antago- 4 Mepacrine (see Antimalarial) 4 nists) Mepenzolate .. 4 Levamisole (see Tetramisole) 4, 5 and 6 Mephenesin, etc. (see Guaiphenesin) 2 and 4 Levodopa 4 Mephentermine 4 Levomethorphan 8 Mepivacaine 4 Levomoramide 8 I Meprobamate 4 Levophenacylmorphan Mepyramine 2, 3 and 4 Levophanol 8 I Mercaptopurine, etc. 4 Lidoflazine 4 I·I Mercuric ammonium chloride 2 Lignocaine (see Anaesthetics, local) 2 and 4 Mercuric chloride . . . . I, 2 and 7 Lincomycin 4 I Mercuric iodide I, 2and 6 Lindane 2, 5 and 6 Mercuric nitrate I and 2 Lithium salts, therapeutic 4 I 1 Mercuric oxides .. 2 Lobelia, except for smoking, etc. I and 2 1 Mercuric potassium iodide I and 2 Lorazepam 4 Mercuric thiocyanate I and 6 Lysergic acid 4 Mercurous chloride .. 4 and 6 Lysergic acid diethylamide (Lysergide) 4 Mercury, metaJJic, except in scientific 2 Lysergide-see above 4 instruments Mercury, organic compounds I, 2, 4, 6A and 7 Mescaline, etc. 4 Maldison 2, 4, 5 and 6 Metacresolsulphonic acid and 6 Mancozeb 5 formaldehyde condensation product Maneb .. 5 Metaldehyde .. 5 and 6 Maphenide 4 Metallic fluorides (see Fluorides) 2, 4, 6 and 7 Mazidox (organo-phos) 7 Metallic oxalates (see Oxalic) 6 Mazindol 4 Metallic phosphides (see Phosp- 6A MCPA 5 hides) MCPB .. 5 Metaraminol 4 Mebendazole 2 and 6 Metazocine 8 Mebeverine 4 Metformin 4 Mebhydrolin 2, 3 and 4 Methabenzthiazuron 5

Mecamylamine 4 , Methacycline .. 4 1 Mecarbam 7 II Methadienone .. 4 204 Alphabetical Substance Index

Substance Schedule Substance Schedule

Methadon (see· Dimepheptanol) 8 Methyld'ihydromorphinone (see 8 Metopon) Methadone 8 Methyldopa 4 Methadone-Intermediate 8 Methylene bisthiocyanate 6 Metham-sodinm 6 Methylene chloride 5 Methamidophos (organo-phos) 7 N-Methylephedrine 2 Methandriol 4 Methyl ester of phenylcinchoninic 4 Methantheline 4 acid (see Methyl cincophen) Methapyrilene 4 Methyl ethyl ketone . , 5 Methaqualone 8 Methyl ethyl ketone peroxide 5 Methazolamide 4 Methyl N-(furo-2-yl)-N-(2,6 xylyl) 5 alaninate Methazofe 5 Methyl iso-amyl ketone 5 Methdilazine 2,3and4 Methyl isobutyl ketone 5 Methenolone 4 Methyl isothiocyanate 6 Methicillin 4 Methyl N-(methoxyacetyl)-N-(2, 6- 5 Methidathion (organo-phos) 7 xylyl) alaninate Methimazole 4 Methyl parathion (see Parathion 7 methyl) Methiocarb 5 and 6 Methylpentynol, etc., internal use 4 Methi::ene 4 Methylphenidate 8 Methocarbamol 4 1-methyl-4 phenylpiperidine-4-carbo 8 Methomyl 6 and 7 xylic acid esters Methotrexate 4 3-(Methylsulfonyl)butanon-0- 5 and 6 methylcarbamoyloxin Methoxamine 2 Methyprylone 4 Methoxsalen 4 Methysergide 4 0-2-Metho xycarbonyprop-1-enyl-O, 6 0-dimethylphosphorothioate 1-(B Methyl sulphonamide ethyl)-2- 6 amino-3-N, N-diethylamino Methoxychlor •. benzene Methoxyflurane 4 Metiram (see Dithiocarbamates) 5 Methoxyphenamine 2 Metoclopramide 4 Methoxyphenylethylamine deri- 4 Metolachlor 5 vatives (see Mescaline) Metolazone 4 Methyl alcohol 6 Metopon 8 Methylamphetamine 8 Metoprolol 4 Methylandrostanolone 4 Metoxanine 6 Methylated spirit 5 Metribuzin 5 Methyl bromide 7 Metronidazole 4 N-methyl carbamates as pesticides 5, 6 and 7 (see Aldicarb Aminocarb Car- Metyrapone 4 baryl Methiocarb) Mevinphos (organo-phos) 7 Methyl chloride 6 Mexiletine Hydrochloride 4 Methyl cincophen 4 Mezineb 5 Methyl demetons (see Demeton) 7 (organo-phos) Mezlocillin 4 Methyldesorphine Mibolerone 4 Methyldihydromorphine 8 Miconazole 4 Alphabetical Substance Index 205

Substance Schedule Substance Schedule

Mineral turpentine 5 Neostigmine 4 Minocycline 4 Nialamide (see Monoamine) 4 Minoxidil 4 Niclosamide for human therapeutic 2 use Mipafox (organo-phos) 7 Nicocodine 2, 4 and 8 Mirex .. 7 Nicodicodine 2,4and8 Mithramycin 4 Nicomorphine 8 Mitobronitol 4 Nicotine (except .tobacco) ·4, 6 and 7 Mitomycin 4 Nicotinic Acid 4 Molinate 6 Nicotinyl alcohol, internal use 4 Monensin 4 Nifenazone 4 Monoamine oxidase inhibitors 4 Nikethamide ...,.-;-- 4 Monobenzone, human therapeutic 4 Nimidane 6 and 7 Monocrotophos (organo-phos) 7 Niridazole 4 Moperone 4 Nithiamide 6 Moramide-lntermediate 8 Nitrazepam 4 Morpheridine 8 Nitric acid 5 and 6 Morphine 8 Nitric esters of polyhydric alcohols 3 Morphine antagonists 4 (see Erythrityl)

Morphine derivatives 8 Nitrilotriacetic acid in detergents and 7 washing preparations Morphine methobromide 8 Nitrobenzene 6 Morphine-N-oxide 8 Nitrofen 7 Morphine substitutes .. 8 Nitrofuran, etc. 4 and 6 Motion sickness packs (see Antihis 3 tamines) Nitrofurazone .. 3 Mustine, etc. . . 4 Nitrophenols .. 6 but see Dinitrophenols Myrophine (myristylbenzylmorphine)

Nitroscanate .. 6 Nitrous oxide .. 4 Nabam (dithiocarbamate) 6 Nitroxynil 6 Naled (organo-phos) 5 and 6 Noracymethadol 8 Nalidixic acid 4 Noradrenaline 4 Nalorphine (see Morphine antago 4 Norbormide 5 nists) Norcodeine 2, 4 and 8 Naloxone (see Morphine antago- 4 nists) Norethandrolone 4 Nandrolone 4 Norlevorphanol 8 Naphazoline 2 Normethadone 8 Naphtalene 5 Normorphine 8 Naphthalene acetic acid 5 Norpipanone 8 Naphthalophos (organo-phos) 6and 7 Nortriptyline 4 Naproxen 4 Noscapine 2 Natamycin 4 Novobiocin 4 and 6 Neomycin 4and6 Nux vomica 206 Alphabetical Substance Index

Substance Schedule Substance Schedule

Octamylamine· 4 Oxymetazoline 2 Octatropine 4 Oxymetholone 4 2-n-Octyl-4-isothiazoUn-3-one .6 Oxymorphone Octyl nitrite 2 Oxyphenbutazone 4 Oestradiol-17-beta 4 and 6 Oxyphencyclimine 4 Oil of turpentine 5 Oxyphenisatin, human therapeutic 4 Olaquindox (Bayo-n-ox) 6 Oxyphenonium 4 Oleandomycin 4 and 6 Oxytetracycline 4 and 6 Omethoate (organo-phos) 6 and 7 Oxythioquinox 5 Opium 8 Orciprenaline 3 and 4 Pamaquine (see Antimalarial) 4

Organo-phosphorus compounds 2, 4, 5, 6 1 Pancuronium 4 and 7 Organo-tin compounds 5 and 6 Papaverine 2 Ornidazole 4 Para-aminosalicylic acid (see 4 Antitubercular) Ornipressin 4 Paracetamol 2 and 4 Orphenadrine 4 Parachlorometacresol (see 5 01thocaine (see Anaesthetics, local) 4 Chlorocresol) Ortho-dichlorobenzene 6 Para-dichlorobenzene 5 Ortho. phenylphenol .. 5 Parahexyl (see 3-Hexyl-1-hy~roxy-7, 8 8,9, I 0-tetrahydro-6,6,9-tn-methyl Orthopterin (see Anti folic) 4 -6H-dibenzo (b, d) pyran Ovulation stimulators (see Clomi 4 Paraldehyde 4 phene) Paraquat 6 and 7 7 -o xabicyclo-(2,2, I )-heptane-2, 3- 6 dicarboxylic acid (see Endothal) Parathion (organo-phos) 7 Oxacillin 4 Parathion-methyl (organo-phos) 7 Oxalates, soluble/metallic (see 6 Parbendazole 6 Oxalic) Paromomycin 4 Oxalic acid 6 Pebulate Oxamyl 7 Pemoline 4 0 xandrolone 4 Pempidine 4 Oxantel pamoate for animal treat 6 ment D-Penicillamine 4 Oxazepam 4 Penicillin (see Benzyl penicillin) 4 and 6 Oxazolidinone derivatives (see 4 Pentachloronitrobenzene (see 5 Troxidone) Quintozene) Oxethazaine 2 Pentachlorophenol 6 and 6A Oxfendazole 6 ·Pentamethonium 4 Oxolamine 2 Penta~ocine 8 Oxprepolol 4 Penthienate 4

0 xyb~procaine 4 Pentolinium 4 Oxycarboxin 5 Perfluidone 6 Oxyclozanide 6 Perhexilene 4 Oxycodone 8 Permanganates 6 Oxymesterone .. 4 Peroxide of hydrogen (see Hydrogen) 5 Alpllabeticar Substance Index 207

Substance Schedule Substance Schedule

Pethidine 8 Phenylephrine •• .. 2 Pethidine-Intermediates, A, B, C 8 Phenylindanedione derivatives (see 4and6 Coumarin)· Petrol 5· Phenylmercuric dimethyldithiocarba~ 6A Phedrazine 2 mate, agricultural, etc., use Phenacemide, etc., therapeutic 4 Phenylpropanolamine .• 4 Phenacetin 4 Phenyltoloxamine 2,3and4 Pheriadoxone 8 Phenytoin, etc., therapeutic 4 Pheriamazoline 2 Pholcodine 2, 4 and 8 Phenampromide 8 Phorate (organo-phos) 7 Phenazocine 8 Phosalone (organo-phos) 6 Phenazone 2and4 Phosfolan (organo-phos) 7 Phenazopyridine 4 Phosphamidon (organo-phos) 7 Phencyclidine •. 8 Phosmet (organo-phos) 6 Phenelzine (see· Monoamine)'. 4 Phosphides, metallic 6A Phenethicillin (see Phenoxyethylpeni- 4 and 6 cillin) Phosphoric acid s Phenformin 4 Phosphorus, yellow 1 and 6 Phenglutarimide 4 Phoxim (organo-phos) 6 Phenindamine .. 2,3and4 Physostigmine .. 4

Pheniprazine (see Monoamine) 4 Picric acid 6 Pheniramine 2, 3 and4 Picrotoxin 4 Phenkapton (organo-phos) 6and 7 Pilocarpine 4 Phenmetrazine 8 Piminodine 8 Phenol, etc. 2 and 6 Pimozide 4 Phenomorphan 8 Pindolol 4 Phenoperidine •. 8 Pindone 6 Phenothiazine derivatives (see Chlor 4 Pipenzolate 4 promazine) Piperidine derivatives; addictive 8 Phenoxybenzamine (see Alpha- 4 receptor) Piperidolate 4 Phenoxyethylpenicillin (see 4 and 6 Piperophos (organo-phos) 6 Phenethicillin) Pipobronian 4 Phenoxymethylpenicillin 4 and 6 Pipradrol 4 Phensuximide, etc., therapeutic 4 Pirimicarb 5 and 6 Phentermine 4 Pirimiphos-ethyl (organo-phos) 6 Phenthimentonium 4 Pirimiphos-methyl (organo-phos) 6 Phentolamine (see Alpha-receptor) 4 Piritramide 8 Phenyapin 4 Pituitary, extracts, principals, etc. 4 and 7 Phenylbutazone 4 Pizotifen 4 Phenylcinchoninic acid methyl ester 4 (see Methyl cincophen) Polychlorinated biphenyls 7 1-(1-Phenylcyclohexyl) pyrrolidine 8 Poly (hexamethylene biguanide) 5 (PHP or PCPY) hydrochloride Phenylene diamine (see Amines and 2 and 6 Polyhydric alcohol nitric esters (see 2 diamines) Erythrityl) · 208 Alphabetical Substance Index

Substance Schedule Substance Schedule

Polymethylene bistrimethyl ammo 4 Propranolol (see Beta-receptor) 4 nium compounds Propylhexedrine 2 and4 Polymyxin 4 Propylphenazone 2 Poppy straw concentrate (see 8 Concentrate) Proquazone 4 Potassium bromate 6 Prostaglandins 4 Potassium chlorate 2 Prothionamide 4 Potassium chromate (see Chromates) 6 Proxymetacaine 4 Potassi urn cyanate 6 Prynachlor 5 Potassium hydroxide 5 and 6 Pseudoephedrine 2 Potassium perchlorate, therapeutic 4 Psilocin 4 Prazepam 4 Psilocybin 4 Pregnenolone acetate, internal use 4 Pyrantel, human therapeutic 2 Prenylamine 4 Pyrazophos (organo-phos) 6 Prilocaine 4 Pyrethrins, etc. 5 Primaquine (see Antimalarial) 4 Pyridostigmine 4 Primidone 4 N-3-pyridylmethyl-N1-p-nitrophen- 5 and 6 ylurea Probenecid 4 Pyrimethamine (see Antimalarial) 4 Procainamide 4 Pyrrobutamine 2, 3 and 4 Procaine 4 Procaine penicillin (see Benzyl peni 4 and 6 cillin) Quaternary ammonium compounds 4 and 5 (see Curare) Procarbazine .. 4 Quinethazone 4 Prochlorperzine 4 Quinidine 4 Procyclidine 2 and 4 Quinine Profenofos 6 Quinomethionate (see Oxythio- 5 Progesterone 4 and 6 quinox) Proguanil (see Antimalarial) 4 Quintozene Proheptazine 8

1 Prolintane 4 Racemethorphan 8 Promacyl 6 Racemoramide 8 Promecarb 6 and 7 Racemorphan 8 Promethazine 2, 3 and 4 Rafoxanide 6 Prometryne Rauwolfia 4 Propacblor 6 Rifampicin 4 Prop ani did 4 Ritordrine 4 Propani! 5 Roliteracycline 4 Propantheline 2 and 4 Properidine 8 Salbutamol 3 and4 Prophos (see Ethoprophos) 6 and 7 Salicylamide 2and 4 Propionic acid, non therapeutic 5 and 6 Salicyanilide 5 Propiram 8 Santonin Propoxur 2, 5 and 6 Savin oil Alphabetical Substance Index 209

Substance Schedule Substance Schedule

Schradan (organo-phos) 7 Sulphamic acid 5 Selenium, compounds of 4, 5 and 6 Sulphanilamide, etc. 4 and6 Sera, human parenteral (see 4 Sulphinpyrazone 4 Vaccines) Sulphomyxin 4 Sex hormones 4 and 6 Suiphonal 4 Silicofluorides (see Hydrofluoric)- 2, 4, 6 and 7 Sulphonamides (see Sulphanilamide) 4 and 6 Silver nitrate . . 2 Sulphotep (organo-phos) 7 Sodium acid sulphate (or bisulphate) 5 Sulphuric acid 6 Sodium bromate 6 Sulprophos 6 Sodium carbonate (see Alkaline salts) 5 Sulthiame 4 Sodium chlorate 5 Suprarenal cortical hormones (see 4 Sodium Cromoglycate 3 and 4 Cortisone) Sodium dichloroisocyanurate (see 5 Suxamethonium 4 dichloroisocyanurates) Sodium Fluoride 2, 4, 6 and 7 Sodium hydrogen sulphate 5 Sodium hydroxide 5 and 6 2,4,5-T 6 Sodium metasilicate (see Alkaline salts) 5 Tacrine 4 Sodium nitrite 2 and 5 Tamoxifen 4 Sodium Nitroprusside 4 Tansy oil Sodium ortbosilicate, (see Alkaline 5 salts) 2,3,6-TBA 5 Sodium silicofluoride (see Hydro- 2, 4, 6 and 7 fluoric) TCA (excluding its salts) 6 Sodium trichloroisocyanurate 5 and 7 TCMTB 6 Sodium Valproate 4 TDE 5 and 6 Sontoquine (see Antimalarial) 4 Temazepam 4 Sorbide nitrate 2 Temphos (organo-phos) 6 Sparteine 4 Tepp (organo-phos) 7 Spectinomycin 4 Terbufos 7 Spiramycin 4 Terbutaline 3 and 4 Spironolactone 4 Terbuthylazine 5 Stanolone 4 Terbutryne 5 Stanozolol 4 Teropterin (see Antifolic) 4 Staphi&agria 2 Terpenes, chlorinated 6 STP (see 2,5-dimethoxy-4-methyl- 4 2-tert butylamino-4-ethylamino-6- 5 amphetamine) methoxy-1,3,5-triazine Stramonium except for smoking, etc. 1 and 2 Testosterone propionate, dipropionate 4 and 6 and enanthate Streptomycin 4 and 6 Tetrachloroethane 7 Strophanthus 4 Tetrachloroethylene 6 Strychnine 4and 7 Tetrachlorosalicylanilide 7 Styrene .. 5 Tetrachlorvinphos (organo-phos) 5 Succinamide derivatives (see Phen 4 suximide) Tetracycline 4 and 6 Sulfallate 6 Tetradifon 6 '110 Alphabetical Substance fnd'ex

Substance Schedule Substance Schedule

Tetrahydrocannabinols 8 Toxoids, human parentehil '(see 4 Vaccines) Tetrahydrozoline 2 Tramazoline 2 Tetramisole, veterinary Sand 6 Tranexamic acid 4 Thalidomide 4 Tretamine 4 Thallium 6. and 7 'tretinoin· '3' Tliebacon 8 Triadimefon 6 Thebaine 8 Triadimenol S' Thenalidine 2, 3 and4 Triallate s Thenyldiamine 2,3and4 Triamiphos '7 Theophylline 3 and 4 Triamterene 4 Thiacetazone (see Antitubercular) 4 Tri3ziqllone 4' Thiambutosine 4 Triazolam 4 Thiazafluron .. 6 s,s,s-tributylphosphorothiolate (org- 6 Thiazosulfone 4 . an

___s_u_bs_t_a_n_ce ______l_s_c_h_e_d_u_le_ Substance Schedule

Troxidone, etc., therapeutic 1 4 Warfarin 4 and6 Tubocurarine, d-tubocurarine and I 4 White spirit 5 d-tubocurarine dimethyl ether (see Curare) Turpentine (see Mineral and Oil) 5 Tylosin .. 4 and 6 Tymazoline 2 Xanthine oxidase inhibitors 4 Xantinol nicotinate 4 Uracil derivatives (see Fluorouracil) 4 Xylazine 4 Urethane, therapeutic 4 Xylene (see Toluene) 6 Urethanes and Ureides, soporific, 4 Xylenol (homologue of Phenol) 2 and 6 etc. I Xylometazoline .. 2

Vaccines- Human parenteral . . 4 Veterinary live virus 4 and 6 I Valnoctamide . . 4 Yellow phosphorus (see Phosphorus) 1 and 6 Vamidothion (organo-phos) . . 6 I Yohimba 4 Veratrum I and 4 Vernolate 5 Vinca alkaloids 4 I Zeranol (see Anabolic steroidal 4 and 6 Vinylchloride Monomer 7 I agents) Vinyl ether 4 11 Zinc chloride .. 6 Viprynium 4 ' Zinc phenolsulphonate 6 Virginiamycin 4 and 6 I Zinc pyridinethione 2 and 5 Visnadine 4 I Zinc sulphate 6 Vitamin A, human use 4 I Zineb .. 5 Vitamin D, human use 4 I.I Ziram .. 5

GENERAL INDEX

TO THE POISONS REGULATIONS OF 1973 GENERAL INDEX

SUBJECT REGULATION, ETC. PAGE

Accounting for dangerous drugs N4 73 Act, the, meaning of term .. AI 8 Active principles of substances specified in Schedules A2.06 9 Addict, drug- authority to prescribe .. M3 71 meaning of term Sect 5 177 approval for treatment M2 .. 71 treatment of M3 .. 71 Adhesives, when poisons, storage of CI.02A 33 Advertisement- meaning of term ...... Sect 5 !77 dangerous or restricted drug, or Schedule 3 poison, of 012.01 (a) .. .. 76 poison, of, by unlicensed person 012.01 (b) and (c) ··J 76 Aerial ambulance- authority re pethidine . . . . D2.11 . . . . 42 written order to obtain pethidine GI.OI, GI.02, GI.03 52, 53 (g) Alkaloids of substances specified in Schedules A2.06 9 Altering prescriptions Nl 72 Ambulance officer, use of restricted drugs by D2.17 43 Analyst, state, authority re drugs .. D2.14 43 Antidote (First Aid Treatment) on labels B7 30 Applications re scheduling substances A3.02, A4, Form X II, 173 Approval by Director-General of poisons container BI.08 23 Approval of Director-General to deal with Diacetylmorphine (Heroin) A5.03 12 Approval of Director-General to prescribe certain drugs A6 12 Approved name- meaning of term AI .. 5 statement of on labels B2.06 25 Approved receptacle for dangerous drug storage KI.OI 69 Arsenical sheep dips, etc. C6 36 Authorised person- meaning of term .. Sect 5 177 accounting for dangerous drugs by N4 73 authorities re drugs .. D2 39 records to be kept by, as directed .. K2 69 self-administration of dangerous drugs by M4 71 Authority re drugs Director-General may grant .. D2.15 .. 1 43 persons under treatment .. Ll 70 suspension and cancellation of D3 43 wholesale Representative's F6, Form P 51, 169

Bachelor of Pharmacy, authorities A7.05, D2.03 15,40 Bacteriologist, authority re biological preparations 02 73 Bacteriostats for therapeutic use A5.02 12 INDEX 215

------S_u_s_rn_CT______, REGULATION, ETC. PAGE

Baits, poison- 1 colouring of cereal 05 74 laying 010 75 Biological preparations 02 73 Bottles, washing. etc. 011.03 76

c Cancellation- authority re drugs D3 43 prescriptions H3.03·,·H5 59, 61 Carrier, authority re drugs in delivery D2.09 42 Cereal baits, colouring of 05 74 Chalks containing poison 07 75 Chemist. (See Pharmaceutical Chemist.) Chlordimeform, restricted sale of C4.01 35 Class, meaning of term AI 5 Colouring of cereal baits 05 74 Compounded preparation, meaning of term AI 5 Concealment- of facts re drugs from practitioner N3 72 of records P4 78 Containers- damaged, to be destroyed CI.04, 011.02 33, 76 defacing, etc. . . 011.01 76 Director-General may approve of BI.08 ?'_, food containers prohibited 09 75 general specifications of B1 .. 21 offences re .. Bll .. 32 Schedule 5 poisons BI.07 22 washing, etc. 011.03 76 Crayons containing poison .. 07 75 Cyanide- meaning of term .. A1 5 authority to purchase, etc. C3, F~·rm Ni. 34, 168 possession or use without authority Sect 131, C3.01 186,34 sale of without authority . . . . C3.05 .. 34 search warrant re suspected possession Sect 131 A .. 186 storage of .. C3.04, C3.06 34 use for unauthorised purpose .. C3.04 (a) 34 wholesale transactions in C3.05 34

Damaged containers to be destroyed CI.04, 011.02 33,76 Dangerous drug- accounting for, by authorized persons N4 .. 73 addiction to ...... M2,M3 71 administration of, in hospital or institution J4 .. 68 advertising of ...... 012 .. 76 authorised persons to account for N4 .. 73 authorities re . . . . D2, L1 39, 70 conditions of dispensing H3 59 delivery of ...... G2 54 disclosure of facts concerning, to practitioner N3 .. .. 72 discrepancy in stocks to be reported .. H6.05 (b), JI.02 (c) .. 63, 66 false representations to obtain N2 72 label. (See J"abel.) lengthy treatment with M1 .. 70 216 INDEX

SUBJECT REGULATION, ETC. PAGE

Dangerous drug-continued licence- to manufacture El, FormT 44, 172 to sell by wholesale E2,FormR 44, 171 packing of, for delivery . . . . 02.03 55 possession, etc., by unauthorised person Sect 130, Dl 178,39 prescription necessary to dispense HI 57 records re- dentist, by ...... II 64 form of, as required by Director-General K2 69 hospital as institution, in J1.02, J3 66 medical practitioner, by .. 11 . • . . 64 pharmaceutical chemist, by. (See Drugs Book) H6, FormD 61, 163 veterinary surgeon, by II 64 wholesaler, by ...... E4 45 reports of transactions in, by wholesaler E5 .. .. 47 sale, etc., by unauthorised person .. Sect 130 (2), Dl 179,39 search warrant re suspected possession Sect 131A !86 samples of- removal by inspector . . . . P2.01 (e), P2.02 77, 78 use by practitioner in profession 12 65 seizure of ...... P2.01 (f), P2.02 78 self-administration of by authorised person M4 71 stock take of by chemist assuming management H6.05 63 storage of- dentist, by .. 13, Kl.Ol 65,69 generally . . . . Kl.Ol, 08 69,75 hospital or institution, in J2, Kl.Ol 66,69 medical practitioner, by .. 13, Kl.Ol 65,69 pharmaceutical chemist, by H8, Kl.Ol 64,69 veterinary surgeon, by 13, Kl.OI •. 65,69 wholesaler by .. E3.04 (e), Kl.OI 45,69 substances prescribed as A2.05, Sch 8 155 substances declared as •. OinC 190 use and disposal of, generally 010 .. 75 written order for wholesale sale of Gl.Ol 52 Declared drug- dispensing to be recorded .. H7 63 self-administration of by authorised person M4 71 substances declared as .. OinC !90 Defacing labels 011 .. 76 Deficiency of dangerous drugs to he reported H6.05 (b), J1.02 (c) .. 63,65 Definitions of terms .. Sect 5, AI 177, 5 Delivery of dangerous and restricted drugs 02 54 Dental therapists, school- use of poisons by .. A7.07 16 use of restricted drugs by D2.16 43 Dentist- meaning oftenn . . . . Sect 5 177 accounting for dangerous drugs by 11.03, N4 65,73 authorised re drugs D2.04 40 authorised re poisons . . . . A7.03 14 records re dangerous drugs to be kept by 11 •• 64 storage of drugs by .. 13,Kl 65,69 use of dangerous drug samples by 12 ...... 65 written order to obtain drugs .. Gl.OI, Gl.02, Gl.03 52, 53 (a) Departments of Government authorised re drugs . . . . D2.07 .. .. 41 written order to obtain drugs .. GI.Ol, Gl.02, Gl.03 52,53 (d) Detailer. (see Wholesale Representative.) Dimethanonaphthalene, restriction on packs C5 35 Director-General, meaning of term Sect 5 177 Discharging poisons, etc. 010 75 Disclosure of facts re drugs to practitioners N3 72 Dispensary, meaning of term AI 6 Dispense, meaning of term .. •. ,AI 6 INDEX 217

SUBJECT REGULATION, ETC. PAGE

Dispensed medicines B8 30 Dispensing- conditions of, re drugs .. H3 59 dangerous drug, recording of .. H6 61 declared drug, recording of H7 63 poisons ...... A7 14 prescription required for HI 57 unauthorised person, by Dl 39

Disposing of drugs and poisons 1010 75 Drug Addict- meaning of term Sect 5 177 treatment of M2,M3 71 Drugs Book- alterations in . . . . H6.04 63 dispenser to initial entries in H6.03 (b) .. 62 pharmaceutical chemist to keep .. H6, Form D 61, 163 stock balances to be brought forward in • . . . H6.02 (d) and (e) 62 stock to be checked with on change of management H6.05 63 Drugs of Dependence, Report on movements of E5 47 Drugs Register, wholesaler to keep E4 45

E Embalming, certain poisons prohibited 01 73 Emergency supply book re restricted drugs Hl.02 (d) 57 Emergency verbal prescriptions H2.02 59 Emetic in paraquat preparation C7 38 Endorsement- of prescription by dispenser HS 61 of written order by seller 03 56 unauthorised, on prescription Nl 72 Exemptions of substances from Schedules A2.02, A2.03, A2.04, 8, 9 A2.07

F Face-depth, meaning of term AI 6 False entries in records N5 73 False name or address, offence to state N2.03 72 False representations re drugs N2 72 Fireworks, arsenic in 013 76 First Aid Treatments on labels B7 30 Fluoroacetamide, Fluoroacetic acid, restricted sale of C4.01 35 Flying Doctor bases and outposts- authority re drugs . . . . D2.10 . . 42 written order to obtain drugs .• G 1.01, G 1.02, G 1.03··I 52, 53 (f) Food containers- use of for poison prohibited 09 75 washing with poison containers 011.03 76 Forging prescriptions Dl,Nl 39,72 Forms Sch 9 161 218 INDEX

SUBJECT REGULATION, ETC. PAGE

Glues. See Adhesives CJ.02A 33 Government Departments authorised re drugs . . . . D2.07 . . . . 41 written order to obtain drugs .. G!.Ol, Gl.02, Gl.03 52,53 (d) Grain baits, colouring of 05 74

H Hallucinogenic drugs subject to approval A6.01 12 Have in possession, meaning of term Sect 5 177 Hawking of Poisons 03 74 Hospital- meaning of term AI 6 administration of dangerous drugs in J4 .. 68 authorised re drugs . . . . D2.08 41 irregularities re drugs to be reported JJ.02 (c) 66 records re dangerous drugs in JI.02, J3 66 storage of drugs at J2, Kl 66, 69 \vrittcn order to obtain drugs Gl.OI, G1.02, G1.03 52, 53 (e)

I Immediate container I meaning of term jAI 6 general requirements of . Bl 21 labelling of : B3 26 Immediate wrapper I meaning of term IAI 6 labelling of B4 29 Inspector- meaning of term AI 6 re arsenical sheep dips, etc. c6.o7, c6.os: c6.o9·. 37, 38 C6.10 38 authorised re drugs D2.14 43 notice, service of, by P3 78 obstruction of .. Sect l31B, P4 187, 78 powers- general .. P2 77 to demand account of dangerous drugs N4 73 to demand account of restricted drugs .. F6.05 (f) 52 to demand production of restricted drugs F6.05 (g) 52 to demand records re restricted drugs . . . . F5 50 to demand written authority re certain poisons C4.02 35 to require particulars re drugs from practitioners 1 11.03 65 to require production of Drugs Book .. : H6.06 63 to require production of Drugs Register i E4.06 46 Institution meaning of term 'AI 6 (See Hospital.)

Internal use, meaning of term IAI .. 6 Interpretation of terms I Sect 5. AI 177,5

Interstate prescriptions j H4 60

Itinerant distribution of poisons I 03,04 74 INDEX 219

SUBJECT REGULATION, ETC. PAGE

J Juveniles, sale of poisons to A9 17

K Keeping of cyanide .. C3.04, C3.06 34 drugs- by medical practitioner, veterinary surgeon and dentist I3,KI 65, 69 by pharmaceutical chemist HS,Kl .. .. 64,69 by wholesaler E3.04 (e), F3.04 (e), 45, 49, 69 Kl by wholesale representative F6.05 (a) 51 in hospital and institution J2,KI 66,69 generally Kl,OS 69,75 poisons .. CI,08 32, 75

L Label- ampoules, of B5 ,. 29 bulk packs, of B3.03 29 certain statements prohibited on B2.09 26 defacing or removing .. 011 .. 76 dispensed medicine, of BS 30 first aid measures on B7 30 general provisions re .. Sect 131I, B2 187, 23 immediate container, of B3 26 immedia[e wrapper, of B4 29 offences re . . . . Sect 13!I, B9 187,32 Schedule 3 poisons, of .. A7.06 15 selected container, of B5 29 sodium fluoride, of BIO 32 special warnings on B6 30 Laying of poison baits 010 75 Licence, meaning of term Sect 5 177 Licence re dangerous drugs- conditions of E3 45 holder and empl~yees .:~thori~~d D2.1J. 42 renewal of ...... E3.02 45 suspension and cancellation of E3.03 45 to manufacture .. El, Form T 44, 172 to sell by wholesale E2, Form R 44, 171 Licence re pmsons- conditions of Al5 19 employees autho~ised u~der Al4 .. 19 renewal of ...... Al5.01 19 suspension and cancellation of A15.02 20 to manufacture .. A!O, FormG 17, 164 to sell by wholesale AIO, FormG 17, 164 to sell for nonMtherape~tic use A13, FormK 19, 166 to sell for photographic purposes A12, Form I 19, 165 to sell in remote localities All, Form C 18, 162 Licence re restricted drugs- conditions of F3 48 holder and empl~yees a"u"thori;~d 02.13 42 renewal of F3.02 49 supply of sampl~; unde~, .. F4 .. 50 suspension and cancellation of F3.03 49 to manufacture .. F1, Form Z 48, 175 to sell by wholesale F2,Form W 48, 173 Local Authority- meaning of term Sect 5 177 laying of baits by 010 75 sale of poisons by AS 16 220 INDEX

SUBrncr REGULATION, ETC. I PAGE M Main Issue Book (Hospital and Institution) J3.01 66 Main label, meaning of term AI 6 Manufacture- meaning of term AI 6 of dangerous drugs licence to .. El, Form T 44, 172 records of .. E4 45 reports of ...... E5 .. .. 47 to be supervised by qualified person El, E3.04 (b) 44,45 of poisons, licence to ...... AIO, FormG 17, 164 of restricted drugs-licence to .. Fl, Form Z 48, 175 to be supervised by qualified person Fl, F3.04 (b) 48,49 Manufacturer- of dangerous drugs- deemed to be licensed wholesale seller . . . • E3.01 45 See also Wholesale Seller of Dangerous Drugs. licence as ...... El, Form T 44, 172 of restricted drugs- deemed to be licensed wholesale seller of restricted drugs and F3.01 (a) and (b) 48 poisons See also Wholesale Seller of Restricted Drugs. licence as .• Fl, FormZ 48, 175 Master of Ship- authorised re drugs . • . . D2.05 .. 41 written order to obtain drugs .. G!.OI, G!.02, G!.03 52, 53,56 (b), G4 Meanings of terms Sect 5, AI 177, 6 Measure pack B9 32 Medical detailer. See Wholesale Representative. Medical practitioner- meaning of term . . • • Sect 5 177 accounting for dangerous drugs by 11.03, N4 65,73 authorised re drugs .. D2.01 39 authorised re poisons . . . . • • . . A7.02 14 notification of patient treated with dangerous drug Ml .. 70 records re dangerous drugs to be kept by II .. 64 self-administration of dangerous drug M4 .. 71 storage of drugs by . . • . 13,KI 65, 69 treatment of drug addict by .. M2,M3 71 use of dangerous drug samples by 12 .. 65 verbal prescription by, in emergency H2.02 .. .. 59 written order to obtain drugs .. GI.Ol, Gl.02, Gl.03 52,53 (a) Medicines dispensed B8 30 Minor, sale of poison to A9 17 Mirex, restricted sale of C4.01 35

N National Health Act (Commonwealth), orders and prescriptions under G3.03, H5.01 (c) 56,61 New drug- meaning of term •• AI .. 7 application re scheduling A3.02, Form X 11, 173 to be restricted drug A3.01 11 Notice to correct breach P3 78 Notification of patient treated with dangerous drug Ml 70 Nurse authorised re drugs •. D2.12, J4.03 42, 68 INDEX 221

SUBJECT REGULATION, ETC. PAGE

0 Obstruction of inspectors or police Sect 131n, P4 187, 78 Offences- general provisions Ql 79 penalties for Q2 79 Official dose, meaning of term Sect 5 177 Opium, meaning of term Sect 5 177 Order. See Written order. Organo-phosphorus, restriction on packs C5 35 Ovulation stimulating drugs, subject to approval A6.01 12

Pack, measure B9 32 Packing- dangerous drug for delivery 02.03 55 food containers prohibited 09 75 general provisions Bl 21 offences re . . . . Bll .. 32 restricted drug for delivery 02.04 (b) 55 Paint- meaning of term .• Sect 5 177 finger, containing poison 07 75 generally, exempt A2.07 9 Paraquat preparations, emetic in C7 38 Part- meaning of term AI 7 division into 3 2 Pastels containing poison 07 75 Patient authorised re drugs Ll 70 Penalties for offences Q2, Sect 152 (I) 79, 189 (xxviii) Percent, per centum meaning of term AI 7 declaration in labels B2.07, B2.08 25 Pharmaceutical chemist- accounting for dangerous drugs by N4 .. 73 assistant authorised to sell poisons .. A7.06 .. 15 assistant may be authorised to dispense A7.05, D2.03 15,40 authorised re drugs .. D2.02 39 authorised re poisons . . . . A7.04 .. .. 15 employee of may deliver medicine . . . . A 7.01 (b), D2.03 (c) 14,40 endorsement and disposal of prescription by H5 61 endorsement and disposal of written order by 03 .. .. 56 records of dangerous drugs by H6, FormD 61, 163 (See also Drugs Book.) stock of dangerous drugs to be taken upon assuming management H6.05 63 storage of drugs by . . . . HS,KI 64,69 to be satisfied regarding prescription H3.01 59 to cancel invalid prescription .. H3.03 (b) 60 to retain suspect prescription .. H3.03 (a) 60 written order to obtain drugs .. 0 1.01, 0 1.02, 01.03 52, 53 (a) Pharmacist meaning of term Sect 5 177 records of declared drugs by HT 63 Pharmacy graduate or student authorised A7.05, D2.03 15,40 222 INDEX

------

SUBJECT REGULATION, ETC. PAGE

Poison- advertising of by unlicensed person 012 .. 76 applications re scheduling .. A4, Form X 11,173 authorities re . . . . A7,A8 14, 16 cereal baits to be coloured 05 74 hawking of . . . . 03 74 labelling of. (See Label.) licences to manufacture and sell AIO, All, A12, A13 17, 18, 19 packing of. (See Container.) prescribing without authority . . . . A7.01 14 purchase of certain subject to authority C4 .. 35 sale without authority . . . . A7.01 14 sales of certain to be recorded C2 33 samples of, distribution .. 04 74 samples of, removal by inspector P2.0i.(e), P2.. 02 77,78 seizure of P2.01 (f), P2.02 78 storage of .. C!,08 .. .. 32, 75 substances prescribed as A2.01, Schs I, 2, 3, 5, 8, 81, 83, 97, 6, 7 127, 135, 151 use and disposal of . . . . 010 .. 75 use of by school dental therapists .. A7.07 16 vaporisers and other devices employing 06 74 wholesale sel1er to issue invoice I A!0.07. .. 18 Police- obstruction of .. Sect 131B, P4 187, 78 powers of- re cyanide . . . . Sect 131, 131A 187 re dangerous drugs Sect 130, 130M 178, 184 re poisons and records PI .. 77 re prohibited plants ...... 02.18 43 search warrant to, re dangerous drug or cyanide Sect 131A 186 Prescribee, authorities and duties of, re drugs Ll 70 Prescription- meaning of term AI ...... 7 authorities to issue A7.02, A7.03, 02.01, 13, 14, 39, 40 D2.04 cancellation of invalid . . . . H3.03 (b) 60 conditions of dispensing upon .. H3 59 endorsement and disposal of by dispenser H5 .. 61 false or suspect, detention and seizure of H3.03 60 false representation concerning N2 72 forging, altering and uttedng .. Nl .. 72 forwarding to Director-General H3.03 (b), H5 60, 61 interstate . . . . H4 .. 60 invalid after six months H3.02 (e) 60 method of writing . . . . H2.01 58 necessary to dispense dangerous or restricted drug HI .. 57 not to be issued for certain drugs without approval A6 .. 12 unauthorised person not to issue I A7.0l,Dl 14, 39 under Commonwealth Acts H5.01 (c) 61 verbal in emergency I H2.02 59 Prescription Book, dispensing of declared drug to be recorded in H7 63 Primary pack- meaning of term AI 7 labelling of B3 26 Prohibited drugs A5 12 Prohibited plants declared OinC 190 Publishing advertisements for drugs and poisons 012 76

R Records concealment of .. P4 78 false entries in ...... N5 73 f0rm to be as required by Director-General K2 .. .. 69 removal and seizure of P2.01 (c) and (d) 77 re dangerous drugs- by medical practitioner, veterinary surgeon and dentist II . . . . 64 by pharmaceutical chemist. (See Drugs Book.) H6,FormD 61, 163 by wholesale seller ...... E4 .. 45 in hospital or institution . . . . Ji.02. J3 66 stock to agree with balance in .. N4.01 (c) 73 INDEX 223

SUBJECT REGULATION, ETC. PAGE

Records-continued re poisons- by retail seller .. C2 33 by wholesale seller AI0.07 18 re restricted drugs- by wholesale representative F6.05 51 by wholesale seller F5.01 50 Regulation, meaning of term AI 7 Removal- of books, etc. P2.01 (c) .. 77 of samples P2.01 (e), P2.02 77, 78 Repatriation Act, prescriptions under H5.01 (c) 61 Repeal of" The Poisons Regulations of 1967 " 2 Report on Movements of Drugs of Dependence E5 47 Responsible person, meaning of term AI 7 Restricted drug- accounting for, by wholesale representative F6.05 (f) and (g) 52 addiction to M2,M3 71 advertising of 012 .. 76 authorities re . . . . D2,Ll 39,70 conditions of dispensing H3 59 delivery of ...... G2.04 55 disclosure of facts concerning to practitioner N3 72 emergency supply of . . . . HI.02 57 false representations to obtain N2 72 intcrst~te prescription for H4 60 label. (See Label.) licence- to manufacture Fl, Form Z 48, 175 to sell by wholesale F2,Form W 48, 173 packing of, for delivery . . . . G2.04 (b) 55 possession, etc., by unauthorised person Dl 39 prescription necessary to dispense HI 57 records re- by wholesale representative F6.05 51 by wholesale seller ...... F5.01 50 form of, as required by Director-General K2 69 sale~ etc. by unauthorised person Dl .. 39 samples of, removal by inspector P2.01 (e), P2.02 77, 78 seizurt: of P2.01 (f), P2.02 78 storage of- dentist, by .. 13,KI.02 65, 69 generally . . . . K1.02,08 69,75 hospital or institution, in J2, KI.02 66,69 medical practitioner, by .. 13, KI.02 65, 69 pharmaceutical chemist, by H8,KI.02 64, 69 veterinary surgeon, by .. 13, KI.02 65, 69 wholesale representative, by F6.05 (a) .. 51 wholesale seller, by F3.04 (e), KI.02 49, 69 substances prescribed as A2.02, Sch 4 8,101 use and disposal of, generally 010 .. 75 use of by school dental therapists D2.16 43 written order for wholesale sale of Gl.Ol 52 Restrictions, re packs of organo-phosphorus, dimethanonaphthalene C5 35 Royal Flying Doctor Service authority re drugs . . . . D2.10 42 written order to obtain drugs .. GI.OI, GI.02, GI.03 52, 53 (f)

s Sale- meaning of term Sect 5 177 ~~~ 0 34 of dangerous drugs- authority required for D I 39 \Vholesale, licence for . . . . E2 44 wholesale, records and reports of ...... E4, E5 45,47 of Fluoroacetic Acid, Fluoroacetamide, Thallium, Chlordimeform C4.01 35 and Mirex l 224 INDEX

SUBmcr REGULATION, ETC. I PAGE

Sale-continued of poisons-- licence required for certain A7.01 .. 14 retail, licences for .. All, Al2, Al3 18, 19 retail, records of .. C2 .. 33 wholesale, licence for AIO .. 17 wholesale, records of AIO.Q7 18 of restricted drugs authority required for Dl 39 wholesale, licence for F2 .. 48 wholesale, records of F5.01 50 Salts of substance specified in Schedules A2.06 9 Samples- of dangerous drugs to be used in profession 12 . . . . 65 removal of by inspector P2.01 (e), P2.02 77, 78 Schedule- meaning of term . . . . A1 ...... 7 application to vary re substance A3.02,A4.01, Form X 11, 173 construction of ...... A2.06 9 effect of specifying substance in A2 ...... 8 exemptions from A2.02, A2.03, A2.04, 8, 9 A2.07 School dental therapists- use of poisons by .. A7.07 16 use of restricted drugs by D2.16 43 Search warrant re dangerous drug or cyanide Sect 131A 186 Secure place for storage of dangerous drugs KI.OI 69 Seizure of- books, etc. • • P2.01 (d) 77 drugs and poisons P2.01 (f), P2.02 78 Selected container- meaning of term .• A1 8 general requirements re Bl 21 labelling of BS 29 Self-administration of dangerous drug by authorised person M4 71 Service of Notice P3 78 Sheep dips, etc., containing arsenic C6 36 Ship- master authorised re drugs D2.05 41 supply of drugs to .. G4 .. .. 56 written order to obtain drugs for Gl.OI, Gl.02, Gl.03 52, 53 (b) Sodium Fluoride, label of .. BIO .. 32 Specified condition, prescribing certain drugs for A6.02 13 State analyst- meaning of term AI 8 authorised re drugs D2.14 43 Storage of- cyanide •• C3.04, C3.06 34 drugs- by medical practitioner, veterinary surgeon and dentist 13,KI 65,69 by pharmaceutical chemist H8,KI .. .. 64,69 by wholesaler E3.04 (e), F3.04 (e), 45, 49, 69 K1 by wholesale representative F6.05 (a) 51 in hospital and institution J2,K1 66, 69 generally KI,08 69,75 poisons .. CI,08 32, 75 Strychnine- authority to purchase, etc. C8, FormBI 38, 162 purchased outside state C8.05 38 sale of without authority C8.06 38 storage of C8.09 39 Student in pharmacy authorised A7.05, D2.03 16,40 INDEX 225

SUBJECT REGULATION, ETC. PAGE

Substance, effect of specifying in a Schedule A2 8 Sugar cane Pest and Disease Control Board, sale of poisons by A8.01 16 Suspension and cancellation- of authority re drugs .. D3 43 of licence. (See Licence.)

T Thallium, restricted sale of .. C4.01 35 The Act, meaning of term .. AI 8 Therapeutic use, meaning of term .. AI 8 Transaction- meaning of term ..· .• AI 8 in dangerous drug to be recorded- by medical practitioner, veterinary surgeon and dentist II . . . . 64 by pharmaceutical chemist. (See Drugs Book.) H6, FormD 61, 163 by manufacturer or wholesale seller .. E4 .. 45 in hospital and institution ...... Jl.02, J3 66 in dangerous drug to be reported by wholesaler . . . . E5 47 in declared drug to be recorded by pharmaceutical chemist H7 63 in restricted drug to be recorded- by wholesale seller .. F5.01 50 by wholesale representative F6.05 51 Transport of drugs, carriers authorised D2.09 42 Treatment with dangerous drugs, notification of Ml .. 70 Treatment of drug addict M2,M3 71

u University- authority re drugs .. D2.06 .. .. 41 written order to obtain drugs .. 01.01, 01.02, 01.03 52,53 (c) Uttering prescriptions Nl 72

v Vapo

SUBJECT REGULATJON, ETC. PAGE

I w ! Ward Drugs Book (Hospital and Institution) J3.01 I 66 Wholesale- meaning of term AI 8 licence to sell by- i dangerous drugs E2, Form R I 44, 171 poisons .. AIO, Form G 17, 164 restricted drugs F2, Form W 48, 173 Wholesale representative authority re restricted drugs D2.13 (e), F6, Form P 43, 51, 169 duties of re restricted drugs F6.05 51 Wholesale Seller of Dangerous Drugs- delivery of dangerous drugs by . . . . G2 54 endorsement and disposal of written orders by G3 56 licence as . . . . E2, Form R 44, 171 manufacturer deemed to be E3.01 45 records of transactions E4 45 reports of transactions E5 47 storage of dangerous drugs .. E3.04 (e), KI.OI 45,69 to operate on licensed premises only E3.04 (a) 45 to sell to authorised persons only .. E3.04 (d) 45 written orders for drugs bought and sold GI,G2 52, 54 Wholesale Seller of Poisons licence as .. AIO, Form G 17, 164 limited sales by .. AI0.04, A10.06 17, 18 records to be kept by .. A10.07 18 Wholesale Seller of Restricted Drugs- deemed to be licensed to sell poisons by wholesale F3.01 (b) 49 delivery of restricted drugs by . . . . G2 54 endorsement and disposal of written orders by G3 56 licence as .. F2, Form W 48, 173 manufacturer deemed to be F3.01 (a) 48 records of sales .. F5.01 50 representatives employed by F5.02, F6 50, 51 storage of restricted drugs F3.04 (e). K1.02 49,69 supply of samples by . . . . F4 50 to operate on licensed premises only F3.04 (a) 49 to sell to authorised persons only .. F3.04 (d) 49 written orders for drugs bought and sold Gl 52 Written order for drugs- content of ...... GI.02 52 endorsement and disposal of by seller G3 56 method of signing G1.03 53 purchaser required to give Gl.OI 52 when to be obtained G2.01 (b), di.02 (b). 54

------·-~------

55819-By Authority: S. R. HAMPSON, Government Printer, Queensland

D-078